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Abstract 
 
Metal-catalyzed cyclopropanation of olefins with diazo reagents is one of the most 
general and efficient methods to prepare cyclopropanes. The resulting cyclopropyl units are 
found as a basic structural element in a wide range of naturally occurring compounds and 
biologically active compounds, and can serve as versatile synthetic intermediates in the synthesis 
of multi-functionalized cycloalkanes and acyclic compounds. Since Co(II) complexes of D2-
symmetric chiral amidoporphyrins [Co(D2-Por*)] were first introduced in 2004, Co(II)-
metalloradical catalysis (MRC) have emerged as a new platform for asymmetric 
cyclopropanation. These metalloradical catalysts have been shown to be highly effective for 
asymmetric intermolecular cyclopropanation of a broad scope of substrates with different diazo 
reagents, with excellent diastereoselectivity and enantioselectivity.  
This dissertation aims to develop new Co(II)-MRC based enantioselective 
cyclopropanation systems. It will elaborate on three types of stereoselective cyclopropanation 
reactions from olefins: radical cyclopropanation with α-halodiazoacetates, asymmetric 
bicyclization of diazoketones, and radical cyclopropanation with fluoroaryl diazomethanes. 
These three processes will be examined in the context of diastereo- and enantiocontrol. And also, 
the application of cyclopropanation products have been demonstrated, which could potentially 
lead to more exciting works.  
 
 
 
- 1 - 
 
 
 
 
 
Chapter 1 
Recent Developments of Transition Metal Catalysts for Enantioselective 
Cyclopropanation Reaction 
1.1. Introduction 
The cyclopropane subunit has attracted considerable attention because of its unique 
reactivities and structural properties. It widely existed in numerous naturally occurring 
compounds, such as Solandelactone E, (+)-Curacin A and (+)-Ambruticin. In addition, it has also 
been proved to be a structural motif in many pharmaceuticals, including Caliastatin, 
Trovafloxacin and Singulair.
1
 The high ring strain and unique electronic properties make 
cyclopropanes very active, undergoing cyclopropane ring-extension and ring-opening reactions 
to form large ring or linear compounds.
2
 In order to prepare enantiopure cyclopropanes, 
transition metal catalyzed cyclopropanation of olefins with diazo compounds represents one of 
the most general and efficient methods. Many catalytic systems have been developed to achieve 
this transformation, and a variety of transition metals have been employed, including Rh, Ru, Cu 
and Co.
3
 This chapter provides an overview of the most important developments of this approach 
over the past two decades, with an emphasis on enantioselective processes.   
1.2. Different Types of Diazo Reagents Involved in Cyclopropanation  
Huw Davies classified carbenoid intermediates into different groups according to the 
carbenoid functionality: acceptor, acceptor/acceptor, and donor/acceptor, donor (Figure 1.1).
4  
 
Figure 1.1. Classification of Diazo Reagents. 
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With pre-functionalized diazo reagents, transition-metal catalyzed cyclopropanation allows for 
direct synthesis of enantiopure cyclopropane derivatives bearing varied functional groups. 
However, many types of diazo reagents have shown low compatibility in many catalytic systems, 
leading to low asymmetric induction.  
1.2.1 Acceptor Diazo Reagents  
The earliest and most exhaustively studied diazo reagents for intermolecular 
cyclopropanation reactions are the α-diazoesters, including some commercial ones, such as t-
BDA, EDA with great success. 
3
 For example, in 1998, Fu and coworkers reported a new class of 
readily available planar-chiral bisazaferrocenes (Figure 1.2), which was used in the Cu-catalyzed 
cyclopropanation of various alkenes with 2,6-di-tert-butyl-4-methylphenyl (BHT) diazoacetate, 
yielding excellent diastereoselectivity and enantioselectivity (up to 99:1 dr and 96% ee).
5
 The 
acceptor diazo reagent was also successfully extended to other acceptor diazo reagents, α-
diazosulfones.
6
  
 
Figure 1.2. Cu-Bisazaferrocene Catalyzed Cyclopropanation. 
1.2.2 Acceptor/Acceptor Diazo Reagents  
Acceptor/acceptor diazo reagents are substantially less reactive than acceptor diazo 
reagents. Activation of the relatively stable acceptor/acceptor diazo reagents, including α-nitro-
diazoacetates and α-cyanodiazoacetates, is a long-standing problem faced by using Cu and Rh 
catalysts. For example, copper catalysts with bis(oxazoline) ligands were used for 
- 3 - 
 
enantioselective cyclopropanation of styrene with nitro diazo carbonyl compounds and found to 
give higher enantioselection, with e.e. up to 72% for the major diastereoisomer and yields up to 
55% ( Figure 1.3).
7
 This represented the best result until 2008 when the Zhang group reported a 
Co(II) porphyrin system for carbene transfer cyclopropanation.
8
 Excellent yields and high 
diastereo- and enantioselectivities were achieved for most of the cyclopropanated products using 
α-nitro-diazoacetates in the Co(II)-Porphyrin system (Figure 1.4). In 2009, Charette reported the 
Rh(II)-catalyzed cyclopropanation of α-nitro diazoacetophenones with olefins, affording nitro-
substituted cyclopropanes in good yields and excellent enantio- and diastereocontrol ( Figure 
1.5).
9
   
 
Figure 1.3. Cu Catalyzed Cyclopropanation of Styrene with α-Nitrodiazoacetates. 
 
Figure 1.4. Cobalt (II)-Porphyrin Catalyzed Asymmetric Cyclopropanation of Alkenes with α-
Nitrodiazoacetates. 
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Figure 1.5. Rhodium-catalyzed Cyclopropanation of Alkenes Using α-Nitro Diazoacetophenones. 
The intramolecular cyclopropanation of alkenes via the transition-metal-catalyzed decomposition 
of diazo derivatives is a simple and convenient method to generate synthetically versatile 
[n.1.0]bicycloalkanes. In 2005, Charette et al. demonstrated that the Rh-catalyzed intramolecular 
cyclopropanation of 3-substituted-2-propenyl cyanodiazoacetates occurred cleanly to form the 
corresponding cyclopropane derivatives in high yields. The highest enantioselectivity of 91% ee 
with a 57% yield was observed when using Rh2[(4S)-FBNAZ]4 as the chiral catalyst. The 
enantiocontrol of the catalytic system was strongly influenced by steric and electronic factors 
arising from substituents on the alkenes, ranging from 29 to 91% ee (Figure 1.6).
10
 
 
Figure 1.6. Rhodium-catalyzed Asymmetric Intramolecular Cyclopropanation of Allylic 
Cyanodiazoacetates.  
Zhang et al reported that the Co(II) complex of 3,5-Di
t
Bu-QingPhyrin was a general and 
effective catalyst for asymmetric intramolecular cyclopropanation of various allylic 
diazoacetates (especially including those with α-acceptor substituents), affording an array of 
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enantioenriched 3-oxabicyclo[3.1.0]hexan-2-one derivatives bearing three contiguous 
stereocenters with multiple functionalities in high yields (Figure 1.7).
11
  
 
Figure 1.7. Asymmetric Intramolecular Cyclopropanation of Acceptor-substituted Diazoacetates 
by Co(II)-Based Metalloradical Catalysis.  
Intramolecular cyclopropanation reactions of olefin-containing diazoketones was also 
explored. Nakada et al. have reported highly enantioselective Cu-catalyzed intramolecular 
cyclopropanation of a range of α-diazo-β-keto sulfones. As shown in Figure 1.8, up to 98% ee  
was obtained for  the products.
12
  
 
Figure 1.8. Asymmetric Intramolecular Cyclopropanation of α-Diazo-β-Keto Sulfones.  
1.2.3 Donor/Acceptor Diazo Reagents 
Davies et al have shown that dirhodium complexes are effective catalysts for the 
decomposition of vinyl- and aryl-substituted diazoacetates in the presence of alkenes. The 
corresponding cycloadducts were obtained in up to 97% ee, as shown in Figure 1.9.
13
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Figure 1.9. Asymmetric Rhodium (II)-catalyzed Cyclopropanations of Alkenes with 
Vinyldiazomethanes. 
1.2.4 Donor Diazo Reagents 
At this time, donor type diazo reagents have not been used for asymmetric 
cyclopropanation reactions.  
1.3. The Catalytic Mechanism 
There are two generally accepted mechanisms for cyclopropanation using transition metal 
catalyzed carbene transfer reactions: i. concerted mechanism; ii. stepwise radical addition 
mechanism. Due to the distinct characteristics of different transition metals, their mechanisms 
are different.   
 
Figure 1.10. Concerted Mechanism.  
The concerted mechanism (Figure 1.10)
3b
 involves the formation of a metal carbene complex, 
followed by attack of the alkene in a side-on approach. Final ring closure to generate the 
- 7 - 
 
cyclopropane product occurs in a concerted manner. This mechanism was usually applied to 
copper, rhodium and ruthenium, whose carbene complexes are known as Fischer-type carbenes 
and are very electrophilic, exhitbing a pronounced reactivity toward electron-rich alkenes.  
 
Figure 1.11 Stepwise Radical Mechanism. 
The stepwise radical addition mechanism (Figure 1.11)
14
 was proposed by the Zhang’s 
group for the cobalt porphyrin catalyzed cyclopropanation. The mechanism involves the 
formation of an α-Co(III)-alkyl radical A, followed by radical addition to an alkene, affording a 
new carbene-based free carbon radical B. The final step of ring closure generates the desired 
cyclopropane product. The mechanism of this reaction was approved by EPR and ESI-MS. 
Experimentental evidence was obtained for the existence of cobalt(III) carbene radicals. In fact, 
in the absence of the alkene substrate, the ‘terminal carbene’ resulting from diazoacetate was 
found to undergo dimerization to furnish a binuclear cobalt(III)–porphyrin complex, which was 
characterized by X-ray analysis.  
1.4. Summary    
Metal-catalyzed inter- and intramolecular cyclopropanation reactions have progressed 
significantly in the last two decades and have proved to be very useful transformations for the 
- 8 - 
 
construction of complex cyclopropane-containing systems. However, this area still needs further 
research, especially to expand the scope of diazo reagents and alkenes.  
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Chapter 2 
Co(II)-Based Metalloradical Catalysis for Asymmetric Radical Olefin Cyclopropanation 
with α-Halodiazoacetates: Enantioselective Synthesis of α-Halocyclopropylcarboxylates  
  
2.1. Introduction  
Cobalt(II)-based metalloradical catalysis (MRC) has been demonstrated to operate a new 
type of cyclopropanation reactions through stereoselective radical pathways.
1
 The Co(II) 
complexes of porphyrins activate diazo reagents to form a new class of α-Co(III)-alkyl radicals, 
which are able to undergo radical  reactions with reactivity and selectivity controlled by the 
metal center and porphyrin ligands.
2
 With D2-symmetric chiral amidoporphyrin ligands, the 
reactivity and stereocontrol of the radical cyclopropanation are likely to be further enhanced by 
potential hydrogen bonding interactions between the amido group of the porphyrin ligand and 
the diazo moiety in the Co(III)-alkyl radical species. While Co(II)-based radical 
cyclopropanation has been shown exceptionally effective for the activation of a variety of widely 
used diazo compounds, including different acceptor
1e,1f,1h-j
 and acceptor/acceptor-substituted 
diazo reagents,
1a-d,1g,1k
 α-halodiazoacetates3 are a special type of potential radical precursors that 
have not been explored for radical cyclopropanation (Scheme 1). Through the radical transfer 
from Co(II) metalloradical to the α-carbon of the diazo, a hypothesized α-halogenated Co(III)-
alkyl radical A would be formed and stabilized by potential double hydrogen bonding 
interactions involving the halogen atom as an acceptor.
4
 The resulting stereoselective 
cyclopropanation would be highly attractive as it provides direct construction of optically active 
halocyclopropanes, which not only serve as key elements in natural products
5
 and 
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pharmaceuticals,
6
 but also would be transformed to other multi-functionalized cyclopropanes 
cyclopropanes based on the rich chemistry of carbon halogen bonds.
7
 
 
Figure 2.1. Radical Cyclopropanation with α-Halodiazoacetates via Cobalt(II)-Based 
Metalloradical catalysis (MRC). 
While various efforts have been made to the synthesis of chiral halocyclopropanes,
8
 
enantioselective cyclopropanation with α-halodiazoacetates still remains particularly challenging 
although the racemic process was demonstrated as one of the most direct syntheses for 
halocyclopropanes.
3a
 None of the existing Rh2-catalyzed metallocarbene cyclopropanation 
reactions has shown significant asymmetric induction and the attempts only led to no more than 
15% enantiomeric excesses for the halocyclopropanes.
9
 To address the challenging 
stereoselectivity issue, we embarked on a project to investigate whether Co(II)-based MRC is 
able to activate α-halodiazo reagents and operate asymmetric cyclopropanation reactions. Herein, 
we present the first highly diastereo- and enantioselective cyclopropanation with α-
halodiazoacetates, including both chlorine and bromine atoms. With the Co(II)-metalloradical 
catalyst, olefin substrates with a wide range of electronic properties and functional groups can be 
- 12 - 
 
transformed to optically active α-halocyclopropylcarboxylates. In contrast to metallocarbene 
cyclopropanation systems,
10
 this radical cyclopropanation is operated in a one-time protocol 
without slow addition of diazo reagents, and alkenes are only required as limiting reagents. 
Moreover, the enantioenriched α-halocyclopropylcarboxylates were shown to be readily 
converted to diversely functionalized cyclopropane derivatives that are challenging for direct 
cyclopropanation processes while retaining high optical purity.  
2.2. Results and Discussion  
2.2.1. Reaction Condition Optimization 
We started to explore this Co(II)-MRC process with t-butyl α-bromodiazoacetate (2a) as 
the potential α-Co(III)-alkyl radical precursor, with styrene as the model substrate (Table 1). 
Although the non-catalytic cyclopropanation was observed as the background reaction that 
produces the racemic cyclopropane 3aa (entry 1), chiral cobalt(II) complex of 3,5-Di
t
Bu-
ChenPhyrin, [Co(P1)], was able to show a competitive catalytic process, as demonstrated by a 
productive and enantioselective formation of 3aa (69% yield, 92:8 dr, 79% ee, entry 2). To 
further suppress the background cyclopropanation, increased catalyst loading was adopted to 
accelerate the radical cyclopropanation, and the resulting stereoselectivities were observed to be 
evaluated (entry 3 and 4). The employment of 5 mol % catalyst enabled formation of 3aa in 93% 
yield with 96:4 dr and 94% ee, which indicated a high level of asymmetric induction of the 
metalloradical catalyst [Co(P1)], as well as a satisfying degree of the relative suppression of the 
background non-catalytic cyclopropanation. Furthermore, α-bromodiazoacetates with different 
steric bulkiness may also be able to undergo enantioselective cyclopropanation with [Co(P1)], as 
demonstrated by the reaction with ethyl α-bromodiazoacetate (2c) (entry 5). In addition to α-
bromodiazoacetates, tert-butyl α-chlorodiazoacetate (2b) was shown to be an equally effective 
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radical precursor for the asymmetric cyclopropanation, producing α-
chlorocyclopropylcarboxylate 3ab in 98% yield with >99:1 dr and 92% ee (entry 6). 
Table 2.1 Enantioselective Radical Cyclopropanation of Styrene with α-Halodiazoacetates 
by [Co(P1)].
a
 
 
a 
Carried out initially at 0 ℃ then gradually warmed up to room temperature during the period of 
3 h in a one-time protocol under N2 with [olefin] = 0.20 M. 
b
 Isolated yields after column 
chromatography. 
c 
Determined by 
1
H NMR spectroscopy of the crude mixture. 
d 
Determined by 
chiral HPLC after derivatization. 
2.2.2. Substrate Scope  
With the optimized conditions, we next explored the scope of alkene substrates for this 
enantioselective radical cyclopropanation, with both α-bromo- and α-chlorodiazoacetates as  
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Table 2.2. [Co(P1)]-Catalyzed Enantioselective Radical Cyclopropanation of Alkenes with 
α-Halodiazoacetates.a 
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a 
Carried out on a 0.2 mmol scale of alkenes initially at 0 ℃ then gradually warmed up to room 
temperature during the period of 3 h in a one-time protocol using 5 mol % [Co(P1)] under N2 
with [olefin] = 0.20 M; isolated yields after column chromatography; diastereomeric ratio 
determined by 1H NMR spectroscopy of the crude mixture; ee determined by chiral HPLC. 
b
 The 
products were synthesized on 2.5 mmol scale. 
c
 Determined by chiral HPLC after derivatization. 
d
 [1S,2S] Absolute configuration determined by X-ray crystal structural analysis. 
e
 0.5 Equiv of 
4-dimethylaminopyridine was added. 
f Ethyl α-chlorodiazoacete was used as the radical 
precursor. The catalytic reactions were carried out at 40 ℃ for 3 h.  
 
radical precursors (Table 2). For example, meta-methyl substituted styrene and 2-
vinylnaphthalene could be cyclopropanated by giving the corresponding products 3ba, 3bb, 3ca 
and 3cb in high yields with up to >99:1 diastereomeric ratio and 96% ee (entries 3–6). Electronic 
properties are observed to be less sensitive in these radical processes. Styrenes with both 
electron-withdrawing groups such as CF3 (entries 7, 8) and electron-donating substituents such 
as MeO (entries 9, 10) appeared to be suitable substrates and led to cyclopropanes 3da, 3db, 3ea 
and 3eb in high yields with excellent stereocontrol. Moreover, the radical process can be applied 
for cyclopropanation of α,α-disubstituted olefins, affording high yielding cyclopropanes with 
excellent diastereoselection and asymmetric induction (entries 11–14). As an attractive feature, 
the radical cyclopropanation is capable of tolerating various functional groups. For example, 
styrene with unprotected aldehyde group has been smoothly converted to chiral cyclopropane 3ib 
with excellent diastereo- and enantiocontrol (entry 15). Heterocyclic olefins and conjugated 
olefins were also cyclopropanated with high stereocontrol, as exemplified by chiral 
cyclopropanes bearing indole (entry 16) and vinyl groups (entries 17, 18) as additional 
functionalities.  
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The broad substrate scope of the Co(II)-based radical process was further highlighted by 
the successful application for varied non-aromatic olefins, especially electron-poor alkenes. For 
instance, both ethyl vinyl ketone and N,N-dimethyl acrylamide were shown to be asymmetrically 
converted to the corresponding cyclopropyl ketone and cyclopropyl amide 3lb and 3mb, 
respectively (entry 19, 20). By using ethyl α-chlorodiazoacetate as the radical precursor, N-
vinylphthalimide was also successfully cyclopropanated in 88% yield and with good 
stereoselectivity (entries 21). To illustrate the preparative utility of this new Co(II)-MRC, several 
halocyclopropanes, including 3aa, 3ab, 3fa and 3fb, were prepared on a 2.5 mmol scale without 
any diminishment in reactivity and stereocontrol (entries 1, 2, 11 and 12). Among the chiral α-
halocyclopropylcarboxylates, the absolute configurations of the two contiguous stereogenic 
centers in the major enantiomers of 3ab, 3da and 3ga were established as (1S,2S) by X-ray 
crystal structure analysis. 
2.2.3. Further Transformations 
The enantioenriched α-halocyclopropylcarboxylates are potentially versatile chiral 
synthons that can be converted to other α-halocyclopropanes without touching the halogen 
substituents. As demonstrated with 13 reduction reactions (eq 1), α-halocyclopropylcarboxylates 
were shown to be readily reduced to the synthetically useful (1-halocyclopropyl)methanols (4) 
without affecting other functionalities or losing optical purity (See supporting information for 
more details).
11
 Moreover, halocyclopropane 3ab could be readily converted to α-
chlorocyclopropanamide 5 in good yield with unchanged stereoselectivity (eq 2, [1S,2S] absolute 
configuration of 5 was confirmed by X-ray analysis). It is worth to note that both types of 
halocyclopropanes (4 and 5) are not likely to be formed by direct catalytic cyclopropanation as 
the corresponding diazo reagents are unknown to be accessible.  
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More broadly, the halocyclopropanes can be converted to many other densely-
functionalized cyclopropanes through the facile transformations of halogen atoms. First, a 
diastereoselective SmI2-promoted Reformatsky-type reaction was investigated for the production 
of cyclopropyl alcohol 6 (Scheme 2).
7c
 As demonstrated with the enantioenriched 6a and 6b, all-
carbon quaternary chiral centers were formed by the radical addition to ketones with complete  
 
Figure 2.2. Synthesis of Enantioenriched α-Halocyclopropyl Alcohols and Amides. 
 
diastereocontrol. Second, a reduction-elimination strategy allowed for the transformation of 3ga 
into enantioenriched methylenecyclopropane derivative 8 (Scheme 3),
12
 which represents a 
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special class of cyclopropanes that are highly useful in organic synthesis.
13
 Furthermore, 
enantioenriched  tetrasubstituted cyclopropane 10 was synthesized through one-pot elimination-
addition reactions developed by Rubin
8d
 (Scheme 4). With the α-halocyclopropylamide 9 formed 
by amidation of 3fb, a base-promoted elimination reaction was able to remove the chloride and 
form a cyclopropene intermediate. A sequential diastereoselective addition of benzyl alcohol 
afforded enantioenriched cyclopropane 10 with 96:4 diastereomeric ratio and 91% ee in 45% 
yield over 4 steps. The absolute configuration of cyclopropane 10 was determined to be 
(1R,2R,3S). This method provided an alternative approach to access densely substituted 
cyclopropanes that are challenging for current asymmetric cyclopropanation systems.    
 
Figure 2.3. SmI2-Promoted Reformatsky-Type Reactions of Chlorocyclopropane 3ab with 
Ketones. 
 
Figure 2.4. Diastereoselective Construction of Chiral Methylenecyclopropane Derivative from 
Bromocyclopropane 3ga. 
 
Figure 2.5 Synthesis of Chiral Tetrasubstituted Cyclopropane Derivative through 
Diastereoselective Nucleophilic Addition from Chlorocyclopropane 3fb.   
2.3 Experiment Section  
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General Considerations.  
 
All reactions were carried out under a nitrogen atmosphere in oven-dried glassware 
following standard Schlenk techniques. Chlorobenzene (Anhydrous, ≥99%) was used directly 
from Sigma-Aldrich Chemical Co. Dichloromethane was freshly distilled/degassed prior to use. 
Thin layer chromatography was performed on Merck TLC plates (silica gel 60 F254) visualizing 
with UV-light 254 nm or 365 nm fluorescence quenching, and ceriumammonium-molybdate 
(CAM) stain (ammonium pentamolybdate, cerium(IV) sulfate,sulfuric acid aqueous solution). 
Flash column chromatography was performed with ICN silica gel (60 Å, 230-400 mesh, 32-63 
μm). Nuclear magnetic resonance spectra were recorded on a Bruker a Bruker 500-MHz, 400-
MHz or 250-MHz instrument. Chemical shifts for protons are reported in parts per million 
downfield from tetramethylsilane and are referenced to residual protium in the NMR solvent 
(CHCl3 = 7.26 ppm). Chemical shifts for carbon are reported in parts per million downfield from 
tetramethylsilane and are referenced to the carbon resonances of the solvent residual peak 
(CDCl3 = 77.16 ppm). 
19
F spectra were recorded on a Bruker 400 spectrometer (376 MHz), 
using CFCl3 (δ=0) as internal standard. HPLC measurements were carried out on a Shimadzu 
HPLC system with Whelk-O1, Chiralcel OD-H, OJ-H, AS-H and AD-H columns. Infrared 
spectra were measured with a Nicolet Avatar 320 spectrometer with a Smart Miracle accessory. 
HRMS data was obtained on an Agilent 1100 LC/MS ESI/TOF mass spectrometer with 
electrospray ionization. Optical rotations were measured on a Rudolph Research Analytical 
AUTOPOL® IV digital polarimeter. The X-ray diffraction data were collected using Bruker-
AXS SMART-APEXII CCD diffractometer (CuKα, λ = 1.54178 Å).  
Catalyst Synthesis:  
 
[Co(P1)]  were synthesized according to our previous reported procedure.
1j
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The crystal structure of P1 is as following:  
 
Figure 2.6. Single-Crystal X-ray Structure of 3, 5-Di
t
Bu-ChenPhyrin. 
Synthesis of Diazo Reagents: 
 
Procedure for the preparation of the tert-butyl 2-bromo-2-diazoacetate (2a):
2
 N-
Bromosuccinimide (56.8 mg, 0.32 mmol, 1.6 equiv.) was added in two portions to a 0 °C stirring 
solution of tert-butyl 2-diazoacetate (28.4 mg, 0.2 mmol) in dichloromethane (1 mL) under the 
shielding of light. A solution of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 43 mg, 0.28 mmol, 
1.4 equiv.) in 1 mL  of dichloromethane was added dropwise over a period of 30 seconds. The 
mixture was stirred at 0 °C for 1 more minutes and TLC showed the reaction was complete. 
Then a solution of Na2S2O3 in water (2 mL, 20 % m/v) was added. The organic layer was passed 
through a fast chromatographic column with Na2SO4 on top of the silica gel using 
dichloromethane as eluent. A 100 mL flask containing 1.4 mL chlorobenzene was used as the 
receiver and kept in ice bath. The flask was wrapped with aluminum foil and evaporated on 
Rotavapor (do not immerse the round flask in water). Dichloromethane needed to be completely 
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removed before being added into the Schlenk tube. All the procedure were running under the 
shielding of light. In order to avoid potential explosion of diazo reagents in pure form, the diazo 
reagents were diluted in chlorobenzene. 
1
H-NMR spectra of diazo reagent 2a was collected in 
the presence of chlorobenzene, in some case, trace amount of dichloromethane was remained 
there. 
1
H NMR (500 MHz, CDCl3): δ 1.53 (s, 9H). 
13
C NMR (125 MHz, CDCl3): δ 162.1, 83.8, 
28.3.    
 
 
Procedure for the preparation of the tert-butyl 2-chloro-2-diazoacetate (2b):
3a 
N-
Chlorosuccinimide (66.5 mg, 0.50 mmol, 2.5 equiv.) was added in two portions to a 0 °C stirring 
solution of tert-butyl 2-diazoacetate (28.4 mg, 0.2 mmol) in dichloromethane (1 mL) under the 
shielding of light. A solution of 1, 8-diazabicyclo[5.4.0]undec-7-ene (DBU, 43 mg, 0.28 mmol, 
1.4 equiv.) in 1 mL dichloromethane was added dropwise over a period of 30 seconds. The 
mixture was stirred at 0 °C for 5 more minutes and TLC showed the reaction was complete. 
Then a solution of Na2S2O3 in water (2 mL, 20 % m/v) was added. The organic layer was passed 
through a fast chromatographic column with Na2SO4 on top of the silica gel using 
dichloromethane as eluent. A 100 mL flask containing 1.4 mL chlorobenzene was used as the 
receiver and kept in ice bath. The flask was wrapped with aluminum foil and evaporated on 
Rotavapor (do not immerse the round flask in water). Dichloromethane needed to be completely 
removed before being added into the Schlenk tube. All the procedure were running under the 
shielding of light. In order to avoid potential explosion of diazo reagents in pure form, the diazo 
reagents were diluted in chlorobenzene. 
1
H-NMR spectra of diazo reagent 2b was collected in 
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the presence of chlorobenzene, in some case, trace amount of dichloromethane was remained 
there. 
1
H NMR (500 MHz, CDCl3): δ 1.64(s, 9H). 
13
C NMR (125 MHz, CDCl3): δ 161.9, 83.6, 
28.1.   
 
ethyl 2-bromo-2-diazoacetate (2c): 2c was prepared as the same procedure as 2a. Ethyl 2-
diazoacetate was used as the precursor to prepare ethyl 2-bromo-2-diazoacetate. In order to avoid 
potential explosion of diazo reagents in pure form, the diazo reagents were diluted in 
chlorobenzene. 
1
H-NMR spectra of diazo reagent 2c was collected in the presence of 
chlorobenzene, in some case, trace amount of dichloromethane was remained there. 
1
H NMR 
(500 MHz, CDCl3): δ 
1
H NMR (500 MHz, CDCl3): δ 4.30 (q, J = 7.1 Hz, 2H), 1.31 (t, J = 7.2 Hz, 
3H). 
13
C NMR (125 MHz, CDCl3): δ 163.1, 62.7, 14.5.   
 
ethyl 2-chloro-2-diazoacetate (2d): 2d was prepared as same procedure as 2b.  Ethyl 2-
diazoacetate was used as the precursor to prepare ethyl 2-chloro-2-diazoacetate. In order to avoid 
potential explosion of diazo reagents in pure form, the diazo reagents were diluted in 
chlorobenzene. 
1
H-NMR spectra of diazo reagent 2d was collected in the presence of 
chlorobenzene, in some case, trace amount of dichloromethane was remained there. 
1
H NMR 
(500 MHz, CDCl3): δ 4.30 (q, J = 7.1 Hz, 2H), 1.30 (t, J = 7.1 Hz, 3H). 
13
C NMR (101 MHz, 
CDCl3): δ 163.1, 62.5, 14.5.   
- 23 - 
 
General Procedure for Cyclopropanation Reactions:  
 
 Catalyst (5 mol %) was placed in an oven-dried, resealable Schlenk tube (in some cases 
0.5 equivalent of 4-dimehtylaminopyridine was added as noted). The tube was capped with a 
Teflon screwcap, evacuated, and backfilled with nitrogen. The screwcap was replaced with a 
rubber septum, and 1.0 equiv. of alkene (0.2 mmol) in 0.65 mL chlorobenzene was added via 
syringe, after cooled to 0 ℃, followed by 2.0 equivalents of diazo compound (0.40 mmol) and 
the remaining solvent (0.3 mL). The tube was wrapped with alumina foil, purged with nitrogen 
for 1 min and its contents were stirred at 0 ℃ to room temperature. After 3 h, the reaction 
mixture was concentrated under reduced pressure to give the crude reaction mixture for the d.r. 
value determination, and was additionally purified by silica gel column to give desired products. 
In most cases, the products were visualized on TLC using the cerium ammonium molybdate 
(CAM) stain.  
Reduction of Halocyclopropylcarboxylates to Halocyclopropyl Methanol:  
 
 A 100 mL oven dried round flask was charged with 30 mL dichloromethane (freshly 
distilled over CaH2) and α-halocyclopropylcarboxylates (0.2 mmol, 1 equiv.) under nitrogen 
atmosphere. diisobutylaluminum hydride (DIBAL-H) (0.8 mmol, 4 equiv.) was added dropwise 
to the flask at 0 ℃ over 10 minutes and the  reaction was carried out at room temperature for 4 h. 
After TLC showed all starting material was gone, the reaction was quenched with 20 mL 
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saturated potassium sodium tartrate tetrahydrate aqueous solution. The mixture was transferred 
to a separation funnel and let it stayed until clear layers formed. Separate bottom layers and 
repeat washing for 2 more times with saturated potassium sodium tartrate tetrahydrate aqueous 
solution. The combined organic layer was dried with Na2SO4, concentrated under reduced 
pressure to give the crude reaction mixture for the d.r. value determination. It was additionally 
purified by silica gel column to give desired products. In most cases, the products were 
visualized on TLC using the cerium ammonium molybdate (CAM) stain. The results are 
summarized.  
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tert-butyl 1-bromo-2-phenylcyclopropanecarboxylate (3aa): 93% yield, 96:4 dr. Rf = 0.5 
(hexanes/ethyl acetate 15:1). 
1
H NMR (500 MHz, CDCl3): δ 7.38 – 7.27 (m, 3H), 7.23 (d, J = 7.3 
Hz, 2H), 2.88 (t, J = 9.3 Hz, 1H), 2.13 (dd, J = 10.1, 6.0 Hz, 1H), 1.74 (dd, J = 8.4, 6.1 Hz, 1H), 
1.51 (s, 9H). 
13
C NMR(125 MHz, CDCl3) : δ 168.8, 136.1, 129.6, 128.2, 127.6, 83.1, 36.9, 32.9, 
28.0, 23.7. HRMS (ESI) ([M+Na]
+) Calc’d. for C14H17BrNaO2: 319.0304; Found 319.0313. IR 
(neat, cm
-1
): 2978, 2928, 1709, 1604, 1498, 1454, 1393, 1368, 1292, 1274, 1083, 1052, 964, 839, 
755, 694, 583. [α]20D = -66.43 (c = 1.13, EtOH).  
 
(1-bromo-2-phenylcyclopropyl)methanol (4aa): 62% yield, 96:4 dr. Rf = 0.19 (hexanes/ethyl 
acetate 5:1). 
1
H NMR (500 MHz, CDCl3) δ 7.34 – 7.27 (m, 3H), 7.26 – 7.21 (m, 2H), 3.92 (dd, J 
= 12.3, 6.1 Hz, 1H), 3.77 (dd, J = 12.3, 7.0 Hz, 1H), 2.27 (dd, J = 9.8, 7.6 Hz, 1H), 2.06 (t, J = 
6.7 Hz, 1H), 1.61 (t, J = 7.2 Hz, 1H), 1.52 (dd, J = 9.8, 6.9 Hz, 1H). 
13
C NMR(126 MHz, CDCl3): 
δ 137.5, 129.2, 128.2, 127.1, 71.8, 45.8, 28.1, 18.7. HRMS (ESI) ([M+NH4]
+) Calc’d. for 
C10H15BrNO: 244.0332; Found 244.0316. IR (neat, cm
-1
): 3351, 3028, 2922, 1604, 1449, 1030, 
1262, 1073, 956, 909, 763, 734, 695, 576, 468. [α]20D = + 95.0 (c = 4.0, CHCl3). HPLC analysis: 
ee (Z)-isomer = 92 %. OD-H (97% hexanes: 3% isopropanol, 0.8 mL/min): (Z)-isomer:  tmajor = 
54.7 min, tminor = 24.9 min.  
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tert-butyl 1-chloro-2-phenylcyclopropanecarboxylate (3ab): 98% yield, >99:1 dr. Rf = 0.45 
(hexanes/ethyl acetate 12:1). 
1
H NMR (500 MHz, CDCl3): δ 7.36 – 7.22 (m, 5H), 3.01 (dd, J = 
9.7, 8.9 Hz, 1H), 2.08 (dd, J = 10.2, 5.9 Hz, 1H), 1.70 (dd, J = 8.4, 5.9 Hz, 1H), 1.52 (s, 8H). 
 13
C 
NMR(125 MHz, CDCl3): δ 169.1, 134.9, 129.6, 128.2, 127.6, 83.0, 45.8, 33.3, 28.1, 23.3. 
HRMS (ESI) ([M+Na]
+) Calc’d. for C14H17ClNaO2: 275.0809, Found 275.0804. IR (neat, cm
-1
): 
2980, 2933, 1712, 1605, 1476, 1455, 1424, 1393, 1368, 1293, 1139, 1127, 1090, 1053, 969, 909, 
840, 759, 694, 593, 541, 468. [α]20D = -325.0 (c = 2.4, CHCl3).  
 
 
Figure 2.7. Single-Crystal X-ray Structure of 3ab. 
 
(1-chloro-2-phenylcyclopropyl)methanol (4ab): 64% yield, >99:1 dr. Rf = 0.31 (hexanes/ethyl 
acetate 4:1). 
1
H NMR (500 MHz, CDCl3): δ 7.41 – 7.23 (m, 5H), 3.91 (d, J = 12.1 Hz, 1H), 3.78 
(d, J = 12.1 Hz, 1H), 2.41 (dd, J = 9.7, 7.7 Hz, 1H), 2.12 (brs, 1H), 1.54 (t, J = 7.2 Hz, 1H), 1.49 
(dd, J = 9.9, 6.7 Hz, 1H). 
13
C NMR (125 MHz, CDCl3): δ 136.3, 129.3, 128.2, 127.0, 70.6, 51.6, 
28.2, 18.2. HRMS (ESI) ([M+Na]
+
) Calc’d. for C10H11ClNaO: 205.0391; Found 205.0392. IR 
(neat, cm
-1
): 3351, 3029, 2924, 1603, 1497, 1449, 1217, 1032, 960, 765, 695, 585, 502. [α]20D = -
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742.71 (c = 0.96, CHCl3). HPLC analysis: ee (Z)-isomer = 92 %. OD-H (97% hexanes: 3% 
isopropanol, 0.8 mL/min): (Z)-isomer:  tmajor = 58.6 min, tminor = 24.5 min.   
 
tert-butyl 1-bromo-2-(m-tolyl)cyclopropanecarboxylate (3ba):  84% yield. 98:2 dr. Rf = 0.47 
(hexanes/ethyl acetate 12:1). 
1
H NMR (500 MHz, CDCl3):  7.23 (t, J = 7.6 Hz, 1H), 7.11 (d, J = 
7.5 Hz, 1H), 7.07 – 6.99 (m, 2H), 2.84 (t, J = 7.5 Hz, 1H), 2.36 (s, 3H), 2.11 (dd, J = 10.1, 6.0 
Hz, 1H), 1.73 (dd, J = 8.4, 6.0 Hz, 1H), 1.51 (s, 9H). 
 13
C NMR (125 MHz, CDCl3):  168.7, 
137.7, 135.9, 130.3, 128.3, 128.0, 126.4, 82.9, 36.9, 32.8, 28.0, 23.6, 21.5. HRMS (ESI) 
([M+H]
+
)  Calc’d. for C15H19BrO2: 311.0641; Found 311.0645. IR (neat, cm
-1
): 2979, 2932, 1708, 
1609, 1456, 1368, 1293, 1255, 1154, 1132, 1083, 1055, 909, 838, 787, 782, 693, 434. [α]20D = -
44.62 (c = 1.3, EtOH).  
 
(1-bromo-2-(m-tolyl)cyclopropyl)methanol (4ba): 65% yield, 98:2 dr. Rf = 0.32 (hexanes/ethyl 
acetate 4:1). 
1
H NMR (500 MHz, CDCl3):  7.24 (t, J = 7.6 Hz, 1H), 7.15 – 7.00 (m, 3H), 3.93 (d, 
J = 12.3 Hz, 1H), 3.78 (d, J = 12.2 Hz, 1H), 2.38 (s, 3H), 2.24 (dd, J = 9.6, 7.8 Hz, 1H), 2.10 (t, J 
= 5.0 Hz, 1H), 1.61 (t, J = 7.2 Hz, 1H), 1.51 (dd, J = 9.8, 6.9 Hz, 1H). 
13
C NMR (100 MHz, 
CDCl3):  137.8, 137.3, 130.1, 128.0, 127.9, 126.2, 71.8, 45.8, 28.0. 21.6, 18.6.  IR (neat, cm
-1
):  
3386, 3051, 2921, 2858, 1608, 1588, 1490, 1451, 1383, 1264, 1208, 1180, 1036, 883, 782, 735, 
696, 460. [α]20D = 5.14 (c = 2.14, CHCl3). HRMS (ESI) ([M+Na]
+) Calc’d. for C11H13BrNaO: 
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263.0042; Found 263.0054. HPLC analysis: ee (Z)-isomer = 93 %. OD-H (97% hexanes: 3% 
isopropanol, 0.8 mL/min): (Z)-isomer:  tmajor = 37.1 min, tminor = 19.0 min.    
 
tert-butyl 1-chloro-2-(m-tolyl)cyclopropanecarboxylate (3bb): 95% yield. > 99:1 dr. Rf = 0.45 
(hexanes/ethyl acetate 15:1). 
1
H NMR (500 MHz, CDCl3): δ 7.23 (t, J = 7.6 Hz, 1H), 7.15 – 6.99 
(m, 3H), 2.97 (t, J = 9.3 Hz, 1H), 2.36 (s, 3H), 2.05 (dd, J = 10.1, 5.9 Hz, 1H), 1.68 (dd, J = 8.4, 
5.9 Hz, 1H), 1.52 (s, 9H).
13
C NMR(125 MHz, CDCl3): δ 169.1, 137.9, 134.8, 130.4, 128.4, 128.1, 
126.5, 82.9, 45.8, 33.3, 28.1, 23.2, 21.6.  IR (neat, cm
-1
): 2981, 1713, 1609, 1476, 1369, 1296, 
1264, 1140, 1086, 1055, 874, 839, 789, 736, 694, 470. HRMS (ESI) ([M+H]
+
) Calc’d. for 
C15H20ClO2: 267.1146; Found 267.1147. [α]
20
D = -58.3 (c = 1.11, CHCl3).   
 
(1-chloro-2-(m-tolyl)cyclopropyl)methanol (4bb):  70% yield, > 99:1 dr. Rf = 0.30 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3): δ 7.24 (t, J = 7.5 Hz, 1H), 7.10 – 7.05 
(m, 3H), 3.90 (d, J = 12.1 Hz, 1H), 3.78 (d, J = 11.9 Hz, 1H), 2.42 – 2.34 (m, 4H), 2.12 (s, 1H), 
1.58 – 1.50 (m, 1H), 1.46 (dd, J = 9.9, 6.7 Hz, 1H). 
13
C NMR (100 MHz, CDCl3):  δ 137.8, 136.2, 
130.1, 128.1, 127.8, 126.2, 70.6, 51.6, 28.2, 21.6, 18.2. HRMS (ESI) ([M+Na]
+) Calc’d. for 
C11H13ClNaO: 219.0547; Found 219.0555. IR (neat, cm
-1
): 3352, 2921, 2857, 1588, 1608, 1491, 
1275, 1084, 1034, 782, 696, 599, 502, 435. [α]20D = - 42.7 (c = 1.42, CHCl3). HPLC analysis: ee 
(Z)-isomer = 96 %. OD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): (Z)-isomer:  tmajor = 20.3 
min, tminor = 11.5 min.   
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tert-butyl 1-bromo-2-(naphthalen-2-yl)cyclopropanecarboxylate (3ca): 96% yield. 88:12 dr. 
Rf = 0.51 (hexanes/ethyl acetate 15:1). 
1
H NMR (500 MHz, CDCl3) δ 7.89 – 7.78 (m, 3H), 7.68 
(s, 1H), 7.53 – 7.44 (m, 2H), 7.38 (dd, J = 8.5, 1.7 Hz, 1H), 3.05 (t, J = 10.0 Hz, 1H), 2.22 (dd, J 
= 10.0, 6.0 Hz, 1H), 1.89 (dd, J = 8.4, 6.0 Hz, 1H), 1.54 (s, 9H). 
13
C NMR (125 MHz, CDCl3): δ 
168.8, 133.8, 133.2, 132.9, 128.2, 127.9, 127.8, 127.8, 127.7, 126.3, 126.1, 83.1, 36.9, 33.1, 28.1, 
23.8. HRMS (ESI) ([M+Na]
+
) Calc’d. for C18H19BrNaO2: 369.0461; Found 369.0487. IR (neat, 
cm
-1
): 3054, 2979, 1708, 1601, 1476, 1390, 1368, 1278, 1257, 1162, 1131, 1083, 1058, 961, 838, 
735, 703, 476. [α]20D = -101.23 (c = 0.81, EtOH).  
 
(1-bromo-2-(naphthalen-2-yl)cyclopropyl)methanol (4ca): 57% yield, 88:12 dr. Rf = 0.33 
(hexanes/ethyl acetate 4:1). 
1
H NMR (400 MHz, CDCl3): δ 7.84 – 7.81 (m, 3H), 7.66 (s, 1H), 
7.50 – 7.44 (m, 2H), 7.40 (dd, J = 8.5, 1.7 Hz, 1H), 3.99 (dd, J = 12.3, 4.4 Hz, 1H), 3.82 (dd, J = 
12.2, 5.6 Hz, 1H), 2.43 (dd, J = 9.6, 7.7 Hz, 1H), 2.18 (s, 1H), 1.75 (t, J = 7.2 Hz, 1H), 1.60 (dd, 
J = 9.8, 6.9 Hz, 1H). 
13
C NMR (125 MHz, CDCl3): δ 135.1, 133.3, 132.7, 127.9, 127.8, 127.7, 
127.7, 127.7, 126.2, 125.9, 71.8, 45.8, 28.3, 18.8. HRMS (ESI) ([M+H]
+
) Calc’d. for C14H14BrO: 
277.0223, Found: 277.0237. IR (neat, cm
-1
): 3262, 3056, 2946, 2909, 1632, 1506, 1430, 1366, 
1264, 1148, 1089, 1048, 860, 818, 754, 703, 595, 478. [α]20D = -28.80 (c = 0.85, CHCl3). HPLC 
analysis: ee (Z)-isomer = 94 %. OD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): (Z)-isomer:  
tmajor = 25.7 min, tminor = 23.0 min.   
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tert-butyl 1-chloro-2-(naphthalen-2-yl)cyclopropanecarboxylate (3cb): 93% yield, 88:12 dr.  
Rf = 0.53 (hexanes/ethyl acetate 15:1). 
1
H NMR (400 MHz, CDCl3): δ 7.86 – 7.72 (m, 3H), 7.72 
(s, 1H), 7.51 – 7.39 (m, 3H), 3.19 (t, J = 9.2 Hz, 1H), 2.18 (dd, J = 10.0, 5.9 Hz, 1H), 1.86 (dd, J 
= 8.3, 6.0 Hz, 1H), 1.57 (s, 9H). 
13
C NMR (100 MHz, CDCl3): δ 169.1, 133.3, 132.8, 132.5, 
128.3, 127.9, 127.8, 127.8, 127.7, 126.3, 126.1, 83.0, 46.0, 33.5, 28.1, 23.4. HRMS (ESI) 
([M+H]
+) Calc’d. for C18H19ClO2: 303.1152; Found 303.1145. IR (neat, cm
-1
): 2982, 1715, 1621, 
1476, 1458, 1394, 1370, 1293, 1164, 1116, 1067, 1018, 972, 836, 747, 711, 623, 590, 412. [α]20D 
= 707.14 (c = 1.4, CHCl3).  
 
 
(1-chloro-2-(naphthalen-2-yl)cyclopropyl)methanol (4cb): 65% yield, 88:12 dr. Rf = 0.31 
(hexanes/ethyl acetate 4:1). 
1
H NMR (400 MHz, CDCl3): δ 7.84 –7.81 (m, 3H), 7.69 (s, 1H), 
7.41 (dd, J = 8.5, 1.5 Hz, 1H), 3.96 (d, J = 12.1 Hz, 1H), 3.82 (d, J = 12.2 Hz, 1H), 2.56 (dd, J = 
9.4, 7.9 Hz, 1H), 2.23 (brs, 1H), 1.68 (t, J = 7.2 Hz, 1H), 1.55 (dd, J = 9.8, 6.7 Hz, 1H). 
13
C 
NMR (125 MHz, CDCl3): δ 134.0, 133.3, 132.6, 127.8, 127.8, 127.8, 127.7, 127.7, 126.2, 125.8, 
70.6, 51.7, 28.5, 18.3. HRMS (ESI) ([M+Na]
+
) Calc’d. for C14H13ClNaO: 255.0547; Found 
255.0557. IR (neat, cm
-1
): 3351, 3052, 2923, 1632, 1600, 1507, 1431, 1267, 1212, 1035, 975, 
959, 857, 816, 747, 621, 562, 476, 417.  [α]20D = -201.01 (c = 2.0, CHCl3). HPLC analysis: ee 
(Z)-isomer = 95 %. OD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): (Z)-isomer:  tmajor = 25.2 
min, tminor = 23.7 min.   
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tert-butyl 1-bromo-2-(4-(trifluoromethyl)phenyl)cyclopropanecarboxylate (3da): 80% yield. 
96:4 dr. Rf = 0.43 (hexanes/ethyl acetate 15:1). 
1
H NMR (500 MHz, CDCl3): δ 7.15 (d, J = 8.4 
Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 3.81 (s, 3H), 2.85 – 2.76 (m, 1H), 2.11 (dd, J = 10.2, 6.0 Hz, 
1H), 1.68 (dd, J = 8.4, 6.0 Hz, 1H), 1.51 (s, 9H). 
13
C NMR (125 MHz, CDCl3): δ 168.3 (s), 140.2 
(d, J = 1.25 Hz), 129.9 (s), 129.7 (q, J = 32.5 Hz), 125.2 (q, J = 3.75 Hz), 124.3 (q, J = 271.25 
Hz), 83.4 (s), 36.2 (s), 32.3 (s), 28.0 (s), 23.8 (s). 
19
F NMR (376 MHz, CFCl3, CDCl3): - 63.0 (s, 
3F). HRMS (ESI) ([M+H]
+) Calc’d. for C15H17BrF3O2: 365.0359; Found 365.0373. IR (neat, cm
-
1
): 2981, 2932, 1730, 1619, 1379, 1324, 1254, 1146, 1125, 1068, 1017, 980, 837, 771, 619. 
[α]20D = -44.62 (c = 1.34, EtOH).   
 
 
 
Figure 2.8. Single-Crystal X-ray Structure of 3da. 
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(1-bromo-2-(4-(trifluoromethyl)phenyl)cyclopropyl)methanol (4da): 72% yield, 96:4 dr. Rf = 
0.34 (hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3) δ 7.59 (d, J = 8.2 Hz, 2H), 7.34 (d, 
J = 8.1 Hz, 2H), 3.96 (d, J = 12.3 Hz, 1H), 3.77 (d, J = 12.3 Hz, 1H), 2.32 (t, J = 10.0 Hz, 1H), 
2.12 (brs, 1H), 1.72 – 1.56 (m, 2H).  13C NMR (100 MHz, CDCl3): δ 141.6 (s), 129.6(s), 129.3(d, 
J = 32.0 Hz), 125.1(q, J = 3.5 Hz), 124.5 (d, J = 245.0 Hz), 71.4 (s), 44.9 (s), 27.7 (s), 18.9 (s). 
19
F NMR (376 MHz, CFCl3, CDCl3): δ -62.9(s, 3F). HRMS (ESI) ([M+Cl]
-
) Calcd. for  
C11H10BrClF3O: 328.9561, Found 328.9559. IR (neat, cm
-1
): 3395, 2928, 1619, 1496, 1444, 1324, 
1265, 1164, 1116, 1068, 1018, 874, 735, 708, 595, 508. [α]20D = 2.40 (c=1.04, CHCl3).
 
HPLC 
analysis: ee (Z)-isomer = 93 %. OD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): (Z)-isomer:  
tmajor = 38.0 min, tminor = 26.7 min.    
 
tert-butyl 1-chloro-2-(4-(trifluoromethyl)phenyl)cyclopropanecarboxylate (3db): 82% yield. 
96:4 dr. Rf = 0.46 (hexanes/ethyl acetate 15:1). 
1
H NMR (500 MHz, CDCl3):  7.59 (d, J = 8.2 
Hz, 2H), 7.36 (d, J = 8.3 Hz, 2H), 3.04 (t, J = 10.0 Hz, 1H), 2.12 (dd, J = 10.1, 6.1 Hz, 1H), 1.71 
(dd, J = 8.4, 6.1 Hz, 1H), 1.52 (s, 9H). 
13
C NMR (125 MHz, CDCl3): δ 168.6(s), 139.1(s), 
129.9(s), 129.7(q, J = 32.5 Hz), 125.2 (q, J = 3.75 Hz), 124.3(q, J = 271.25 Hz), 83.4(s), 45.6(s), 
32.7(s), 28.0(s), 23.4(s). 
19
F NMR (376 MHz, CFCl3, CDCl3): δ -63.0(s, 3F).  IR (neat, cm
-1
): 
2978, 2932, 1711, 1634, 1368, 1292, 1132, 1120, 1087, 1057, 1018, 816, 747, 619, 475. HRMS 
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(ESI) ([M+NH4]
+
) Calcd. for C15H20ClF3NO2: 338.1129, Found 338.1078. [α]
20
D = -57.92 (c = 
1.2, EtOH).  
 
(1-chloro-2-(4-(trifluoromethyl)phenyl)cyclopropyl)methanol (4db), 67% yield, 96:4 dr. Rf = 
0.32 (hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3): δ 7.58 (d, J = 8.2 Hz, 2H), 7.36 (d, 
J = 8.4 Hz, 2H), 3.93 (d, J = 12.2 Hz, 1H), 3.77 (d, J = 12.1 Hz, 1H), 2.45 (t, J = 8.7 Hz, 1H), 
2.17 (brs, 1H), 1.60 – 1.52 (m, 2H). 13C NMR (125 MHz, CDCl3): δ 140.5 (s), 129.6(s), 129.2(d, 
J = 32.5 Hz), 125.1(q, J = 3.75 Hz), 124.4 (q, J = 271.25 Hz), 70.2 (s), 51.3 (s), 27.9 (s), 18.5 (s). 
19
F NMR (376 MHz, CFCl3, CDCl3): δ -62.95(s, 3F).  IR (neat, cm
-1
): 3367, 2928, 1620, 1445, 
1410, 1322, 1217, 1161, 1113, 1067, 1017, 848, 748, 604. HRMS (ESI) ([M-H]
-
) Calcd. for 
C11H9ClF3O: 249.0300, Found 249.0335. [α]
20
D = -225.12(c = 2.0, CHCl3). HPLC analysis: ee 
(Z)-isomer = 93 %. OD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): (Z)-isomer:  tmajor = 15.2 
min, tminor = 13.0 min.    
 
tert-butyl 1-bromo-2-(4-methoxyphenyl)cyclopropanecarboxylate (3ea): 98% yield. > 99:1 
dr. Rf = 0.36 (hexanes/ethyl acetate 15:1). 
1
H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 8.5 Hz, 2H), 
6.87 (d, J = 8.7 Hz, 2H), 3.81 (s, 3H), 2.81 (dd, J = 10.0, 8.5 Hz, 1H), 2.11 (dd, J = 10.2, 6.0 Hz, 
1H), 1.68 (dd, J = 8.4, 6.0 Hz, 1H), 1.51 (s, 9H). 
13
C NMR (125 MHz, CDCl3): δ 168.8, 159.0, 
130.6, 128.2, 113.6, 82.9, 55.3, 37.3, 32.3, 28.0, 23.8. HRMS (ESI) ([M+Na]
+): Calc’d. for 
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C15H19BrNaO3: 349.0410; Found 349.0426. IR (neat, cm
-1
): 2978, 2933, 2836, 1707, 1612, 1515, 
1368, 1250, 1165, 1033, 965, 827, 713, 565, 458. [α]20D = - 57.52 (c = 1.8, Ethanol).   
 
(1-bromo-2-(4-methoxyphenyl)cyclopropyl)methanol (4ea): 67% yield, >99:1 dr. Rf = 0.18 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3): δ 7.15 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 
8.7 Hz, 2H), 3.91 (d, J = 12.3 Hz, 1H), 3.81 (s, 3H), 3.75 (d, J = 12.3 Hz, 1H),  2.19 (dd, J = 9.9, 
7.6 Hz, 1H), 1.81 (brs, 1H), 1.53 (t, J = 7.2 Hz, 1H), 1.49 (dd, J = 9.9, 6.8 Hz, 1H). 
13
C NMR 
(125 MHz, CDCl3): δ 158.7, 130.3, 129.6, 113.6, 71.8, 55.4, 46.2, 27.4, 18.8. HRMS (ESI) 
([M+Na]
+)  Calc’d. for C11H13BrNaO2: 278.9991; Found 278.9987. IR (neat, cm
-1
): 3369, 3000, 
2933, 2835, 1583, 1611, 1514, 1440, 1243, 1178, 1030, 835, 801, 549, 518. [α]20D = 1.5 (c = 3.85, 
CHCl3). HPLC analysis: ee (Z)-isomer = 94 %. OD-H (95% hexanes: 5% isopropanol, 0.8 
mL/min): (Z)-isomer:  tmajor = 35.6 min, tminor = 25.6 min.  
 
tert-butyl 1-chloro-2-(4-methoxyphenyl)cyclopropanecarboxylate (3eb): 88% yield. >99:1 dr. 
Rf = 0.39 (hexanes/ethyl acetate 15:1). 
1
H NMR (400 MHz, CDCl3): δ 7.16 (d, J = 8.6 Hz, 2H), 
6.88 (d, J = 8.6 Hz, 2H), 3.80 (s, 3H), 2.95 (t, J = 10.0 Hz, 1H), 2.05 (dd, J = 10.2, 5.9 Hz, 1H), 
1.63 (dd, J = 8.4, 6.0 Hz, 1H), 1.52 (s, 9H). 
 13
C NMR (125 MHz, CDCl3): δ 169.2, 159.1, 130.6, 
127.0, 113.7, 82.9, 55.4, 46.0, 32.8, 28.1, 23.4. HRMS (ESI) ([M+Na]
+)  Calc’d. for 
C15H19ClNaO3: 305.0915; Found 305.0911. IR (neat, cm
-1
): 3054, 2979, 1708, 1601, 1508, 1476, 
1368, 1257, 1278, 1131, 1058, 816, 735, 685, 476. [α]20D = -87.80 (c = 1.22, EtOH).  
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(1-chloro-2-(4-methoxyphenyl)cyclopropyl)methanol (4eb): 63% yield, >99:1 dr. Rf = 0.16 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3) δ 7.17 (d, J = 8.8, 2H), 6.88 (d, J = 8.8, 
2H), 3.88 (d, J = 12.2 Hz, 1H), 3.80 (s, 3H), 3.75 (d, J = 12.1 Hz, 1H), 2.35 – 2.32 (m, 1H), 2.23 
(s, 1H), 1.47 – 1.45 (m, 1H), 1.45 – 1.43 (m, 1H). 
13
C NMR (125 MHz, CDCl3): 158.6, 130.3, 
128.4, 113.6, 70.5, 55.4, 51.7, 27.5, 18.3. HRMS (ESI) ([M+Na]
+)  Calc’d. for C11H13ClNaO2: 
235.0496; Found 235.0491. IR (neat, cm
-1
): 3378, 3002, 2934, 2836, 1612, 1515, 1441, 1245, 
1179, 1088, 1031, 829, 802, 733, 700, 568. [α]20D = -729.53 (c = 1.41, CHCl3). HPLC analysis: 
ee (Z)-isomer = 92 %. OD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): (Z)-isomer:  tmajor = 
32.4 min, tminor = 23.2 min.     
 
tert-butyl 1-bromo-2-methyl-2-phenylcyclopropanecarboxylate (3fa): 97% yield. 95:5 dr. Rf 
= 0.50 (hexanes/ethyl acetate 15:1). 
1
H NMR (500 MHz, CDCl3):  7.41 – 7.23 (m, 5H), 1.96 (d, 
J = 6.6 Hz, 1H), 1.66 (d, J = 6.6 Hz, 1H), 1.54 (s, 9H), 1.50 (s, 3H). 
13
C NMR (62.5 MHz, 
CDCl3): 167.8, 142.9, 129.0, 128.4, 127.3, 82.7, 39.4, 34.8, 28.1, 26.8, 22.7. HRMS (ESI) 
([M+Na]
+
)  Calc’d. for C15H19BrNaO2: 333.0461; Found 333.0455. IR (neat, cm
-1
): 2978, 2930, 
1719, 1602, 1496, 1368, 1273, 1129, 1097, 1043, 909, 842, 765, 698, 561, 543. [α]20D = 14.7 (c = 
0.86, CHCl3).   
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(1-bromo-2-methyl-2-phenylcyclopropyl)methanol (4fa): 75% yield, 95:5 dr. Rf = 0.34 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3) δ 7.41 – 7.24 (m, 5H), 4.15 (dd, J = 
12.9, 5.4 Hz, 1H), 3.89 (dd, J = 12.9, 8.0 Hz, 1H), 2.14 (dd, J = 8.1, 5.5 Hz, 1H), 1.73 (d, J = 6.8 
Hz, 1H), 1.56 (s, 3H), 1.26 (d, J = 6.8 Hz, 1H). 
13
C NMR (62.5 MHz, CDCl3): 144.7, 129.0, 
128.3, 126.9, 69.1, 49.4, 33.0, 26.2, 23.2.  HRMS (ESI) ([M+Na]
+
)  Calc’d. for C11H13BrNaO: 
263.0042; Found 263.0054. IR (neat, cm
-1
): 3383, 3025, 2925, 1601, 1496, 1444, 1375, 1266, 
1182, 1049, 1025, 801, 762, 699, 608, 553, 469. [α]20D = 47.6 (c = 0.97, CHCl3).  HPLC analysis: 
ee (Z)-isomer = 91 %. AS-H (99% hexanes: 1% isopropanol, 0.8 mL/min): (Z)-isomer:  tmajor = 
23.3 min, tminor = 26.9 min.    
 
tert-butyl 1-chloro-2-methyl-2-phenylcyclopropanecarboxylate (3fb): 98% yield. 96:4 dr. Rf 
= 0.52 (hexanes/ethyl acetate 15:1). 
1
H NMR (400 MHz, CDCl3)  7.39 – 7.25 (m, 5H), 1.93 (d, 
J = 6.4 Hz, 1H), 1.62 (d, J = 6.4 Hz, 1H), 1.53 (s, 9H), 1.48 (s, 3H). 
13
C NMR (125 MHz, 
CDCl3):  167.9, 141.7, 129.1, 128.4, 127.2, 82.8, 49.0, 36.1, 28.2, 26.9, 22.7. HRMS (ESI) 
([M+H]
+
)  Calc’d. for C15H20ClO2: 267.1146; Found 267.1141. IR (neat, cm
-1
): 2979, 2931, 1721, 
1603, 1368, 1344, 1275, 1256, 1132, 1080, 1098, 1050, 841, 767, 698, 575.  [α]20D = -31.2 (c = 
2.49, CHCl3).    
 
(1-chloro-2-methyl-2-phenylcyclopropyl)methanol (4fb): 79% yield, 96:4 dr. Rf = 0.30 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3):  7.41 – 7.23 (m, 5H), 4.13 (d, J = 12.7 
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Hz, 1H), 3.90 (d, J = 12.7 Hz, 1H), 1.64 (d, J = 6.6 Hz, 1H), 1.55 (s, 3H), 1.21 (d, J = 6.6 Hz, 
1H). 
13
C NMR (126 MHz, CDCl3): δ 143.1, 129.2, 128.4, 126.9, 67.9, 54.6, 33.2, 25.7, 23.8. 
HRMS (ESI) ([M+NH4]
+
)  Calc’d. for C11H17ClNO: 214.0993; Found 214.0998. IR (neat, cm
-1
): 
3589, 3054, 2989, 1497, 1445, 1264, 1048, 1027, 895, 733, 701, 556. [α]20D = 34.7 (c = 0.62, 
CHCl3). HPLC analysis: ee (Z)-isomer = 96 %. OD-H (95% hexanes: 5% isopropanol, 0.8 
mL/min): (Z)-isomer:  tmajor = 12.5 min, tminor = 14.0 min.   
 
tert-butyl-1-bromo-2-methyl-2-(naphthalen-2-yl)cyclopropane-1-carboxylate (3ga) ： 84% 
yield. > 99:1 dr. Rf = 0.52 (hexanes/ethyl acetate 15:1). 
1
H NMR (500 MHz, CDCl3) δ 7.92 – 
7.81 (m, 3H), 7.71 (s, 1H), 7.50 – 7.48 (m, 3H), 2.08 (d, J = 6.6 Hz, 1H), 1.83 (d, J = 6.6 Hz, 1H), 
1.59 – 1.58 (m, 12H). 13C NMR (126 MHz, CDCl3) δ 167.9, 140.5, 133.4, 132.7, 128.1, 128.0, 
127.8, 127.5, 127.3, 126.2, 126.0,  82.8, 39.3, 35.1, 28.1, 27.1, 22.6. HRMS (ESI) 
([M+Na]
+
);Calc’d. for C19H21BrNaO2: 383.0617; Found 383.0618. IR (neat, cm
-1
): 3016, 2981, 
1716, 1600, 1456, 1369, 1278, 1046, 746, 667, 478. [α]20D = -34.2 (c = 2.28, CHCl3).    
 
Figure 2.9. Single-Crystal X-ray Structure of 3ga. 
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(1-bromo-2-methyl-2-(naphthalen-2-yl)cyclopropyl)methanol (4ga): 74% yield, >99:1 dr. Rf 
= 0.31 (hexanes/ethyl acetate 4:1). 
1
H NMR (400 MHz, CDCl3): δ 7.84 – 7.79 (m, 3H), 7.67 (s, 
1H), 7.46 – 7.43 (m, 3H), 4.18 (dd, J = 12.9, 5.4 Hz, 1H), 3.91 (dd, J = 12.9, 8.0 Hz, 1H), 2.18 
(dd, J = 8.1, 5.4 Hz, 1H), 1.85 (d, J = 6.8 Hz, 1H), 1.60 (s, 3H), 1.33 (d, J = 6.8 Hz, 1H). 
13
C 
NMR (100 MHz, CDCl3): δ 142.3, 133.4, 132.5, 127.9, 127.8, 127.1, 126.1, 125.9, 69.1, 49.2, 
33.2, 26.4, 23.1. HRMS (ESI) ([M+Na]
+
); Calc’d. for C15H15BrNaO: 313.0198; Found 313.0193.  
IR (neat, cm
-1
): 3584, 3053, 2983, 1600, 1504, 1434, 1264, 1049, 1030, 732, 703, 479. [α]20D = 
11.3 (c = 2.85, CHCl3). HPLC analysis: ee (Z)-isomer = 92 %. AD-H (97% hexanes: 3% 
isopropanol, 0.8 mL/min): (Z)-isomer:  tmajor = 23.9 min, tminor = 20.3 min.    
 
tert-butyl 2-chloro-2',3'-dihydrospiro[cyclopropane-1,1'-indene]-2-carboxylate (3hb): 98% 
yield. 98:2 dr. Rf = 0.48 (hexanes/ethyl acetate 15:1). 
1
H NMR (400 MHz, CDCl3)  7.29 – 7.14 
(m, 3H), 7.10 –7.08(m, 1H), 3.13 – 2.85 (m, 2H), 2.36 – 2.25 (m, 1H), 2.20 (d, J = 6.7 Hz, 1H), 
2.17 – 2.13 (m, 1H), 1.65 (d, J = 6.7 Hz, 1H), 1.51 (s, 9H). 
13
C NMR (100 MHz, CDCl3): 
168.0, 146.0, 140.6, 127.6, 125.7, 124.5, 124.2, 82.8, 42.8, 31.8, 30.8, 28.1, 27.8, 26.5. HRMS 
(ESI) ([M+Na]
+
); Calc’d. for C16H19ClNaO2: 301.0966; Found 301.0963. IR (neat, cm
-1
): 2984, 
1718, 1458, 1369, 1296, 1264, 1130, 1161, 1074, 734, 708. [α]20D = -171.3 (c = 1.2, CHCl3). 
- 39 - 
 
HPLC analysis: ee = 92 %. OD-H (100% hexanes, 0.8 mL/min):  tmajor = 11.4 min, tminor = 14.0 
min.    
 
tert-butyl -1-chloro-2-(3-formylphenyl)cyclopropane-1-carboxylate (3ib): 47% yield, >99:1 
dr. Rf = 0.53 (hexanes/ethyl acetate 6:1). 
1
H NMR (400 MHz, CDCl3) δ 10.02 (s, 1H), 7.86 – 
7.72 (m, 2H), 7.58 – 7.48 (m, 2H), 3.07 (t, J = 10.0, 1H), 2.20 – 2.08 (m, 1H), 1.75 (dd, J = 8.3, 
6.1 Hz, 1H), 1.52 (s, 9H). 
13
C NMR (100 MHz, CDCl3): δ 192.1, 168.5, 136.3, 136.2, 135.5, 
130.2, 129.1, 128.8, 83.2, 45.4, 32.5, 27.9, 23.2. HRMS (ESI) ([M+Na]
+
)  Calc’d. for 
C15H17ClNaO3: 303.0758; Found 303.0741. IR (neat, cm
-1
): 3060, 2985, 1734, 1700, 1422, 1370, 
1264, 1129, 895, 732, 703. [α]20D = -67.16 (c = 2.64, CHCl3). HPLC analysis: ee (Z)-isomer = 
94 %. OD-H (99% hexanes: 1% isopropanol, 0.8 mL/min): (Z)-isomer:  tmajor = 13.7 min, tminor = 
18.3 min.    
 
tert-butyl 3-2-(tert-butoxycarbonyl)-2-chlorocyclopropyl)-1H-indole-1-carboxylate (3jb): 
60% yield. >99:1 dr. Rf = 0.44 (hexanes/ethyl acetate 20:1). 
1
H NMR (400 MHz, CDCl3): δ 8.12 
(d, J = 7.8 Hz, 1H), 7.51 (d, J = 7.6 Hz, 1H), 7.43 (s, 1H), 7.34 (dt, J = 8.4, 4.3 Hz, 1H), 7.30 – 
7.24 (m, 2H), 2.91 (dd, J = 9.8, 8.5 Hz, 1H), 2.15 (dd, J = 10.0, 5.6 Hz, 1H), 1.68 (s, 9H), 1.66 – 
1.62  (m, 1H), 1.56 (s, 9H). 
13
C NMR (100 MHz, CDCl3): δ 169.2, 149.8, 135.5, 130.9, 124.8, 
124.8, 122.9, 119.1, 116.3, 115.5, 84.0, 83.1, 45.3, 28.4, 28.1, 24.7, 23.6. HRMS (ESI) ([M+H]
+
); 
Calc’d. for C21H27ClNO4: 392.1623; Found 392.1632. IR (neat, cm
-1
): 2979, 2933, 1730, 1451, 
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1368, 1309, 1254, 1220, 1080, 1017, 840, 762, 743, 644, 473. [α]20D  = - 47.7 (c =1.54, CHCl3). 
HPLC analysis: ee (Z)-isomer = 96 %. OD-H (100% hexanes, 0.8 mL/min): (Z)-isomer:  tmajor = 
36.6 min, tminor = 34.2 min.   
 
tert-butyl-1-bromo-2-((E)-styryl)cyclopropane-1-carboxylate (3ka): 52% yield. > 99:1 dr. Rf 
= 0.63 (hexanes/ethyl acetate 12:1). 
1
H NMR (400 MHz, CDCl3): δ 7.45 – 7.17 (m, 5H), 6.65 (d, 
J = 15.8 Hz, 1H), 6.04 (dd, J = 15.8, 8.5 Hz, 1H), 2.36 (dd, J = 17.6, 8.4 Hz, 1H), 2.05 (dd, J = 
9.8, 5.8 Hz, 1H), 1.49 (s, 9H), 1.48 – 1.37 (m, 1H). 
13
C NMR (100 MHz, CDCl3): δ 168.4, 136.9, 
133.7, 128.7, 128.2, 127.7, 126.3, 83.1, 36.4, 31.2, 28.0, 26.3.  HRMS (ESI) ([M+H]
+
); Calc’d. 
for C16H20BrO2: 323.0641; Found 323.0625.  IR (neat, cm
-1
): 2979, 2932, 1708, 1594, 1450, 
1368, 1284, 1250, 1130, 1048, 956, 840, 737, 692, 467. [α]20D = -138.19 (c =1.60, CHCl3). 
HPLC analysis: ee (Z)-isomer = > 99 %. OJ-H (100% hexanes, 0.8 mL/min): (Z)-isomer:  tmajor = 
33.0 min, tminor = 27.4 min.    
 
tert-butyl-1-chloro-2-((E)-styryl)cyclopropane-1-carboxylate (3kb): 81% yield. >99:1 dr. Rf 
= 0.50 (hexanes/ethyl acetate 20:1). 
1
H NMR (400 MHz, CDCl3): δ 7.38 – 7.17 (m, 5H), 6.66 (d, 
J = 15.8 Hz, 1H), 6.04 (dd, J = 15.8, 8.6 Hz, 1H), 2.56 – 2.49 (m, 1H), 2.00 (dd, J = 12.0, 8.0 Hz, 
1H), 1.50 (s, 9H), 1.38 (dd, J = 7.7, 5.7 Hz, 1H). 
13
C NMR (100 MHz, CDCl3): δ 168.8, 137.0, 
133.8, 128.7, 127.7, 126.4, 126.3, 83.0, 46.0, 31.7, 28.0, 25.8.  HRMS (ESI) ([M+Na]
+
);  Calc’d. 
for C16H19ClNaO2: 301.0966; Found 301.0975. IR (neat, cm
-1
): 2979, 2933, 1712, 1595, 1476, 
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1494, 1450, 1368, 1290, 1251, 1136, 1120, 957, 909, 840, 749, 691, 471. [α]20D = -136.9 (c = 
2.30, CHCl3).HPLC analysis: ee (Z)-isomer = 92 %. AD-H (100% hexanes, 0.8 mL/min): (Z)-
isomer:  tmajor = 10.6 min, tminor = 12.9 min.    
 
tert-butyl 1-chloro-2-propionylcyclopropane-1-carboxylate (3lb): 55% yield. Rf = 0.50 
(hexanes/ethyl acetate 10:1). Compound exists as a mixture of 95: 5 diastereoisomers, only 
major isomer peaks are reported. 
1
H NMR (500 MHz, CDCl3) δ 2.82 (dd, J = 8.8, 8.0 Hz, 1H), 
2.62 (qd, J = 7.3, 1.8 Hz, 2H), 1.94 (dd, J = 7.8, 5.5 Hz, 1H), 1.77 (dd, J = 9.0, 5.5 Hz, 1H), 1.49 
(s, 9H), 1.12 (t, J = 7.3 Hz, 3H). 
13
C NMR (126 MHz, CDCl3) δ 202.6, 167.6, 83.8, 44.2, 38.0, 
35.6, 28.0, 21.9, 7.7.  HRMS (ESI) ([M+Na]
+
); Calc’d. for C11H17ClNaO3: 255.0758; Found 
255.0763. IR (neat, cm
-1
): 2982, 2941, 1732, 1714, 1458, 1370, 1292, 1265, 1217, 1169, 1133, 
1067, 1032, 972, 840, 734, 703.   
 
1-chloro-2-propionylcyclopropane-1-carboxylic acid (4lb): 94% yield.  
 
A 100 ml flask was charged with tert-butyl (1S, 2S)-1-chloro-2-propionylcyclopropane-1-
carboxylate (3lb) (0.2 mmol, 46 mg), 30 equiv. of trifluoroacetic acid (6 mmol, 0.68 g), and 
dichloromethane (2 mL). The mixture was stirred at room temperature for 12 h. Evaporation of 
the solvent afforded the free acid 4lb in 94% yield. Compound exists as a mixture of 95: 5 
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diastereoisomers, only major isomer peaks are reported. 
1
H NMR (500 MHz, CDCl3) δ 10.42 (s, 
1H), 2.95 (t, J = 8.4 Hz, 1H), 2.64 (dd, J = 13.1, 6.5 Hz, 2H), 2.07 (t, J = 6.5 Hz, 1H), 1.96 – 
1.84 (m, 1H), 1.13 (t, J = 6.9 Hz, 3H). 
13
C NMR (126 MHz, CDCl3) δ 202.0, 174.6, 42.8, 38.1, 
36.4, 22.6, 7.7. HRMS (ESI) ([M-H]
-
); Calc’d. for C7H8ClO3: 175.0167; Found 175.0173. IR 
(neat, cm
-1
): 3055, 1711, 1422, 1377, 1264, 1116, 1033, 733. HPLC analysis: ee (Z)-isomer = 
90 %. AD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): (Z)-isomer:  tmajor = 12.8 min, tminor = 
14.8 min.   
 
ethyl 1-chloro-2-(dimethylcarbamoyl)cyclopropane-1-carboxylate (3mb): 42% yield. Rf = 
0.20 (hexanes/ethyl acetate 2:1). Compound exists as a mixture of 90: 10 diastereoisomers, only 
major isomer peaks are reported. 
1
H NMR (500 MHz, CDCl3) δ 4.27 (q, J = 7.1 Hz, 2H), 3.07 (s, 
3H), 3.03 (s, 3H), 2.72 (dd, J = 9.5, 8.0 Hz, 1H), 2.04 (dd, J = 7.7, 5.9 Hz, 1H), 1.89 (dd, J = 9.7, 
5.8 Hz, 1H), 1.32 (t, J = 7.1 Hz, 3H). 
13
C NMR (126 MHz, CDCl3) δ 169.1, 165.7, 63.2, 37.2, 
35.9, 31.5, 22.7, 14.3. HRMS (ESI) ([M+H]
+
); Calc’d. for C9H15ClNO3: 220.0735; Found 
220.0710. IR (neat, cm
-1
): 3354, 2965, 2930, 1723, 1650, 1587, 1498, 1464, 1402, 1269, 1132, 
1092, 1052, 857, 796, 765.  HPLC analysis: ee (Z)-isomer = 54 %. AD-H (95% hexanes: 5% 
isopropanol, 0.8 mL/min): (Z)-isomer:  tmajor = 15.2 min, tminor = 14.0 min.   
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Ethyl 1-chloro-2-(1, 3-dioxoisoindolin-2-yl)cyclopropanecarboxylate (3nb): 86% yield. Rf = 
0.36 (hexanes/ethyl acetate 4:1). Compound exists as a mixture of 95: 5 diastereoisomers, only 
major isomer peaks are reported. 
1
H NMR (400MHz, CDCl3): δ 7.86-7.83 (m, 2H), 7.76-7.72 (m, 
2H), 4.28 (q, J = 7.1 Hz, 2H), 3.58 (dd, J = 9.5, 6.8 Hz, 1H), 2.57 (dd, J = 7.5, 6.9 Hz, 1H), 2.31 
(dd, J = 9.5, 7.6 Hz, 1H), 1.33 (t, J = 7.1 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 168.7, 167.9, 
134.4, 131.4, 123.6, 62.9, 42.0, 35.7, 22.8, 14.1. HRMS (ESI) ([M+H]
+
); Calc’d. for 
C14H12ClNO4: 293.0528; Found 293.0530.  IR (neat, cm
-1
): 2985, 1781, 1721, 1613, 1468, 1393, 
1283, 1267, 1201, 1130, 1099, 1053, 970, 873, 716, 702, 607, 529. [α]20D = -29.49 (c = 1.56, 
CHCl3). HPLC analysis: ee (Z)-isomer = 60 %. Whelk (95% hexanes: 5% isopropanol, 0.8 
mL/min): (Z)-isomer:  tmajor = 30.4 min, tminor = 26.4 min.  
Preparation of (1S, 2S)-1-chloro-2-phenylcyclopropane-1-carboxamide (5):
1b
 
 
 
A 100 ml flask was charged with tert-butyl (1S, 2S)-1-chloro-2-phenylcyclopropane-1-
carboxylate (3ab) (1 mmol, 252 mg), 30 equiv of trifluoroacetic acid (30 mmol, 3.42 g), and 
dichloromethane (50 mL). The mixture was stirred at room temperature for 12 h. Evaporation of 
the solvent afforded the free acid. Without further purification, it was used directly for next step.  
The solution of the free acid and oxalyl chloride (250 mg, 2 mmol) in DCM (15 mL) was cooled 
to 0 ℃, 1 drop of DMF was then added. The mixture was stirred for 2 h under 0 ℃, then 5 h 
under room temperature. Remove most of oxalyl chloride and DCM under rotavape, the residue 
was then dissolved in 15 mL DCM again and added dropwise to the saturate NH3/MeOH 
solution (10 eq). After reaction finished, the resulting mixture was concentrated under rotavape, 
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and the residue was purified by flash silica gel chromatography to afford the (1S, 2S)-1-chloro-2-
phenylcyclopropane-1-carboxamide 5 with 78% overall yield with only one  diastereomer in 90% 
ee. Rf = 0.57 (hexanes/ethyl acetate 2:1). The product was recrystallized from 
MeOH/DCM/Hexane to further improve the enantio- purity to > 99% ee. 
1
H NMR (500 MHz, 
CDCl3) δ 7.40 – 7.27(m, 5H), 6.89 (d, J = 75.6 Hz, 2H), 3.16 (t, J = 10.0 Hz, 1H), 2.23 – 2.19 (m, 
1H), 1.73 (dd, J = 8.5, 5.9 Hz, 1H).  
13
C NMR (126 MHz, CDCl3) δ 172.4, 135.0, 129.3, 128.2, 
127.5, 47.0, 32.7, 22.5. HRMS (ESI) ([M+H]
+
); Calc’d. for C10H11ClNO: 196.0524; Found 
196.0521. IR (neat, cm
-1
):  3455, 3282, 3227, 1677, 1655, 1591, 1392, 1227, 1057, 958, 772, 702, 
526. [α]20D  = -150.23 (c = 1.3 , CHCl3). HPLC analysis: ee > 99 %. AD-H (80% hexanes : 20% 
isopropanol, 0.8 mL/min). tmajor = 7.2 min, tminor = 6.8 min.  
 
Figure 2.10. Single-Crystal X-ray Structure of 5.  
SmI2-promoted Reformatsky-type reaction of tert-butyl -1-chloro-2-phenylcyclopropane-1-
carboxylate with ketone.
14
   
 
A solution of SmI2 in THF (0.1 M in THF, 0.6 mmol, 6 mL) was added to a Schlenk tube 
at room temperature under an Ar atmosphere. HMPA (417 μL, 2.4 mmol) was added to the 
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solution at the same temperature and the mixture was stirred for 15 min. A solution of ester 3ab 
(50 mg, 0.2 mmol) and ketone (0.24 mmol) in THF (0.2 mL) was added to the mixture at the 
same temperature, followed by stirring for 2 h. The reaction was quenched with sat. NH4Cl 
aqueous solution (10 mL). Water was added to the mixture, which was extracted with Et2O (10 
ml x 5). The organic phase was washed with water and brine, dried (Na2SO4), and concentrated. 
The obtained crude oil was purified by column chromatography to give the product 6.  
  
tert-butyl-1-(2-hydroxypropan-2-yl)-2-phenylcyclopropane-1-carboxylate (6a): 51% 
yield, >99:1 dr. Rf = 0.27 (hexanes/ethyl acetate 12:1). 
1
H NMR (500 MHz, CDCl3)： δ 7.27-
7.19 (m, 5H), 4.16 (s, 1H), 2.68 (t, J = 8.1 Hz, 1H), 1.92 – 1.82 (m, 1H), 1.59 (s, 1H), 1.45 (s, 
3H), 1.23 (dd, J = 9.0, 5.2 Hz, 1H), 1.18 (s, 3H), 1.02 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ 
171.6, 137.2, 129.5, 128.0, 126.6, 81.6, 71.2, 41.2, 29.0, 27.5, 25.5, 13.9. [α]20D  = - 16.93 (c = 
0.75, CHCl3). IR (neat, cm
-1
): 3456, 2978, 1710, 1497, 1392, 1366, 1112, 845, 735. HRMS (ESI) 
([M+Na]
+)  Calc’d. for C17H24NaO3: 299.1618; Found 299.1624. HPLC analysis: ee = 87 %. 
OD-H (% hexanes, 0.8 mL/min): tmajor = 7.8 min, tminor = 6.6 min.  
Relative configuration of product 6a was assigned based on 1D NOEDIFF experiment. Relative 
configurations of 6b were assigned by analogy. The observed 1H-1H NOE effects are listed in 
Figure S6.  
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Figure 2.11. Observed NOEs upon irradiation at 2.66 ppm(blue)  and 1.19 ppm(red) for 
compound 6a.  
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Figure 2.12. 1D NOEDIFF spectra of 6a. Chemical shifts of the irradiated multiplets are listed at 
the left side of the chart. 
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tert-butyl-1-(3-hydroxypentan-3-yl)-2-phenylcyclopropane-1-carboxylate (6b): 75% 
yield, >99:1 dr. Rf = 0.28 (hexanes/ethyl acetate 15:1). 
1
H NMR (400 MHz, CDCl3): δ 7.29 – 
7.03 (m, 5H), 2.88 (s, 1H), 2.51 (t, J = 8.1 Hz, 1H), 1.97 – 1.67 (m, 3H), 1.63 – 1.33 (m, 2H), 
1.27 – 1.23 (m, 1H), 0.95 (s, 9H), 0.90 (t, J = 7.4 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ 170.6, 
137.5, 129.3, 128.0, 126.5, 81.1, 74.3, 40.8, 31.8, 27.8, 27.5, 25.1, 13.3, 9.0, 7.6. HRMS (ESI) 
([M+H]
+
)  Calc’d. for C19H29O3: 305.2111; Found 305.2099. IR (neat, cm
-1
): 3564, 2972, 2935, 
1707, 1603, 1498, 1458, 1367, 1154, 1030, 739. [α]20D  = - 15.50 (c = 1.09, CHCl3). HPLC 
analysis: ee = 90 %. OD-H (95% hexanes: 5% isopropanol, 0.8 ml/min): tmajor = 6.78 min, tminor = 
5.93 min.   
Construction of Methylenecyclopropane Motif.
15
   
 
NaH (60% suspension in mineral oil, 42 mg, 1.05 mmol) was added in small portions to 
an ice-cooled solution of 4ga (290 mg, 1 mmol), benzyl bromide (171 mg, 1 mmol) and tetra-n-
butylammonium iodide (5 mg, 0.0135 mmol) in THF (2 mL)  with stirring  under an Ar 
atmosphere during 1 h. The reaction mixture was allowed to warm to ambient temperature and 
stirred for 70 h, then water (5 mL) was added, and THF was removed by evaporation under 
reduced pressure. The aqueous solution was extracted with dichloromethane (3 × 10 mL). The 
combined dichloromethane solution was washed with water (4 × 10 mL) and brine (10 mL), 
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dried with NaSO4 and concentrated under reduced pressure, purified by flash column to give the 
bromocyclopropane 7 (380 mg, quantitative yield) as a white solid.   
 Bromocyclopropane 7 (76 mg, 0.2 mmol) was added to a solution of 
t
BuOK (33.6 mg, 
0.3 mmol) in anhydrous DMSO (2.0 mL) during 30 min with stirring and cooling with a water 
bath. After stirring for 36 h at ambient temperature, the mixture was diluted with 
dichloromethane (5 mL) and ice-cold water (6 mL). The water phase was extracted with 
dichloromethane (3 × 5 mL), the combined pentane solutions were washed with water (5 × 6 mL) 
and brine (10 mL), and dried over Na2SO4. Dichloromethane was removed under reduced 
pressure, and the residue was purified through a flash column to give enol ether 8 in 72% yield.   
 
2-((benzyloxy)methyl)-2-bromo-1-methylcyclopropyl)naphthalene (7): quantitative yield. Rf 
= 0.48 (hexanes/ethyl acetate 12:1). 
1
H NMR (400 MHz, CDCl3) δ 7.88 – 7.78 (m, 3H), 7.70 (s, 
1H), 7.55 – 7.29 (m, 8H), 4.78 (d, J = 12.3 Hz, 1H), 4.67 (d, J = 12.3 Hz, 1H), 4.08 (d, J = 11.5 
Hz, 1H), 3.81 (d, J = 11.5 Hz, 1H), 1.82 (d, J = 6.6 Hz, 1H), 1.55 (s, 3H), 1.32 (d, J = 6.6 Hz, 
1H). 
13
C NMR (100 MHz, CDCl3) δ 142.6, 138.3, 133.4, 132.5, 128.6, 128.0, 128.0, 127.9, 
127.8, 127.1, 126.0, 125.8, 76.1, 73.2, 43.6, 33.2, 26.9, 23.4. HRMS (ESI) ([M+Na]
+
);  Calc’d. 
for C22H21BrNaO: 403.0668; Found 403.0685.  IR (neat, cm
-1
): 3053, 2858, 1632, 1600, 1453, 
1361, 1090, 818, 744, 697, 478. [α]20D  = - 26.57 (c = 1.05, CHCl3).   
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2-(2-((benzyloxy)methylene)-1-methylcyclopropyl)naphthalene (8) : 72% yield. Rf = 0.50 
(hexanes/ethyl acetate 10:1). Compound exists as a 78:22 mixture of diasteromers. Characteristic 
data of the major isomer was reported: 
1
H NMR (400 MHz, CDCl3) δ 7.80 – 7.73 (m, 5H), 7.52 
– 7.33 (m, 5H), 7.24 – 7.23 (m, 2H), 6.84 (s, 1H), 4.77 (q, J = 11.9 Hz, 2H), 1.76 (s, 3H), 1.58 
(dd, J = 6.8, 1.8 Hz, 1H), 1.51 (dd, J = 6.8, 1.7 Hz, 1H). 
13
C NMR (126 MHz, CDCl3) δ 143.1, 
136.6, 128.6, 128.5, 128.1, 127.9, 127.8, 127.6, 127.6, 126.1, 125.4, 124.5, 124.2, 106.6, 71.2, 
24.4, 23.9, 20.8. IR (neat, cm
-1
): 3054, 2986, 1422, 1264, 1138, 895, 732, 703. HRMS (ESI) 
([M+Na]
+)  Calc’d. for C22H20NaO: 323.1406; Found 323.1434. HPLC analysis: ee (major)-
isomer = 92 %. AS-H (100% hexanes, 0.8 mL/min): (major)-isomer:  tmajor = 9.74 min, tminor = 
12.64 min.   
Synthesis of Tetrasubstituted Cyclopropane:
16
  
 
A 100 mL flask was charged with tert-butyl-1-chloro-2-methyl-2-phenylcyclopropane-1-
carboxylate (3fb) (1 mmol, 266 mg), 30 equiv of trifluoroacetic acid (30 mmol, 3.42 g), and 
dichloromethane (50 mL). The mixture was stirred at room temperature for 12 h. Evaporation of 
the solvent afforded the free acid.   
A flame dried 100 mL round-bottom flask equipped with a drying tube and magnetic stir bar 
was charged with 1-chloro-2-methyl-2-phenylcyclopropane-1-carboxylic acid (210 mg, 1.00 
mmol, 1.00 equiv), DMF (1 drop) and CH2Cl2 (8 mL). The mixture was then treated with oxalyl 
chloride (189 mg, 1.5 mmol, 1.5 equiv) at 0 ℃, stirred for 15 min, then warmed to room 
temperature additionally stirred for 2 hours. The solvent was then removed in vacuum and the 
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crude acyl chloride was dissolved in dry THF(4 mL), followed by the addition of a solution of 
tert-butyl amine (219 mg, 3.0 mmol, 3.00 equiv) in THF(20 mL). The reaction mixture was 
stirred overnight. After the reaction was complete, the solvent was removed in vacuum and the 
resulting residue was partitioned between EtOAc (5 mL) and water (5 mL). The organic phase 
was separated; the aqueous layer was extracted with EtOAc (2 x 10 mL). The combined organic 
phases were dried (MgSO4) and concentrated. The residue was purified by chromatography on 
silica gel to afford N-(tert-butyl)-1-chloro-2-methyl-2-phenylcyclopropane-1-carboxamide 9.  
An oven‐dried Schlenk tube was charged with 18-crown‐6 (5.3 mg, 20 μmol, 10 mol %), t-
BuOK (134 mg, 1.20 mmol, 6.00 equiv), benzyl alcohol (65 mg, 0.60 mmol, 3.0 equiv) and 
anhydrous THF (10.0 mL). The mixture was stirred at room temperature for 1 minute and 
chlorocyclopropane 9 (53 mg, 0.20 mmol, 1.0 equiv.) was added in a single portion. The 
reaction mixture was stirred overnight at 80 ℃, then solvent was removed in vacuo, and the 
residue was partitioned between water (15 mL) and ethyl acetate (15 mL), aqueous layer was 
extracted with ethyl acetate (3 x 15 mL). Combined organic extracts were washed with brine and 
dried over MgSO4, filtered and evaporated. Flash column chromatography on silica gel afforded  
3-(benzyloxy)-N-(tert-butyl)-2-methyl-2-phenylcyclopropane-1-carboxamide 10.  
 
1-chloro-2-methyl-2-phenylcyclopropane-1-carboxylic acid (3fb-acid): quantitative yield. 
1
H 
NMR (500 MHz, CDCl3) δ 7.44 – 7.27 (m, 5H), 2.14 (d, J = 6.4 Hz, 1H), 1.84 (d, J = 6.4 Hz, 
1H), 1.62 (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 175.2, 141.1, 129.0, 128.6, 127.6, 47.6, 38.7, 
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28.7, 22.4. [α]20D  = - 27.6 (c = 2.0, CHCl3).  HRMS (ESI) ([M-H]
-
); Calc’d. for C11H10ClO2: 
209.0375; Found 209.0377. IR (neat, cm
-1
): 3054, 2989, 1702, 1421, 1264, 895, 733, 703.  
 
N-(tert-butyl)-1-chloro-2-methyl-2-phenylcyclopropane-1-carboxamide (9): the major 
diastereomer was isolated in 72% yield, Rf = 0.32 (hexanes/ethyl acetate 6:1). 
1
H NMR (500 
MHz, CDCl3) δ 7.41 – 7.22 (m, 5H), 6.46 (s, 1H), 2.13 (d, J = 6.2 Hz, 1H), 1.64 (d, J = 6.3 Hz, 
1H), 1.52 (s, 3H), 1.43 (s, 9H). 
13
C NMR (126 MHz, CDCl3) δ 166.7, 142.4, 128.9, 128.4, 127.1, 
52.0, 51.1, 36.2, 28.8, 25.5, 21.4. HRMS (ESI) ([M+H]
+)  Calc’d. for C15H21ClNO: 266.1306; 
Found 266.1285.  [α]20D  = - 91.5 (c = 1.0, CHCl3).  IR (neat, cm
-1
): 3425, 2968, 1674, 1514, 
1446, 1393, 1264, 1215, 1079, 734, 700, 541.    
 
3-(benzyloxy)-N-(tert-butyl)-2-methyl-2-phenylcyclopropane-1-carboxamide (10): 63% 
yield, 96:4 dr. Rf = 0.40 (hexanes/ethyl acetate 5:1). 
1
H NMR (500 MHz, CDCl3) δ 7.47 – 7.15 
(m, 10H), 4.99 (s, 1H), 4.70 (d, J = 2.3 Hz, 2H), 4.14 (d, J = 3.3 Hz, 1H), 1.68 (d, J = 3.3 Hz, 
1H), 1.56 (s, 3H), 1.14 (s, 9H). 
13
C NMR (126 MHz, CDCl3) δ 167.9, 141.3, 137.7, 128.7, 128.6, 
128.5, 128.3, 128.1, 127.0, 73.5, 66.4, 51.2, 37.3, 37.2, 28.8, 22.0. [α]20D  = - 3.75 (c = 0.64, 
CHCl3). HRMS (ESI) ([M+H]
+
); Calc’d. for C22H28NO2: 338.2115; Found 338.2105. IR (neat, 
cm
-1
): 3307, 3027, 2966, 2926, 1642, 1602, 1540, 1496, 1390, 1375, 1364, 1265, 1225, 1138, 
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1103, 1026, 982, 947, 735, 698.  HPLC analysis: ee (major)-isomer = 91 %. OD-H (95% 
hexanes: 5% isopropanol, 0.8 mL/min): tmajor = 17.27 min, tminor = 10.18 min.   
                  
Figure 2.13. Single-Crystal X-ray Structure of 10. 
 
X-ray Crystallography  
The X-ray diffraction data for 3, 5-Di
t
Bu-ChenPhyrin and 3da were collected using Bruker-
AXS SMART-APEXII CCD diffractometer (CuKα, λ = 1.54178 Å). Indexing was performed 
using APEX2 [1] (Difference Vectors method). Data integration and reduction were performed 
using SaintPlus 6.01 [2]. Absorption correction was performed by multi-scan method 
implemented in SADABS [3]. Space groups were determined using XPREP implemented in 
APEX2 [1]. The structure was solved using SHELXS-97 (direct methods) and refined using 
SHELXL-97 (full-matrix least-squares on F
2
) contained in APEX2 [1] and WinGX v1.70.01 [4, 
5, 6, 7] programs packages.  
[1] Bruker (2008). APEX2 (Version 2008.1-0). Bruker AXS Inc., Madison, Wisconsin, USA. 
[2] Bruker (2001b). SAINT-V6.28A. Data Reduction Software. 
[3] Sheldrick, G. M. (1996). SADABS. Program for Empirical Absorption 
Correction. University of Gottingen, Germany. 
[4] Farrugia L.J. Appl. Cryst. (1999). 32, 837±838 
[5] Sheldrick, G.M. (1997) SHELXL-97. Program for the Refinement of Crystal 
[6] Sheldrick, G.M. (1990) Acta Cryst. A46, 467-473 
- 54 - 
 
[7] Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  
 
The X-ray diffraction data for 3ab, 3ga, 5, 10 were measured on a Bruker D8 Venture PHOTON 
100 CMOS diffractometer equipped with a Cu Kα INCOATEC Imus micro-focus source (λ = 
1.54178 Å). Indexing was performed using APEX2 [1] (Difference Vectors method). Data 
integration and reduction were performed using SaintPlus 6.01 [2]. Absorption correction was 
performed by multi-scan method implemented in SADABS [3]. Space groups were determined 
using XPREP implemented in APEX2 [1]. The structure was solved using SHELXS-97 (direct 
methods) and refined using SHELXL-2013 [7] (full-matrix least-squares on F
2
) contained in 
APEX2 [1,7], WinGX v1.70.01 [4,5,6,7] and OLEX2 [7,8].  
3,5-Di
t
Bu-ChenPhyrin: All non-hydrogen atoms of porphyrin molecule were refined 
anisotropically and with restraints in case of disordered groups. The disordered atoms of solvent 
molecules have been refined isotropically. Hydrogen atoms were placed in geometrically 
calculated positions and included in the refinement process using riding model with isotropic 
thermal parameters: Uiso(H) = 1.5Ueq(-CH3), Uiso(H) = 1.2Ueq(-CH2,-CH,-NH). Structural 
voids are partially occupied by disordered solvent molecules (CHCl3, C6H14). Disordered groups 
(t-butyl, -NHCOC5H9) / molecules (CHCl3, C6H14) have been refined using geometry restraints 
(DFIX, DANG, SIMU, DELU). Some of the residual electron density peaks in structural voids 
have been modeled as oxygen molecules which could be attributed to the presence of water. 
Targeted distances have been taken from CSD (Cambridge Structural Database) search of similar 
fragments. Crystal data and refinement conditions are shown in Table 1.  
3ab: All non-hydrogen atoms were refined anisotropically. Hydrogen atoms of –CH, -CH2 and -
CH3 groups were placed in geometrically calculated positions and included in the refinement 
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process using riding model with isotropic thermal parameters: Uiso(H) = 1.2(1.5)Ueq(-CH,-
CH2(-CH3)). Crystal data and refinement conditions are shown in Tables 2.  
3da: All non-hydrogen atoms were refined anisotropically. Hydrogen atoms were placed in 
geometrically calculated positions and included in the refinement process using riding model 
with isotropic thermal parameters: Uiso(H) = 1.5Ueq(-CH3), Uiso(H) = 1.2Ueq(-CH2,-CH). 
Disordered –CF3 groups have been refined using geometry restraints (DFIX, DANG and ISOR 
for F atoms). Targeted distances have been taken from CSD (Cambridge Structural Database) 
search of similar fragments. Crystal data and refinement conditions are shown in Table 3. 
3ga: All non-hydrogen atoms were refined anisotropically. Hydrogen atoms of –CH, -CH2 and -
CH3 groups were placed in geometrically calculated positions and included in the refinement 
process using riding model with isotropic thermal parameters: Uiso(H) = 1.2(1.5)Ueq(-CH,-
CH2(-CH3)) The crystal was pseudomerohedrally twinned and was refined with (1,0,0/0,-1,0/-
1,0,-1) twinning law resulting in significant drop of R-factor (from 12% to 4.5%) and BASF of 
0.203(1). There are four molecules of analyzed compound in asymmetric unit. Crystal data and 
refinement conditions are shown in Table 4.  
5: All non-hydrogen atoms were refined anisotropically. Hydrogen atoms of -NH2 group have 
been found from difference Fourier map and were freely refined. Crystal data and refinement 
conditions are shown in Table 5.  
10: All non-hydrogen atoms were refined anisotropically. Hydrogen atoms of –CH, -CH2 and -
CH3 groups were placed in geometrically calculated positions and included in the refinement 
process using riding model with isotropic thermal parameters: Uiso(H) = 1.2(1.5)Ueq(-CH,-
CH2(-CH3)) Hydrogen atoms of –NH groups have been found from difference Fourier map and 
were freely refined. The absolute configuration for 10 has been additionally verified by Bijvoet-
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Pair Analysis and Bayesian Statistic method implemented in program Platon [9,10], in which the 
value of P2(true) gives the probability (scale 0 to 1) that the current absolute structure is the 
correct one, assuming that the compound is enantiopure. As can be seen from Table 7 the P2 
parameter equals 1 suggesting the absolute configuration of the molecule is correct. Crystal data 
and refinement conditions are shown in Tables 6.  
[1] Bruker (2013). APEX2 (Version 2013.6-2). Bruker AXS Inc., Madison, Wisconsin, USA. 
[2] Bruker (2013). SAINT-V8.32A. Data Reduction Software. 
[3] Sheldrick, G. M. (1996). SADABS. Program for Empirical Absorption 
Correction. University of Gottingen, Germany. 
[4] Farrugia L.J. Appl. Cryst. (1999). 32, 837±838 
[5] Sheldrick, G.M. (1997) SHELXL-97. Program for the Refinement of Crystal 
[6] Sheldrick, G.M. (1990) Acta Cryst. A46, 467-473 
[7] Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122. 
[8] Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H., OLEX2: A 
complete structure solution, refinement and analysis program (2009). J. Appl. Cryst., 42, 339-
341.  
[9] Spek, A.L., Acta Cryst. (1990). A46, 194-201.  
[10] Spek, A.L., Acta Cryst. (1990). A46, c34.  
Table 2.3 Crystal data and structure refinement for 3, 5-Di
t
Bu-ChenPhyrin. 
Identification code 3,5-Di
t
Bu-ChenPhyrin 
Empirical formula C85.36H100.36Cl1.84N8O4.56 
Moiety formula C84H98N8O4, 0.125(C6H14O2), 0.613(CHCl3), 0.298O 
Formula weight 1376.64 
Temperature/K 228(2) 
Crystal system monoclinic 
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Table 2.3 Continued 
Space group 
 
P21 
a/Å 17.8323(2) 
b/Å 18.4144(2) 
c/Å 25.7409(4) 
α/° 90.00 
β/° 105.8270(10) 
γ/° 90.00 
Volume/Å
3
 8132.13(18) 
Z 4 
μ/mm-1 1.082 
F(000) 2945.0 
Crystal size/mm
3
 0.21 × 0.17 × 0.13 
Radiation CuKα (λ = 1.54178) 
2Θ range for data collection/° 3.56 to 140.4 
Index ranges -21 ≤ h ≤ 21, -22 ≤ k ≤ 22, -31 ≤ l ≤ 31 
Reflections collected 97753 
Independent reflections 28950 [Rint = 0.0425, Rsigma = 0.0451] 
Data/restraints/parameters 28950/372/1988 
Goodness-of-fit on F
2
 1.034 
Final R indexes [I>=2σ (I)] R1 = 0.0564, wR2 = 0.1493 
Final R indexes [all data] R1 = 0.0705, wR2 = 0.1619 
Largest diff. peak/hole / e Å
-3
 0.59/-0.30 
Flack parameter 0.028(17) 
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Table 2.4. Crystal data and structure refinement for 3ab. 
Identification code 3ab 
Empirical formula C14H17ClO2 
Formula weight 252.72 
Temperature/K 100.04 
Crystal system orthorhombic 
Space group P212121 
a/Å 5.63770(10) 
b/Å 9.2621(2) 
α/° 90 
β/° 90 
γ/° 90 
Volume/Å
3
 1346.96(5) 
Z 4 
ρcalcg/cm
3
 1.246 
μ/mm-1 2.411 
F(000) 536.0 
Crystal size/mm
3
 0.16 × 0.09 × 0.04 
Radiation CuKα (λ = 1.54178) 
2Θ range for data collection/° 6.854 to 138.696 
Index ranges -6 ≤ h ≤ 6, -11 ≤ k ≤ 11, -30 ≤ l ≤ 30 
Reflections collected 17776 
Independent reflections 2491 [Rint = 0.0363, Rsigma = 0.0244] 
Data/restraints/parameters 2491/0/157 
Goodness-of-fit on F
2
 1.064 
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Table 2.4 Continued 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0264, wR2 = 0.0633 
Final R indexes [all data] R1 = 0.0288, wR2 = 0.0644 
Largest diff. peak/hole / e Å
-3
 0.24/-0.17 
Flack parameter 0.020(6) 
 
 
Table 2.5 Crystal data and structure refinement for compound 3da. 
Identification code 3da 
Empirical formula C15H16BrF3O2 
Formula weight 365.19 
Temperature/K 298(2) 
Crystal system monoclinic 
Space group P21 
a/Å 6.0389(5) 
b/Å 25.216(2) 
c/Å 10.7961(9) 
α/° 90.00 
β/° 90.616(5) 
γ/° 90.00 
Volume/Å
3
 1643.9(2) 
Z 4 
ρcalcmg/mm
3
 1.476 
m/mm
-1
 3.713 
F(000) 736.0 
Crystal size/mm
3
 0.24 × 0.21 × 0.14 
2Θ range for data collection 8.18 to 133.3° 
- 60 - 
 
Table 2.5 Continued 
Index ranges 
 
-6 ≤ h ≤ 6, -30 ≤ k ≤ 29, -12 ≤ l ≤ 12 
Reflections collected 12642 
Independent reflections 5246[R(int) = 0.0706] 
Data/restraints/parameters 5246/97/433 
Goodness-of-fit on F
2
 1.030 
Largest diff. peak/hole / e Å
-3
 0.30/-0.44 
Flack parameter 0.00(3) 
 
 
Table 2.6 Crystal data and structure refinement for 3ga. 
Identification code 3ga 
Empirical formula C19H21BrO2 
Formula weight 361.27 
Temperature/K 100.0 
Crystal system monoclinic 
Space group P21 
a/Å 19.6221(4) 
b/Å 6.3159(2) 
c/Å 29.7549(7) 
α/° 90 
β/° 109.0820(10) 
γ/° 90 
Volume/Å
3
 3484.94(16) 
Z 8 
ρcalcg/cm
3
 1.377 
μ/mm-1 3.244 
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Table 2.6  Continued 
F(000) 
 
1488.0 
Crystal size/mm
3
 0.08 × 0.06 × 0.01 
Radiation CuKα (λ = 1.54178) 
2Θ range for data collection/° 6.286 to 138.66 
Index ranges -23 ≤ h ≤ 23, -7 ≤ k ≤ 7, -35 ≤ l ≤ 36 
Reflections collected 45568 
Independent reflections 12107 [Rint = 0.0693, Rsigma = 0.0626] 
Data/restraints/parameters 12107/1/810 
Goodness-of-fit on F
2
 1.082 
Final R indexes [I>=2σ (I)] R1 = 0.0445, wR2 = 0.0962 
Final R indexes [all data] R1 = 0.0497, wR2 = 0.0997 
Largest diff. peak/hole / e Å
-3
 0.68/-0.45 
Flack parameter 0.022(11) 
 
 
Table 2.7 Crystal data and structure refinement for 5. 
Identification code 5 
Empirical formula C10H10ClNO 
Formula weight 195.64 
Temperature/K 100.01 
Crystal system orthorhombic 
Space group P212121 
a/Å 7.5274(2) 
b/Å 9.5790(2) 
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Table 2.7 Continued 
c/Å 
 
13.0611(3) 
α/° 90 
β/° 90 
γ/° 90 
Volume/Å
3
 941.77(4) 
Z 4 
ρcalcg/cm
3
 1.380 
μ/mm-1 3.238 
F(000) 408.0 
Crystal size/mm
3
 0.21 × 0.19 × 0.16 
Radiation CuKα (λ = 1.54178) 
2Θ range for data collection/° 11.456 to 138.666 
Index ranges -9 ≤ h ≤ 9, -11 ≤ k ≤ 11, -15 ≤ l ≤ 15 
Reflections collected 12533 
Independent reflections 1751 [Rint = 0.0290, Rsigma = 0.0155] 
Data/restraints/parameters 1751/0/126 
Goodness-of-fit on F
2
 1.109 
Final R indexes [I>=2σ (I)] R1 = 0.0256, wR2 = 0.0635 
Final R indexes [all data] R1 = 0.0261, wR2 = 0.0639 
Largest diff. peak/hole / e Å
-3
 0.34/-0.23 
Flack parameter -0.006(5) 
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Table 2.8 Crystal data and structure refinement for 10. 
Identification code 10 
Empirical formula C22H27NO2 
Formula weight 337.44 
Temperature/K 100.0 
Crystal system orthorhombic 
a/Å 9.7103(2) 
b/Å 19.6860(4) 
c/Å 20.5525(4) 
α/° 90 
β/° 90 
γ/° 90 
Volume/Å
3
 3928.75(14) 
Z 8 
ρcalcg/cm
3
 1.141 
μ/mm-1 0.565 
F(000) 1456.0 
Crystal size/mm
3
 0.26 × 0.05 × 0.02 
Radiation CuKα (λ = 1.54178) 
2Θ range for data collection/° 6.216 to 138.602 
Index ranges -11 ≤ h ≤ 11, -23 ≤ k ≤ 22, -23 ≤ l ≤ 24 
Reflections collected 33544 
Independent reflections 7273 [Rint = 0.0951, Rsigma = 0.0666] 
Data/restraints/parameters 7273/0/467 
Goodness-of-fit on F
2
 1.049 
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Table 2.8  Continued 
Final R indexes [I>=2σ (I)] 
 
R1 = 0.0452, wR2 = 0.1030 
Final R indexes [all data] R1 = 0.0576, wR2 = 0.1099 
Largest diff. peak/hole / e Å
-3
 0.19/-0.26 
Flack parameter -0.06(15) 
 
Table 2.9. Results of Bijvoet-Pair Analysis and Bayesian Statistics for compound 10. 
Space Group   P212121 
Wavelength    1.54178 
Flack x .... -0.06(15) 
Parsons z .. -0.10(16) 
Bijvoet Pairs    3171 
Coverage ...       98 
DiffCalcMax.    46.23 
Outlier Crit    92.45 
Scatter Plot 
Sigma Crit..     0.25 
Select Pairs        5 
Number Plus         4 
Number Minus        1 
Aver. Ratio     0.658 
Slope ......    0.644 
Normal Prob. Plot 
Sample Size.     3008 
Corr. Coeff.    0.999 
Intercept ..   -0.027 
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Table 2.9 Continued 
Slope ......    0.873 
Bayesian Statistics 
Type ....... Gaussian 
Select Pairs     3008 
P2(true)....    1.000 
P3(true)....    0.992 
P3(rac-twin)    0.008 
P3(false) ..  0.3E-08 
G ..........   0.9843 
G (su) .....   0.3167 
Hooft y ....  0.01(16) 
 
2.4 Conclusions  
In conclusion, the concept of Co(II)-based metalloradical catalysis (MRC) has been 
successfully applied for a new type of asymmetric radical cyclopropanation with α-
bromodiazoacetate and α-chlorodiazoacetate, marking the first effective enantioselective olefin 
cyclopropanation with α-halodiazoacetates. This operationally simple catalytic process is 
suitable for a wide range of olefin substrates with various electronic properties and 
functionalities, and allows for highly diastereo- and enantioselective formation of α-
halocyclopropylcarboxylates. These optically pure halocyclopropanes, along with their facile 
transformations into other densely-functionalized compounds, would stimulate broader 
application of chiral organic halides as versatile building blocks for accessing synthetically and 
biologically meaningful molecules. The success of this radical cyclopropanation system also 
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encourages further applications of metalloradical catalyzed selective processes with α-
halodiazoacetates and other challenging diazo reagents as radical precursors.    
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Chapter 3 
Asymmetric Bicyclization of Diazoketones via Co(II)-Based Metalloradical Catalysis 
3.1 Introduction 
As stable metalloradicals, cobalt(II) complexes of porphyrins [Co(Por)] have 
demonstrated distinctive activities in activating a broad type of diazo compounds for the 
generation of α-Co(III)-alkyl radical intermediates through single-electron radical pathway. 
Upon exposure to different olefins, cyclopropanations proceeded in high yields with excellent 
enantioselectivity as well as high diastereoselectivity.
1
 The attractive heterocyclic [3.1.0] 
structures
1c
 was achieved by intramolecular protocol with excellent enantioselectivity. We 
became intrigued by the possibility of activating olefin-containing α-acceptor substituted 
diazoketones for enantioselective synthesis of [3.1.0.]carbobicycles containing full carbons with 
[Co(Por)] catalysts, since the resulting enantioenriched [3.1.0.] bicyclic compounds containing 
full carbons with a variety of functionalities would afford versatile chiral building blocks to 
expediently access the bioactive molecules featuring chiral cyclopentanone as core moieties.
2
 In 
this bicyclization process, the putative α-Co(III)-alkyl radical A could be stabilized by the 
hydrogen-bonding with amide group of the porphyrin ligand, and would deliver radical 
intermediate B through intramolecular radical addition followed by radical substitution to release 
the bicyclic product (Figure 3.1).   
Although significant advances has been made to enantioselective intramolecular 
cyclopropanation of diazoacetates
3
 and diazoacetamides,
4
 analogous transformation for 
diazoketones finds considerably less successful,
5
 particularly for extra acceptor-substituted 
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diazoketones. Reported methods typically focused on electrophilic cyclopropanation where the 
challenges arises from due to the carbenes derived from diazoketones which are more electron-
deficient than those resulting from diazoacetates.
5e,6
 Some results also indicate that the catalytic 
systems which are capable of highly enantioselective intramolecular cyclopropanation of 
diazoacetates may not necessarily be effective for diazoketones due to the different 
conformations of the intermediates.
5h
 Successful examples of this transformation have to date 
limited to sulfonyl-substituted diazoketones by taking advantage of the big steric difference of 
sulfonyl and keto groups.
7
 The products would be more impressive and have broader synthetic 
utilities if pervasive carbonyl
8,9,10
 or cyano
11
 substituted substrates were used instead of sulfonyl 
substituted counterparts. In considering the inherent challenge of electrophilic cyclopropanation 
 
Figure 3.1. Radical Intramolecular Cyclopropanation for Enantioselective Synthesis of 
[3.1.0]Carbobicycles. 
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associated with this transformation, it would be desirable to establish a fundamentally different 
catalytic system that operates in a nonionic manner. Here, we report a highly asymmetric 
bicyclization of carbonyl and cyano substituted diazoketones via catalytic radical process that 
offers a solution to this challenge. In addition to its fundamental importance, this metalloradical 
catalysis would be synthetically attractive, as it enables the direct synthesis of architecturally 
complex polycyclic molecules possessing a variety of functionalities
12
 and contiguous three 
chiral centers from simple achiral linear precursors, therefore allowing for further stereoselective 
elaboration to afford useful cyclopentanone derivatives (eq. 1).
13,14
 
   
 
3.2 Results and Discussion 
3.2.1 Reaction Conditions Optimization  
Initial studies were focused on the reaction of α-methoxycarbonyl-α-diazoketone 1a in 
the presence of Co(II)-based metalloradical catalysts (Scheme 2). By designing [Co(Por)] 
catalysts, we were delighted to find that [Co(3,5-DitBu-QingPhyrin)] could successfully furnish 
the product in 77% yield with 78% ee. Use of the new catalyst [Co(2,6-DiMeO-Qing(2’-
Naph)Phyrin)] could substantially improve stereoselectivity of the product to complete control  
with the stereoselectivity of the product to complete control with the increment of yield to 90%. 
The effectiveness of new catalyst in this process may be due, in part, to its influence on 
electronic effect of the intermediates. It is also possible that the new ligand creates a more 
sterically accessible and stereospecifically chiral environment for radical sequence.
5h
 
Subsequently, it was revealed that this catalyst could perform as a general catalyst for 
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enantioselective intramolecular cyclopropanation of diverse α-substituted diazoketones, 
including α-esterdiazoketone 1a, α-ketodiazoketone 1b and  α-cyanodiazoketone 1c (Table1). 
Among the reaction parameters, temperature, catalyst loading, solvent and  reaction time were 
found to exert profound effects on enantioselectivity although the condition varied depending on 
the types of the diazo reagents. High yield of highly enantioenriched product was obtained with 
α-ketodiazoketone 1b under as similar reaction conditions as 1a  but reduced time was used 
(entry 2). Lower reaction temperature and elevated catalyst loadings were required for α-
cyanodiazoketone 1c to produce the desired product with high stereoselectivities (entry 3). In 
addition to acceptor-substituted diazoketones, the [Co(P2)]-based system could be also applied 
to unsubstituted diazoketone compound 1d (entry 4). Cyclopropanation of 1d offered the 
corresponding bicyclization product in a highly enantioenriched form in excellent yield at 0 ℃.   
 
Figure 3.2. New Catalyst [Co(P2)] for Enantioselective Intramolecular Cyclopropanation of α-
Esterdiazoketones 1a.  
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Table 3.1. Enantioselective Intramolecular Cyclopropanation of Allyl Diazoketones with 
Different α-Substituents.a  
 
a 
Carried out under N2  in an one-time fashion without slow addition of the diazo reagents; [diazo] 
= 0.10 M. Condition A: 40 ℃ for 72 h; 2 mol % catalyst; TBME as solvent. Condition B: 40 ℃ 
for 40 h; 2 mol % catalyst; TBME as solvent. Condition C: 10 ℃ for 72 h; 5 mol % catalyst; 
benzene as solvent. Condition D: 0 ℃ for 36 h; 2 mol % catalyst; TBME as solvent. b Isolated 
yields after column chromatography. 
c 
Determined by 
1
H NMR spectroscopy of the crude 
mixture. 
d 
Determined by chiral HPLC.   
3.2.2. Diazo Reagent Scope  
After identifying optimal catalytic conditions, we investigated the substrate scope of this 
bicyclization protocol. This reactivity profile appears to be general with a range of disparate 
examples while maintaining excellent stereoselectivities (Table 2). For example, a number of α-
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diazoketone derivatives with different α-substitutes and diverse halogenated phenyl rings all 
underwent cyclopropanation with high enantioselectivity to afford single diastereomers under the 
action of catalyst [Co(P2)] (entry 1–4). By changing electronic properties of the substituents on 
the phenyl rings, including electron-donating Me, MeO groups as well as electron-withdrawing 
F, CF3 groups (entries 5–8), the substrates could be reliably cyclopropanated to generate the 
corresponding bicyclization products 2i–l in high yields with both high diastereoselectivities and 
enantioselectivities regardless the types of the diazo reagents. Not surprisingly, the conjugated 
olefin-containing substrate is also well-suited to this process, leading to exclusive formation of 
2m with high diastereo- and enantioselectivity (entry 9). Subsequent studies were focused on 
aliphatic alkenes, which were also efficiently converted into the desired cyclopropanes as 
exemplified with  highly diastereoselective formation of 2n and 2o, despite moderate 
enantioselectivities facilitated by [Co(P1)] which provided relatively higher enantiocontrol than 
[Co(P2)] did. To illustrate the preparative utility of this methodology, the synthesis of 2j was 
carried out successfully on 0.65 gram of starting material without any diminishment in reactivity 
and stereocontrol (entries 6). The absolute configuration of 2e was identified to be (1R,5S,6S) by 
X-ray crystal structural analysis. The configurations of the rest were assigned by analogy. 
Several different unsubstituted α-diazoketone derivatives were also examined with varied 
substitutes on the phenyl rings at different positions, including a thiophene-based substrate, 
similar reactivities and selectivities were observed (entries 12–15). The absolute configuration of 
2p was established to be  (1R,5R,6R) by X-ray crystal structural analysis. The configurations of 
2q, 2r, 2s were assigned by analogy. 
3.2.3 Further Transformations  
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Table 3.2. [Co(P2)]-Catalyzed Enantioselective Synthesis of Bicylo[3.1.0]alkanes with Various 
Allyl Diazoketones.
a
 
 
a
 Carried out in different conditions depending on the type of diazo reagents as shown in 
footnotes in Table 3.1; isolated yields after column chromatography; dr determined by 
1
H NMR 
spectroscopy of the crude mixture; ee determined by chiral HPLC. 
b
 [1R,5S,6S] Absolute 
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configuration determined by X-ray crystal structural analysis. 
c
 2j was prepared on a 2.5 mmol 
scale. 
d
 5 mol % [Co(P1)] as catalyst. 
e
 Room temperature. 
f
 [1R,5R,6R] Absolute configuration 
determined by X-ray crystal structural analysis.   
 
In order to better establish the synthetic utility of this chiral [3.1.0]carbobicycles 
synthetic methodology, we sought to develop protocols to provide access to other 
cyclopentanone and fused cyclopentanone derivatives. The combined effects of vicinal electron-
donating and electron-accepting moieties on the cyclopropanes render them prone to be easily 
opened.
2a
 Accordingly, 2a and 2j were subjected to hydrogenation reaction to afford optically 
active α,β-disubstituted cyclopentanones 3a and 3j in high yields and high enantiomeric 
excesses, respectively. Although optically active 3a and 3j could be prepared by using α-
esterdiazoketone compounds via C-H insertion, it has not shown comparable stereocontrol and 
remains a challenge for catalyst development via C-H insertion of α-esterdiazoketones.15 
Application of the hydrogenation protocol to 2d led to high yields of β-substituted 
cyclopentanone 3d with 92% ee (entry 3). Structurally similar compounds 2q and 2r could also 
be applied to the ring-opening reaction to afford the desired products in high yields without 
significant loss of enantiomeric excess (entries 4 and 5). This method provided an alternative 
means to access chiral β-substituted cyclopentanones in addition to asymmetric conjugate 
reduction
16
 and asymmetric hydrogenation of cyclic enones.
17
    
Also, the cyclopropane ring can be enlarged through [3+2] dipolar cycloaddition. When 
benzaldehyde was used as dipolarophile,
1c,14i-m
 highly functionalized bicyclic cyclopentanone 4 
was furnished as a single isomer in 85% yield with high retention of the original optical purity 
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(eq. 2). The absolute configuration of 4 was determined to be (1S,3S,3aR,6aR) by X-ray crystal 
structural analysis.   
 
Table 3.3.  Hydrogenation of [3.1.0]Carbobicycles for the Synthesis of Enantioenriched 
Cyclopentanone Derivatives.
a 
 
a 
Carried out at room temperature for 14 h under 1 atm H2 atmosphere using 0.3 mmol substrate 
and 22 mg 10% Pd/C in 1.8 mL MeOH. 
b
 Isolated yields after column chromatography. 
c 
Determined by 
1
H NMR spectroscopy of the crude mixture. 
d 
Determined by chiral HPLC. 
e 
Determined by chiral HPLC after derivatization.       
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3.3 Experiment Section 
General Considerations 
All reactions were carried out under a nitrogen atmosphere in oven-dried glassware 
following standard Schlenk techniques. Methyl tert-butyl ether and Benzene (Anhydrous, ≥99%) 
were used directly from Sigma-Aldrich Chemical Co. Dichloromethane and Acetonitrile were 
freshly distilled from CaH prior to use. Tetrahydrofuran and Toluene were freshly distilled from 
Na prior to use. Thin layer chromatography was performed on Merck TLC plates (silica gel 60 
F254) visualizing with UV-light 254 nm or 365 nm fluorescence quenching, and cerium 
ammonium-molybdate (CAM) stain (ammonium pentamolybdate, cerium(IV) sulfate, sulfuric 
acid aqueous solution). Flash column chromatography was performed with ICN silica gel (60 Å, 
230-400 mesh, 32-63 μm). Nuclear magnetic resonance spectra were recorded on a Bruker a 
Bruker 500-MHz, 400-MHz or 250-MHz instrument. Chemical shifts for protons are reported in 
parts per million downfield from tetramethylsilane and are referenced to residual protium in the 
NMR solvent (CHCl3 = 7.26 ppm). Chemical shifts for carbon are reported in parts per million 
downfield from tetramethylsilane and are referenced to the carbon resonances of the solvent 
residual peak (CDCl3 = 77.16 ppm). 
19
F spectra were recorded on a Bruker 400 spectrometer 
(376 MHz), using CFCl3 (δ=0) as internal standard. HPLC measurements were carried out on a 
Shimadzu HPLC system with Whelk-O1, Chiralcel OD-H, OJ-H, and AD-H columns. Infrared 
spectra were measured with a Nicolet Avatar 320 spectrometer with a Smart Miracle accessory. 
HRMS data was obtained on an Agilent 1100 LC/MS ESI/TOF mass spectrometer with 
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electrospray ionization. Optical rotations were measured on a Rudolph Research Analytical 
AUTOPOL® IV digital polarimeter.  
Catalyst Synthesis: 
 
 
 
tert-butyl (1R,2R)-2-methyl-2-(naphthalen-2-yl)cyclopropane-1-carboxylate:  
[Co(3,5-di-
t
butylChenPhyrin)]
1k
 (1 mol %) and DMAP (40 mol %) were placed in an 
oven-dried, resealable Schlenk tube. The tube was capped with a Teflon screwcap, evacuated, 
and backfilled with nitrogen. The screwcap was replaced with a rubber septum, and toluene (9 
mL) and 3.0 equiv of 2-(prop-1-en-2-yl)naphthalene (4.5 mmol) were added via syringe, after 
cooled to -20 ℃ , followed by 1.0 equiv of tert-butyl 2-diazoacetate (1.5 mmol) and toluene 
again (2 mL). The tube was purged with nitrogen for 1 min and its contents were stirred at -20 ℃ 
for one day, then 0 ℃ for one day. After the reaction finished, the resulting mixture was 
concentrated and the residue was purified by flash silica gel chromatography to give the tert-
butyl (1R,2R)-2-methyl-2-(naphthalen-2-yl)cyclopropane-1-carboxylate in 67% yield. Rf = 0.65 
(hexanes/ethyl acetate 15:1). 
1
H NMR (500 MHz, CDCl3) δ 7.82 – 7.74 (m, 4H), 7.53 – 7.39 (m, 
3H), 2.02 (dd, J = 7.9, 6.4 Hz, 1H), 1.62 (s, 3H), 1.53 (s, 9H), 1.49 – 1.44 (m, 2H). 13C NMR 
(126 MHz, CDCl3) δ 171.5, 143.7, 133.5, 132.2, 128.3, 127.8, 127.7, 126.3, 125.9, 125.7, 125.7, 
80.6, 30.2, 29.2, 28.5, 20.5, 19.8.  IR (neat, cm
-1
): 3054, 2919, 1716, 1443, 1392, 1265, 1150, 
734, 704. HRMS (ESI) ([M+Na]
+) Calc’d. for C19H22NaO2: 305.1512; Found 305.1523.  
(1R,2R)-2-methyl-2-(naphthalen-2-yl)cyclopropane-1-carboxamide:  
A 100 mL flask was charged with tert-butyl (1R,2R)-2-methyl-2-(naphthalen-2-
yl)cyclopropane-1-carboxylate (1.0 mmol), 30 equiv of trifluoroacetic acid and Dichloromethane 
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(15 mL). The mixture was stirred at room temperature for 12 h tracked with TLC. After the 
reaction was done, DCM and TFA was removed under Rotavape affording the free acid. The 
flask was charged with 30 mL DCM and oxayl chloride (300 mg, 1.95 mmol), and then was 
cooled to 0 ℃. 2 - 3 drops of DMF was added. The mixture was stirred for 2 h under 0 ℃ then 5 
h under room temperature, remove oxayl chloride and DCM under Rotavape, the residue was 
then dissolved in 30 mL DCM again and added dropwise to the saturate NH3/MeOH solution (10 
equiv). After reaction finished, the resulting mixture was concentrated under Rotavape, and the 
residue was purified by flash silica gel chromatography to afford the (1R,2R)-2-methyl-2-
(naphthalen-2-yl)cyclopropane-1-carboxamide with 78% overall yield. The product was 
recrystallized from MeOH/DCM/Hexane to further improve the enantio- purity to >99% ee with 
only one diastereomer. 
1
H NMR (500 MHz, CDCl3) δ 7.83 – 7.78 (m, 3H), 7.73 (d, J = 1.6 Hz, 
1H), 7.54 – 7.43 (m, 2H), 7.40 (dd, J = 8.6, 1.8 Hz, 1H), 5.68 (d, J = 41.8 Hz, 2H), 1.86 (dd, J = 
8.3, 5.9 Hz, 1H), 1.64 (s, 3H), 1.60 – 1.52 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 172.9, 143.5, 
133.5, 132.2, 128.4, 127.7,127.7, 126.4, 125.8, 125.5,125.4, 30.0, 29.8, 19.9, 19.3. HRMS (ESI) 
([M+H]
+) Calc’d. for C15H16NO: 226.1226; Found 226.1220. IR (neat, cm
-1
): 3006, 1682, 1590, 
1411, 1276, 764. [α]20D  = - 225.26 (c = 0.76, MeOH). HPLC analysis: ee > 99 %. OD-H (80% 
hexanes: 20% isopropanol, 0.8 mL/min): tmajor = 14.6 min, tminor = 12.1 min.  
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H2P2 were synthesized according to our previous reported procedure with 56% yield.
1k 
Rf = 0.32 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3) δ 9.05 (d, J = 4.2 Hz, 4H), 8.96 (d, J = 
4.7 Hz, 4H), 8.61 (d, J = 8.0 Hz, 4H), 7.99 (t, J = 8.2 Hz, 3H), 7.58 (t, J = 8.5 Hz, 2H), 6.82 – 
6.62 (m, 12H), 6.52 (brs, 4H), 6.27 (brs, 4H), 5.57 (s, 4H), 5.30 (brs, 5H), 5.10 (brs, 4H), 4.81 
(brs, 4H), 2.44 (s, 12H), 1.54 (brs, 4H), 0.96 (s, 12H), 0.38 (brs, 4H), -0.19 (brs, 4H), -1.79 (s, 
2H). 
13
C NMR (125 MHz, CDCl3) δ 168.7, 160.5, 141.7, 139.4, 131.8, 130.8, 130.7, 130.6, 
126.6, 126.5, 126.2, 124.7, 124.4, 124.2, 124.1, 117.5, 116.7, 115.6, 107.1, 103.7, 54.5, 30.1, 
30.0, 19.8 , 17.6. HRMS (ESI) ([M+H]
+) Calc’d. for C108H91N8O8: 1627.6954; Found 1627.6895. 
UV–vis (CHCl3): λmax nm (log ε): 424(3.30), 516(2.63), 552(2.49), 598(2.47), 648(2.42). 
 
 
[Co(P2)] were synthesized according to our previous reported procedure with 95% yield.
1k
 Rf = 
0.32 (hexanes/ethyl acetate 4:1). HRMS(ESI) ([M+H]
+
) Calcd. for C108H89CoN8O8: 1684.6130, 
Found 1684.6094. UV–vis (CHCl3), λmax nm (log ε): 444(2.97), 562(2.21), 612(1.94).  
General procedure for preparation of methyl α-esterdiazoketones:  
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A 25 mL round bottom flask was charged with β-ketoester (1 mmol, 1 equiv) and para-
acetamidobenzenesulfonyl azide (1.1 mmol, 1.1 equiv) and CH3CN (10 mL), followed by 
cooling to 0 °C in an ice bath. Triethylamine (3.3 mmol, 3.3 equiv) was added in 10 minutes and 
a clear yellow solution resulted. After finishing the addition of triethylamine, the reaction was 
allowed to warm to room temperature, during which time a flocculent white precipitate occurred. 
After 3 h, TLC analysis indicated complete consumption of the starting material, the precipitate 
was filtered. The solvent was concentrated under reduced pressure, and the crude residue was 
purified by flash chromatography yielding α-esterdiazoketones.  
  
methyl (E)-2-diazo-3-oxo-7-phenylhept-6-enoate (1a): 97% yield. Rf = 0.80 (hexanes/ethyl 
acetate 4:1). 
1
H NMR (500 MHz, CDCl3) 7.34 – 7.32 (m, 2H), 7.30 – 7.26 (m, 2H), 7.22 – 7.18 
(m, 1H), 6.44 (d, J = 15.8 Hz, 1H), 6.24 (dt, J = 15.8, 6.9 Hz, 1H), 3.84 (s, 3H), 3.04 (t, J = 7.4 
Hz, 2H), 2.56 (qd, J = 7.3, 1.4 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) 192.0, 161.9, 137.6, 
131.0, 128.9, 128.6, 127.2, 126.2, 52.33, 40.0, 27.7. HRMS (ESI) ([M+Na]
+) Calc’d. for 
C14H14N2NaO3: 281.0897; Found 281.0889. IR (neat, cm
-1
): 3025, 2954, 1716, 1652, 1435, 1305, 
1208, 1055, 964, 742.  
  
methyl (E)-7-(2-bromophenyl)-2-diazo-3-oxohept-6-enoate (1e): 93% yield. Rf = 0.82 
(hexanes/ethyl acetate 4:1). 
1
H NMR (400 MHz, CDCl3)  7.49 (ddd, J = 17.9, 7.9, 1.4 Hz, 2H), 
7.23 (t, J = 7.9, 1H), 7.05 (td, J = 7.8, 1.7 Hz, 1H), 6.76 (d, J = 15.7 Hz, 1H), 6.19 (dt, J = 15.7, 
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6.9 Hz, 1H), 3.84 (s, 3H), 3.06 (t, J = 7.3 Hz, 2H), 2.60 (qd, J = 7.2, 1.5 Hz, 2H). 
13
C NMR (100 
MHz, CDCl3) 191.8, 161.9, 137.4, 132.9, 132.0, 129.9, 128.5, 127.5, 127.1, 123.3, 52.34, 39.8, 
27.8. HRMS (ESI) ([M+H]
+) Calc’d. for C14H14BrN2O3: 337.0182. Found 337.0179. IR (neat, 
cm
-1
): 3056, 2955, 2138, 1720, 1650, 1437, 1308, 1265, 1022, 964, 734.   
  
methyl (E)-7-(4-chlorophenyl)-2-diazo-3-oxohept-6-enoate (1f): 95% yield. Rf = 0.63 
(hexanes/ethyl acetate 5:1). 
1
H NMR (500 MHz, CDCl3)  7.25 (s, 4H), 6.38 (dt, J = 15.8, 1.4 Hz, 
1H), 6.21 (dt, J = 15.8, 6.9 Hz, 1H), 3.84 (s, 3H), 3.03 (t, J = 7.3 Hz, 2H), 2.55 (qd, J = 7.3, 1.4 
Hz, 2H). 
13
C NMR (125 MHz, CDCl3) 191.9, 161.9, 136.1, 132.7, 129.8, 129.7, 128.7, 127.4, 
52.4, 39.8, 27.6. HRMS (ESI) ([M+Na]
+) Calc’d. for C14H13ClN2NaO3: 315.0507. Found 
315.0496. IR (neat, cm
-1
): 2954, 1717, 1652, 1490, 1408, 1436, 1307, 1090, 804, 744.   
 
methyl (E)-2-diazo-7-(4-methoxyphenyl)-3-oxohept-6-enoate (1g): 95% yield. Rf = 0.71 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3): 7.26 (d, J = 8.8 Hz, 2H), 6.83 (d, J = 
8.8 Hz, 2H), 6.39 (d, J = 15.8 Hz, 1H), 6.10 (dt, J = 15.8, 6.9 Hz, 1H), 3.85 (s, 3H), 3.81 (s, 3H), 
3.03 (t, J = 7.5 Hz, 2H), 2.54 (q, J = 7.3, 1.4 Hz, 2H). 
13
C NMR (125 MHz, CDCl3): 192.1, 
161.9, 158.9, 130.4, 127.3, 126.7, 114.0, 55.4, 52.4, 40.2, 27.7. HRMS (ESI) ([M+H]
+) Calc’d. 
for C15H16N2NaO4: 311.1002. Found 311.1008. IR (neat, cm
-1
): 3055, 1721, 1608, 1438, 1265, 
1134, 1034, 732.  
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methyl (E)-2-diazo-3-oxo-7-(4-(trifluoromethyl)phenyl)hept-6-enoate (1l): 90% yield. Rf = 
0.77 (hexanes/ethyl acetate 4:1). 
1
H NMR (400 MHz, CDCl3) δ 7.53 (d, J = 8.6 Hz, 2H), 7.41 (d, 
J = 8.1 Hz, 2H), 6.47 (d, J = 16.1 Hz, 1H), 6.34 (dt, J = 16.0, 6.0 Hz, 1H), 3.84 (s, 3H), 3.05 (t, J 
= 7.3 Hz, 2H), 2.59 (q, J = 7.1 Hz, 2H). 
19
F NMR (376 MHz, CDCl3) δ -63.0 (s). 
13
C NMR (100 
MHz, CDCl3) δ 191.6(s), 161.7(s), 140.9(s), 131.6(s), 129.7(s), 128.9(d, J = 30 Hz), 126.1(s), 
125.4 (q, J = 4 Hz), 127.3 (d, J = 327 Hz), 52.2(s), 39.5(s), 27.4(s). HRMS (ESI) ([M+H]
+
) 
Calc’d. for C15H14F3N2O3: 327.0951. Found 327.0957. IR (neat, cm
-1
): 3004, 2141, 1721, 1651, 
1438, 1325, 1275, 1124, 1067, 749.   
  
methyl (6E,8E)-2-diazo-3-oxo-9-phenylnona-6,8-dienoate (1m): 94% yield. Rf = 0.44 
(hexanes/ethyl acetate 5:1).  
1
H NMR (500 MHz, CDCl3) 7.38 – 7.36 (m,  2H), 7.31 – 7.27 (m, 
2H), 7.23 – 7.16 (m, 1H), 6.73 (dd, J = 15.6, 10.4 Hz, 1H), 6.46 (d, J = 15.7 Hz, 1H), 6.26 (ddd, J 
= 15.1, 10.4, 0.6 Hz, 1H), 5.89 – 5.79 (m, 1H), 3.84 (s, 3H), 3.00 (t, J = 7.4 Hz, 2H), 2.50 (q, J = 
6.8 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) 192.0, 161.9, 137.6, 133.4, 131.7, 131.0, 129.1, 
128.7, 127.4, 126.3, 52.4, 39.9, 27.5. HRMS (ESI) ([M+Na]
+) Calc’d. for C16H16N2NaO3: 
307.1053. Found 307.1042. IR (neat, cm
-1
): 3024, 2955, 1720, 1652, 1437, 1310, 1127, 990, 735.  
General procedure for preparation of α-ketodiazoketones:  
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Procedure for α-ketodiazoketones was the same as the preparation of methyl α-esterdiazoketones.  
  
(E)-3-diazo-8-phenyloct-7-ene-2,4-dione (1b): 92% yield. Rf = 0.72 (hexanes/ethyl acetate 5:1). 
1
H NMR (500 MHz, CDCl3)  7.36 – 7.27 (m, 4H), 7.23 – 7.18 (m, 1H), 6.44 (d, J = 15.8 Hz, 
1H), 6.22 (dt, J = 15.8, 7.0 Hz, 1H), 2.92 (t, J = 7.3 Hz, 2H), 2.57 (q, J = 7.2, 1.4 Hz, 2H), 2.44 (s, 
3H). 
13
C NMR (100 MHz, CDCl3) 190.4, 188.3, 137.4, 131.4, 128.6, 128.4, 127.3, 126.2, 84.2, 
40.5, 28.7, 27.4. HRMS (ESI) ([M+Na]
+) Calc’d. for C14H14N2NaO2: 265.0947. Found 265.0955. 
IR (neat, cm
-1
): 3056, 2120, 1665, 1493, 1365, 1265, 1197, 965, 732, 702.  
   
(E)-8-(4-bromophenyl)-3-diazooct-7-ene-2,4-dione (1g): 87% yield. Rf = 0.27 (hexanes/ethyl 
acetate 10:1). 
1
H NMR (500 MHz, CDCl3)  7.42 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 8.5 Hz, 2H), 
6.39 (d, J = 15.8 Hz, 1H), 6.23 (dt, J = 15.8, 6.9 Hz, 1H), 2.94 (t, J = 7.2 Hz, 2H), 2.57 (q, J = 7.1 
Hz, 2H), 2.45 (s, 3H). 
13
C NMR (125 MHz, CDCl3)  190.4, 188.1, 136.4, 131.7, 130.2, 129.4, 
127.7, 121.0, 84.3, 40.3, 28.6, 27.4. HRMS (ESI) ([M+Na]
+) Calc’d. for C14H13BrN2NaO2: 
343.0053. Found: 343.0041. IR (neat, cm
-1
): 2923, 1657, 1487, 1400, 1363, 1290, 964, 804, 613.  
  
(E)-3-diazo-8-(2,6-difluorophenyl)oct-7-ene-2,4-dione (1k): 81% yield. Rf = 0.30 
(hexanes/ethyl acetate 10:1). 
1
H NMR (500 MHz, CDCl3)  7.18 – 7.07 (m, 1H), 6.86 (t, J = 8.6 
Hz, 2H), 6.57 – 6.45 (m, 2H), 2.94 (t, J = 7.3 Hz, 2H), 2.63 (q, J = 7.5 Hz, 2H), 2.46 (s, 3H). 19F 
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NMR (376 MHz, CFCl3, CDCl3) δ -114.4 (m, 2F). 
13
C NMR (126 MHz, CDCl3) 161.9 (d, J = 
7.5 Hz), 159.9 (d, J = 7.5 Hz), 135.9 (t, J = 7.5 Hz), 127.7 (t, J = 10.0 Hz), 117.9 (t, J = 1.2 Hz), 
114.6 (t, J = 14.5 Hz), 111.6 (d, J = 5.0 Hz), 111.5 (d, J = 5.0 Hz),  84.3(s), 40.2(s), 28.7(s). 
HRMS (ESI) ([M+H]
+) Calc’d. for C14H13F2N2O2: 279.0940. Found 279.0936. IR (neat, cm
-1
): 
3076, 2898, 1666, 1646, 1463, 1238, 970,791, 634.     
General procedure for preparation of α-cyanodiazoketones:18  
 
Imidazole-1-sulfonylazide (1.3 mmol, 1.3 equiv) was added to the substrate (1.0 mmol, 1 
equiv) and pyridine (5.0 mmol, 5 equiv) in MeCN (5 mL) and the mixture stirred at 35 C. The 
reaction was tracked by TLC. After all starting material was consumed, the mixture was diluted 
with EtOAc (15 mL), washed with hydrochloric acid (2 ×15 mL, 1 M), H2O (15 mL), dried with 
Na2SO4, filtered and concentrated. Purification with flash chromatography gave α-
cyanodiazoketones.  
  
(E)-2-diazo-3-oxo-7-phenylhept-6-enenitrile (1c): 73% yield. Rf = 0.50 (hexanes/ethyl acetate 
4:1). 
1
H-NMR (500 MHz, CDCl3) 7.38 – 7.27 (m, 4H), 7.24 – 7.21 (m, 1H), 6.46 (d, J = 15.8 
Hz, 1H), 6.19 (dt, J = 15.8, 6.9 Hz, 1H), 2.81 (t, J = 7.3 Hz, 2H), 2.61 (qd, J = 7.1, 1.3 Hz, 2H). 
13
C NMR (125 MHz, CDCl3)  189.5, 137.1, 132.0, 128.7, 127.5, 127.3, 126.3, 108.5, 39.2, 27.7. 
HRMS (ESI) ([M+NH4]
+) Calc’d. for C13H15N4O: 243.1209. Found 243.1220. IR (neat, cm
-1
): 
2906, 2151, 1669, 1439, 1369, 1264, 971, 748. 694.  
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(E)-7-(4-bromophenyl)-2-diazo-3-oxohept-6-enenitrile (1h): 74% yield. Rf = 0.52 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3)  7.42 (d, J = 8.5 Hz, 2H), 7.20 (d, J = 
8.5 Hz, 2H), 6.40 (d, J = 15.8 Hz, 1H), 6.19 (dt, J = 15.8, 6.9 Hz, 1H), 2.82 (t, J = 7.2 Hz, 2H), 
2.60 (qd, J = 7.1, 1.3 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) 189.4, 136.1, 131.8, 130.9, 128.2, 
127.8, 121.3, 108.5, 39.1, 31.1, 27.6. HRMS (ESI) (M - H]
-) Calc’d. for C13H9BrN3O: 301.9935. 
Found 301.9946. IR (neat, cm
-1
): 3058, 2987, 2127, 1677, 1421, 1264, 895, 733, 704.  
  
(E)-2-diazo-7-(3,5-dimethylphenyl)-3-oxohept-6-enenitrile (1i): 71% yield. Rf = 0.78 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3) 6.98 (s, 2H), 6.88 (s, 1H), 6.40 (d, J = 
15.8 Hz, 1H), 6.17 (dt, J = 15.7, 6.9 Hz, 1H), 2.81 (t, J = 7.2 Hz, 2H), 2.60 (q, J = 7.1 Hz, 2H), 
2.31 (s, 6H). 
13
C NMR (125 MHz, CDCl3) 189.6, 138.2, 137.0, 132.1, 129.3, 126.8, 124.2, 
108.5, 39.3, 29.9, 27.7, 21.4. HRMS (ESI) ([M - H]
-) Calc’d. for C15H14N3O: 252.1142. Found 
252.1161. IR (neat, cm
-1
): 3020, 2918, 2851, 2119, 1678, 1598, 1175, 966, 712.  
  
(E)-2-diazo-3-oxo-9-phenylnon-6-enenitrile (1n): 84% yield. Rf = 0.61 (hexanes/ethyl acetate 
4:1). 
1
H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.23 – 7.15 (m, 3H), 5.59 – 5.50 (m, 
1H), 5.42 (m, 1H), 2.67 (dd, J = 14.4, 7.2 Hz, 4H), 2.43 – 2.27 (m, 4H). 13C NMR (125 MHz, 
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CDCl3) δ 189.8, 141.9, 131.9, 128.6, 128.4, 127.9, 125.9, 108.6, 39.5, 35.9, 34.3, 27.3. HRMS 
(ESI) ([M - H]
-) Calc’d. for C15H14N3O: 252.1143. Found 252.1169. IR (neat, cm
-1
): 2934, 2223, 
1680, 1275, 1182, 970, 749.  
  
(E)-7-cyclohexyl-2-diazo-3-oxohept-6-enenitrile (1o): 70% yield. Rf = 0.75 (hexanes/ethyl 
acetate 3:1). 
1
H NMR (400 MHz, CDCl3) δ 5.47 – 5.36 (m, 1H), 5.37 – 5.30 (m, 1H), 2.64 (t, J = 
7.3 Hz, 2H), 2.42 – 2.30 (m, 2H), 1.95 – 1.80 (m, 1H), 1.77 – 1.62 (m, 6H), 1.35 – 0.89 (m, 6H). 
13
C NMR (100 MHz, CDCl3) δ 189.9, 138.9, 124.4, 108.6, 40.7, 39.7, 33.1, 28.7, 27.5, 26.3, 26.2, 
25.4. HRMS (ESI) ([M - H]-) Calc’d. for. C13H16N3O: 230.1299. Found 230.1329. IR (neat, cm
-1
): 
2926, 2126, 1678, 1276,  1182, 970, 764.  
General procedure for synthesis of unsubstituted diazoketones:  
 
The preparation of unsubstituted α-diazo ketones was based on the reported procedure:19   
The acid (1 equiv, 1 mmol) was reacted with oxalyl chloride(1.7 mmol, 1.7 equiv) for 1 h in dry 
DCM under N2. The reaction mixture was concentrated by rotary evaporation to give a brown 
liquid which can be used for the next step without further purification. The residual from the 
above step was dissolved in CH3CN (5 mL), followed by the addition of TMSCHN2 (2.0 mmol, 
2.0 equiv) at 0°C. The reaction mixture was allowed to stir for 24 h. The reaction was quenched 
with satd. NaHCO3, extracted with DCM and dried over Na2SO4. Purification of the product by 
column chromatography on silica gel gave the pure  diazo compounds.   
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(E)-1-diazo-6-phenylhex-5-en-2-one (1d): 76% yield. Rf = 0.52 (hexanes/ethyl acetate 5:1). 
1
H 
NMR (400 MHz, CDCl3) δ 7.25 – 7.09 (m, 5H), 6.33 (d, J = 15.8 Hz, 1H), 6.10 (dt, J = 15.8, 6.7 
Hz, 1H), 5.17 (s, 1H), 2.46 – 2.41 (m, 4H). 13C NMR (101 MHz, CDCl3) δ 194.1, 137.4, 131.1, 
128.6, 127.2, 126.1, 54.6, 40.5, 28.4. IR (neat, cm
-1
): 3083, 3025, 2919, 2098, 1634, 1492, 1446, 
1346, 1319, 1140, 964, 744, 693.  
 
(E)-6-(2-bromophenyl)-1-diazohex-5-en-2-one (1p): 84% yield. Rf = 0.50 (hexanes/ethyl 
acetate 5:1). 
1
H NMR (400 MHz, CDCl3) 7.51 (dd, J = 8.0, 1.2 Hz, 1H), 7.45 (dd, J = 7.8, 1.6 
Hz, 1H), 7.23 (t, J = 7.5 Hz, 1H), 7.06 (dd, J = 7.7, 1.6 Hz, 1H), 6.74 (d, J = 15.7 Hz, 1H), 6.15 
(dt, J = 15.7, 6.7 Hz, 1H ), 5.30 (brs, 1H), 2.60 – 2.50(m, 4H). 13C NMR (100 MHz, CDCl3) 
194.0, 137.2, 132.9, 131.7, 129.9, 129.0, 127.5, 127.0, 123.3, 54.7, 40.3, 28.4. HRMS (ESI) 
([M+H]
+) Calc’d. for C12H12BrN2O: 279.0128; Found 279.0115. IR (neat, cm
-1
): 3054, 2986, 
1642, 1368, 1139, 1023, 962.   
 
(E)-1-diazo-6-(m-tolyl)hex-5-en-2-one (1q): 73% yield. Rf = 0.55 (hexanes/ethyl acetate 5:1) 
1
H NMR (500 MHz, CDCl3) 7.21 – 7.13 (m, 3H), 7.03 (d, J = 7.4 Hz, 1H), 6.40 (d, J = 15.8 Hz, 
1H), 6.22 – 6.16 (m, 1H), 5.27 (brs, 1H), 2.54 – 2.48 (m, 4H), 2.34 (m, 3H). 13C NMR (100 MHz, 
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CDCl3)  194.2, 138.1, 137.3, 131.2, 128.5, 128.3, 128.0, 126.8, 123.3, 54.6, 40.6, 28.4, 21.5. IR 
(neat, cm
-1
): 3054, 2986, 1642, 1368, 1139, 1023, 962.    
 
(E)-1-diazo-6-(4-methoxyphenyl)hex-5-en-2-one (1r): 61% yield. Rf = 0.47 (hexanes/ethyl 
acetate 5:1). 1H NMR (500 MHz, CDCl3)  7.27 (d, J = 7.9 Hz, 2H), 6.82 (d, J = 8.7 Hz, 2H), 
6.38 (d, J = 15.8 Hz, 1H), 6.05 (dt, J = 16.0, 8.0 Hz, 1H), 5.27 (s, 1H), 3.80 (s, 3H), 2.52 - 2.49 
(m, 4H). 
13
C NMR (125 MHz, CDCl3) 
 
194.3, 159.0, 130.5, 130.2, 127.3, 126.4, 114.0, 55.4, 
54.7, 40.8, 28.5. HRMS (ESI) ([M+Na]
+) Calc’d. for C13H14N2NaO2: 253.0947; Found 253.0953. 
IR (neat, cm
-1
): 3098, 2932, 2836, 1634, 1605, 1509, 1245, 1369, 1032, 965.   
 
(E)-1-diazo-6-(thiophen-2-yl)hex-5-en-2-one (1s): 67% yield. Rf = 0.52 (hexanes/ethyl acetate 
5:1). 
1
H NMR (400 MHz, CDCl3) 7.09 (d, J = 5.1 Hz, 1H), 6.93 – 6.87 (m, 2H), 6.54 (d, J = 
15.6 Hz, 1H), 6.02 (dt, J = 15.5, 6.7 Hz, 1H), 5.26 (s, 1H), 2.50 – 2.28 (m, 4H). 13C NMR (100 
MHz, CDCl3)193.9, 142.5, 128.4, 127.3, 124.9, 124.3, 123.6, 54.6, 40.3, 28.1. IR (neat, cm
-1
): 
3117, 3053, 2912, 1636, 1371, 1263, 1144, 964.   
General procedure for enantioselective intramolecular cyclopropanation of diazoketones:  
An oven dried Schlenk tube, that was previously evacuated and backfilled with nitrogen 
gas, was charged with catalyst. The Schlenk tube was then evacuated and back filled with 
nitrogen. The Teflon screw cap was replaced with a rubber septum and 1.0 mL portion of solvent 
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was added followed by diazo (0.2 mmol), and the remaining solvent (total 1.0 mL). The Schlenk 
tube was then purged with nitrogen for 1 minute and the rubber septum was replaced with a 
Teflon screw cap. The Schlenk tube was then placed in an oil bath for the desired time and 
temperature (if the reaction was at 0 ℃, the Schlenk tube was initially placed in ice bath). 
Following completion of the reaction, the reaction mixture was purified by flash chromatography. 
The fractions containing product were collected and concentrated by rotary evaporation to afford 
the compound. In some cases, the product was visualized on TLC using the cerium ammonium 
molybdate (CAM) stain.  
Condition A: Condition A was applicable to α-esterdiazoketones. Reactions were carried out at 
40 ℃ for 72 h in an one-time fashion without slow addition of the diazo reagents by using 2 mol % 
catalyst and TBME as solvent under N2.  [diazo] = 0.10 M;  
Condition B: Condition B was applicable to α-ketodiazoketones. Reactions were carried out at 
40 ℃ for 40 h  in an one-time fashion without slow addition of the diazo reagents by using 2 
mol % catalyst and TBME as solvent under N2.  [diazo] = 0.10 M;   
Condition C: Condition C was applicable to α-cyanodiazoketones. Reactions were carried out at 
10 ℃ for 72 h in an one-time fashion without slow addition of the diazo reagents by using 5 mol % 
catalyst and benzene as solvent under N2.  [diazo] = 0.10 M;   
Condition D: Condition D was applicable to unsubstituted α-diazoketones. Reactions were 
carried out at 0 ℃ for 36 h in a one-time fashion without slow addition of the diazo reagents by 
using 2 mol % catalyst and TBME as solvent under N2. [diazo] = 0.10 M.  
General procedure for preparation of racemic samples:  
The cyclopropanation reactions were carried out as the same procedures as above, but replacing 
the chiral catalyst with [Co(3,5-di-tBuIbuPhyrin)].  
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methyl 2-oxo-6-phenylbicyclo[3.1.0]hexane-1-carboxylate (2a): 90% yield. Rf = 0.20 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3)  7.30 – 7.25 (m, 3H), 7.22 – 7.20 (m, 
2H), 3.43 (s, 3H), 3.16 (t, J = 5.6 Hz,1H), 2.92 (d, J = 5.0 Hz, 1H), 2.39 – 2.32 (m, 3H), 2.20 – 
2.14 (m, 1H). 
13
C NMR (125 MHz, CDCl3)  206.3, 165.4, 133.5, 128.6, 128.50, 127.9, 52.3, 
47.8, 38.2, 33.5, 31.6, 21.2. HRMS (ESI) ([M+H]
+) Calc’d. for C14H15O3: 231.1016; Found 
231.1021. IR (neat, cm
-1
): 2950, 1749, 1721, 1498, 1436, 1355, 1168, 1036, 730. [α]20D  = - 17.34 
(c = 0.94, CHCl3). HPLC analysis: ee >99%. OD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): 
tmajor = 37.6 min, tminor = 33.7 min.   
 
methyl 6-(2-bromophenyl)-2-oxobicyclo[3.1.0]hexane-1-carboxylate (2e): 85% yield. Rf = 
0.18 (hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3)  7.55 (dd, J = 7.9, 1.2, 1H), 7.30 – 
7.21 (m, 2H), 7.19 – 7.11 (m, 1H), 3.49 (s, 3H), 3.18 (t, J = 5.6 Hz, 1H), 2.97 (d, J = 6.0 Hz, 1H), 
2.44 - 2.40 (m, 2H), 2.37 – 2.31 (m, 1H), 2.22 – 2.17 (m, 1H). 13C NMR (125 MHz, CDCl3) 
 
205.7, 165.9, 133.6, 132.7, 130.1, 129.4, 127.2, 126.5, 52.3, 45.6, 39.7, 34.0, 33.3, 21.0. HRMS 
(ESI) ([M+H]
+) Calc’d. for C14H14BrO3: 309.0121; Found 309.0121. IR (neat, cm
-1
): 2949, 1725, 
1476, 1436, 1350, 1200, 1034, 762, 743. [α]20D  =  -95.28 (c = 1.25, CHCl3).  HPLC analysis: ee > 
99%. OD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): tmajor = 40.7 min, tminor = 35.4 min.  
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methyl 6-(4-chlorophenyl)-2-oxobicyclo[3.1.0]hexane-1-carboxylate (2f) ：85% yield. Rf = 
0.23 (hexanes/ethyl acetate 3:1). 
1
H NMR (500 MHz, CDCl3) 7.28 – 7.24 (m, 2H), 7.17 – 7.12 
(m, 2H), 3.47 (s, 3H), 3.12-3.10 (m, 1H), 2.87 (d, J = 5.6 Hz, 1H), 2.41 – 2.27 (m, 3H), 2.22 – 
2.09 (m, 1H). 
13
C NMR (125 MHz, CDCl3) 205.9, 165.3, 133.8, 132.1, 129.9, 128.6, 52.4, 47.5, 
37.4, 33.4, 31.7, 21.1. HRMS (ESI) ([M+H]
+) Calc’d. for C14H14ClO3: 265.0626; Found 
265.0631. IR (neat, cm
-1
): 2948, 2852, 1715, 1493, 1443, 1302, 1027, 835, 784, 572. [α]20D  = - 
10.18 (c = 1.10, CHCl3). HPLC analysis: ee = 99%. OD-H (95% hexanes: 5% isopropanol, 0.8 
mL/min): tmajor = 27.1 min, tminor = 36.5 min.  
 
methyl 6-(4-methoxyphenyl)-2-oxobicyclo[3.1.0]hexane-1-carboxylate (2j): 98% yield. Rf = 
0.20 (hexanes/ethyl acetate 2:1). 
1
H NMR (400 MHz, CDCl3) 7.12 – 7.10 (m, 2H), 6.80 – 6.78 
(m, 2H), 3.75 (s, 3H), 3.43 (s, 3H), 3.12 – 3.09 (m, 1H), 2.87 (d, J = 5.6 Hz, 1H), 2.39 – 2.22 (m, 
3H), 2.21 – 2.05 (m, 1H). 13C NMR (125 MHz, CDCl3)  206.2, 165.5, 159.2, 129.8, 125.3, 
113.8, 55.4, 52.3, 47.8, 38.1, 33.6, 31.7, 21.2. HRMS (ESI) ([M+H]
+) Calc’d. for C15H17O4: 
261.1121; Found 261.1130. IR (neat, cm
-1
): 2953, 1750, 1725, 1516, 1438, 1265, 1036, 732. 
[α]20D  =  - 4.46 (c = 1.48, CHCl3). HPLC analysis: ee > 99%. OD-H (95% hexanes: 5% 
isopropanol, 0.8 mL/min): tmajor = 31.6 min, tminor = 43.4 min.   
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methyl 2-oxo-6-(4-(trifluoromethyl)phenyl)bicyclo[3.1.0]hexane-1-carboxylate (2l): 80% 
yield, Rf = 0.45 (hexanes/ethyl acetate 3:1). 
1
H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 8.2 Hz, 
2H), 7.33 (d, J = 8.1 Hz, 2H), 3.46 (s, 3H), 3.16 (t, J = 5.2 Hz, 1H), 2.91 (d, J = 5.5 Hz, 1H), 2.58 
– 2.32 (m, 3H), 2.29 – 2.02 (m, 1H).
 19
F NMR (376 MHz, CDCl3) δ -63.1(s). 
13
C NMR (125 
MHz, CDCl3) δ 205.7 (s), 165.2 (s), 137.8 (s), 130.1 (q, J = 32.5 Hz), 129.0 (s), 125.4 (d, J = 2.5 
Hz), 124.1 (q, J = 270 Hz), 52.5 (s), 47.5 (s), 37.1 (s), 33.4 (s), 31.7 (s), 21.1 (s). HRMS (ESI) 
([M˙]-) Calc’d. for C15H13F3O3: 298.0812; Found 298.0835. IR (neat, cm
-1
): 2954, 1730, 1619, 
1439, 1326, 1168, 1069, 749. [α]20D  = -18.10 (c = 1.16, CHCl3). HPLC analysis: ee = 97%. OD-H 
(95% hexanes: 5% isopropanol, 0.8 mL/min): tmajor = 23.5 min, tminor = 33.7 min.  
 
methyl (E)-2-oxo-6-styrylbicyclo[3.1.0]hexane-1-carboxylate (2m): 99% yield. Rf = 0.22 
(hexanes/ethyl acetate 3:1). 
1
H NMR (500 MHz, CDCl3, compound exists as a 87:13 mixture of 
diastereo isomers, only major isomer peaks are reported) 7.33 – 7.28 (m, 4H), 7.25 – 7.21 (m, 
1H), 6.63 (d, J = 15.8 Hz, 1H), 6.05 (dd, J = 15.8, 9.2 Hz, 1H), 3.77 (s, 3H), 2.83 (t, J = 5.3 Hz, 
1H), 2.53 (dd, J = 9.2, 5.4 Hz, 1H), 2.38 – 2.19 (m, 3H), 2.15 – 2.05 (m, 1H). 13C NMR (125 
MHz, CDCl3)  205.8, 166.8, 136.6, 134.2, 128.8, 127.9, 126.4, 123.3, 52.6, 45.7, 38.8, 35.6, 
33.8, 21.0. HRMS (ESI) ([M+H]
+) Calc’d. for C16H17O3: 257.1172; Found 257.1179. IR (neat, 
cm
-1
): 3056, 1751, 1729, 1439, 1265, 1028, 964, 732. [α]20D  =  26.90 (c = 1.00, CHCl3). HPLC 
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analysis: ee = 95%. AD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): tmajor = 14.9 min, tminor = 
25.4 min.  
 
1-acetyl-6-phenylbicyclo[3.1.0]hexan-2-one (2b) : 91% yield. Rf = 0.51 (hexanes/ethyl acetate 
5:1). 
1
H NMR (500 MHz, CDCl3) δ 7.26 – 7.15 (m, 3H), 7.12 – 7.05 (m, 2H), 3.19 (t, J = 5.5 Hz, 
1H), 2.93 (d, J = 5.7 Hz, 1H), 2.44 – 2.27 (m, 2H), 2.25 – 2.16 (m, 1H), 2.14 (m, 3H), 2.11 – 
2.01 (m, 1H). 
13
C NMR (100 MHz, CDCl3) δ 208.3, 199.2, 132.7, 128.7, 128.6, 127.9, 55.3, 41.2, 
34.1, 30.9, 30.7, 20.8. HRMS (ESI) ([M+H]
+) Calc’d. for C14H14O2: 215.1067; Found 215.1070. 
IR (neat, cm
-1
): 3057, 2952, 1718, 1649, 1365, 1265, 1081, 732, 697. 557. [α]20D  =  15.77 (c = 
0.71, CHCl3). HPLC analysis: ee = 97%. AD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): 
tmajor = 10.5 min, tminor = 11.6 min.  
 
1-acetyl-6-(4-bromophenyl)bicyclo[3.1.0]hexan-2-one (2g): 91% yield. Rf = 0.40 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3) 7.40 (d, J = 8.5 Hz, 2H), 7.03 (d, J = 
8.5 Hz, 2H), 3.20 (t, J = 5.5 Hz, 1H), 2.94 (d, J = 5.8 Hz, 1H), 2.47 – 2.35 (m, 2H), 2.32 – 2.19 
(m, 3H), 2.23(s, 3H), 2.13 (m, 1H). 
13
C NMR (126 MHz, CDCl3) 208.0, 199.0, 131.7, 130.4, 
122.1, 54.9, 40.7, 34.0, 31.2, 30.7, 20.8. HRMS (ESI) ([M+H]
+) Calc’d. for C14H14BrO2: 
293.0172; Found 293.0165. IR (neat, cm
-1
): 3055, 2953, 1720, 1694, 1492, 1265, 1011, 733. 
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[α]20D = 60.78 (c = 0.77, CHCl3). HPLC analysis: ee = 93%. AD-H (95% hexanes: 5% 
isopropanol, 0.8 mL/min): tmajor = 12.7 min, tminor = 15.0 min.  
 
1-acetyl-6-(2,6-difluorophenyl)bicyclo[3.1.0]hexan-2-one (2k): 47 % yield, Rf = 0.57 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3) 7.22 (m, 1H), 6.85 (m, 2H), 3.35 (d, J 
= 5.7 Hz, 1H), 2.77 (d, J = 6.2 Hz, 1H), 2.50 (s, 3H), 2.47 – 2.39 (m, 2H), 2.31 – 2.20 (m, 2H). 
1
F NMR (376MHz, CDCl3): -111.85(m, 2F). 
13
C NMR (126 MHz, CDCl3)  208.6, 200.0, 163.2 
(d, J = 7.5 Hz), 161.2 (d, J = 7.5 Hz), 129.6 (t, J = 10.0 Hz), 111.6(d, J = 5.6 Hz), 111.4 (d, J = 
5.6 Hz), 50.5, 35.3(t, J = 5.0 Hz), 34.2, 31.9 (t, J = 1.9 Hz), 30.2, 20.8. HRMS (ESI) ([M+H]
+
) 
Calc’d. for C14H13F2O2: 251.0878; Found 251.0864. IR (neat, cm
-1
): 2951, 1717, 1690, 1626, 
1466, 1365, 987, 797. [α]20D  =  58.70 (c = 0.92, CHCl3). HPLC analysis: ee = 90%. OD-H (95% 
hexanes: 5% isopropanol, 0.8 mL/min): tmajor = 14.7 min, tminor = 19.3 min.  
 
2-oxo-6-phenylbicyclo[3.1.0]hexane-1-carbonitrile (2c): 81% yield. Rf = 0.23 (hexanes/ethyl 
acetate 4:1). 
1
H NMR (500 MHz, CDCl3)  7.35 – 7.24 (m, 3H), 7.21 – 7.15 (m, 2H), 3.11 (t, J = 
5.4 Hz, 1H), 2.91 (d, J = 5.6 Hz, 1H), 2.43 – 2.27 (m, 3H), 2.24 – 2.16 (m, 1H). 13C NMR (125 
MHz, CDCl3)  203.4, 132.2, 129.1, 128.8, 128.0, 114.6, 37.4, 35.1,35.0, 31.9, 22.0. HRMS (ESI) 
([M+Na]
+) Calc’d. for C13H11NNaO: 220.0733; 220.0726. IR (neat, cm
-1
): 3060, 2957, 1731, 
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1265, 1042, 735, 558. [α]20D  = 52.69 (c = 0.92, CHCl3). HPLC analysis: ee = 94%. AD-H (95% 
hexanes: 5% isopropanol, 0.8 mL/min): tmajor = 32.5 min, tminor = 47.8 min.   
 
6-(4-bromophenyl)-2-oxobicyclo[3.1.0]hexane-1-carbonitrile (2h): 81% yield. Rf = 0.27 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3)  7.52 (d, J = 8.5 Hz, 2H), 7.12 (d, J = 
8.4 Hz, 2H), 3.14 (t, J = 5.3 Hz, 1H), 2.92 (d, J = 5.6 Hz, 1H), 2.49 – 2.41 (m, 1H), 2.39 – 2.33 
(m, 2H), 2.32 – 2.24 (m, 1H). 13C NMR (125 MHz, CDCl3)  203.0, 132.3, 131.3, 129.6, 123.0, 
114.4, 36.6, 35.0, 34.8, 31.8, 22.0. HRMS (ESI) ([M+Na]
+) Calc’d. for C13H10BrNNaO: 
297.9835; Found 297.9835. IR (neat, cm
-1
): 3046, 2924, 2244, 1728, 1491, 1040, 1008, 830, 738. 
[α]20D = 37.50 (c = 0.83, CHCl3).  HPLC analysis: ee = 93%. AD-H (95% hexanes: 5% 
isopropanol, 0.8 mL/min): tmajor = 42.6 min, tminor = 66.3 min.  
 
6-(3,5-dimethylphenyl)-2-oxobicyclo[3.1.0]hexane-1-carbonitrile (2i): 76% yield. Rf = 0.25 
(hexanes/ethyl acetate 4:1). 
1
H NMR (500 MHz, CDCl3)  6.97 (s, 1H), 6.85 (s, 2H), 3.17 (t, J = 
5.4 Hz, 1H), 2.90 (t, J = 5.7 Hz, 1H), 2.47 – 2.39 (m, 1H), 2.39 – 2.33 (m, 2H), 2.32 (s, 6H), 2.27 
– 2.21 (m, 1H). 13C NMR (125 MHz, CDCl3) 203.6, 138.6, 132.0, 130.5, 125.8, 114.7, 37.57 
(s), 34.98 (s), 31.9, 22.1, 21.4. HRMS (ESI) ([M+H]
+) Calc’d. for C15H16NO: 226.1226; Found 
226.1218. IR (neat, cm
-1
): 2919, 2238, 1732, 1605, 1461, 1414, 1339, 1052, 707. [α]20D = 47.01 
(c = 0.77, CHCl3). HPLC analysis: ee = 94%. AD-H (95% hexanes: 5% isopropanol, 0.8 
mL/min): tmajor = 22.2 min, tminor = 25.1 min.  
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2-oxo-6-phenethylbicyclo[3.1.0]hexane-1-carbonitrile (2n): 93% yield. Rf = 0.35 
(hexanes/ethyl acetate 3:1). 
1
H NMR (500 MHz, CDCl3) δ 7.31 (t, J = 7.4 Hz, 2H), 7.25 – 7.17 
(m, 3H), 2.94 – 2.88 (m, 1H), 2.78 (dt, J = 13.8, 7.9 Hz, 1H), 2.39 (t, J = 5.0 Hz, 1H), 2.29 – 2.08 
(m, 3H), 2.01 – 1.96 (m, 2H), 1.94 – 1.88 (m, 1H), 1.77 – 1.73 (m, 1H). 13C NMR (125 MHz, 
CDCl3) δ 204.1, 140.3, 128.8, 128.6, 126.6, 115.7, 37.4, 34.5, 33.2, 32.1, 32.0, 31.1, 21.9. 
HRMS (ESI) ([M+Na]
+) Calc’d. for C15H15NNaO: 248.1046; Found 248.1046. IR (neat, cm
-1
): 
3028, 2931, 2242, 1732, 1494, 1456, 1018, 757. [α]20D = 18.38 (c = 0.68, CHCl3). HPLC analysis: 
ee = 58%. AD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): tmajor = 22.8 min, tminor = 27.2 min.   
 
6-cyclohexyl-2-oxobicyclo[3.1.0]hexane-1-carbonitrile (2o): 82% yield.
 
Rf = 0.40 
(hexanes/ethyl acetate 3:1). 
1
H NMR (500 MHz, CDCl3) δ 2.50 (t, J = 5.0 Hz, 1H), 2.34 – 2.11 
(m, 3H), 2.07 – 2.00 (m, 2H), 1.84 (d, J = 10.0 Hz, 1H), 1.81 – 1.64 (m, 3H), 1.57 – 1.54 (m, 1H), 
1.37 – 1.04 (m, 6H). 13C NMR (125 MHz, CDCl3) δ 204.4, 115.8, 39.9, 39.7, 36.3, 32.6, 32.2, 
32.0, 29.9, 26.1, 26.0, 25.7, 22.1. HRMS (ESI) ([M+Na]
+) Calc’d. for C13H17NNaO: 226.1202; 
Found 226.1207. IR (neat, cm
-1
): 2929, 2853, 2237, 1736, 1450, 1275, 1004, 746. [α]20D = - 
20.28 (c = 0.7, CHCl3). HPLC analysis: ee = 66%. OD-H (95% hexanes: 5% isopropanol, 0.8 
mL/min): tmajor = 16.4 min, tminor = 18.4 min.   
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6-phenylbicyclo[3.1.0]hexan-2-one (2d): 92% yield. Rf = 0.30 (hexanes/ethyl acetate 5:1). 
1
H 
NMR (400 MHz, CDCl3)  7.30 – 7.26 (m, 2H), 7.23 – 7.20(m, 1H), 7.06 – 7.04 (m, 2H), 2.39 – 
2.36 (m, 2H) 2.29 – 2.16(m, 4H) 2.07 – 2.05 (m, 1H). 13C NMR (100 MHz, CDCl3) 
HRMS (ESI) ([M+H]+) Calc’d. 
for C12H13O: 173.0961; Found 173.0962. IR (neat, cm
-1
): 3054, 2987, 1722, 1421, 1264, 895, 
732. [α]20D  = - 96.56 (c = 0.28, CHCl3) (lit.
20
 [α]20D = - 95.0 (c = 0.275, CHCl3). HPLC analysis: 
ee = 95%. OD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): tmajor = 17.1 min, tminor = 19.9 min.    
 
6-(2-bromophenyl)bicyclo[3.1.0]hexan-2-one (2p): 93% yield. Rf = 0.34 (hexanes/ethyl acetate 
5:1). 
1
H NMR (500 MHz, CDCl3)  7.56 (dd, J = 8.0, 1.2 Hz, 1H), 7.23 (td, J = 7.6, 1.1 Hz, 1H), 
7.09 (td, J = 7.7, 1.6 Hz, 4 H), 6.97 (dd, J = 7.7, 1.4 Hz, 1H), 2.60 (t, J = 3.4 Hz, 1H), 2.34 – 2.14 
(m, 5H), 2.12 – 2.06 (m, 1H). 13C-NMR(125MHz,CDCl3) 213.4, 137.9, 132.9, 129.4, 127.6, 
127.4, 125.8, 37.1, 32.7, 31.0, 30.1, 23.3. HRMS (ESI) ([M+H]
+) Calc’d. for C12H12BrO: 
251.0066; Found 251.0068. IR (neat, cm
-1
): 3064, 2943, 1724, 1426, 1186. 842. [α]20D = 3.28 (c 
= 1.01, CHCl3). HPLC analysis: ee = 95%. Whelk (97% hexanes: 3% isopropanol, 0.8 mL/min): 
tmajor = 30.5 min, tminor = 46.6 min.   
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6-(m-tolyl)bicyclo[3.1.0]hexan-2-one (2q): 76% yield. Rf = 0.30 (hexanes/ethyl acetate 5:1). 
1
H 
NMR (500 MHz, CDCl3)  7.17 (t, J = 7.6 Hz, 1H), 7.02 (d, J = 7.5 Hz, 1H), 6.91 – 6.80 (m, 2H), 
2.38 (dd, J = 9.3, 5.1 Hz, 1H), 2.36 – 2.33 (m, 1H), 2.32 (s, 3H), 2.31 – 2.08 (m, 4H), 2.07 – 2.03 
(m, 1H). 
13
C NMR (125 MHz, CDCl3) 
HRMS (ESI) ([M+H]+) Calc’d. for C13H15O: 187.1117; Found 
187.1120. IR (neat, cm
-1
): 3053, 2946, 2921, 2881, 1722, 1606, 1266, 1187，749. [α]20D = - 86.7 
(c = 1.55, CHCl3) HPLC analysis: ee = 94%. Whelk (97% hexanes: 3% isopropanol, 0.8 
mL/min): tmajor = 31.5 min, tminor = 66.9 min.  
 
 
6-(4-methoxyphenyl)bicyclo[3.1.0]hexan-2-one (2r): 93% yield. Rf = 0.26 (hexanes/ethyl 
acetate 5:1). 
1
H NMR (500 MHz, CDCl3) δ 6.98 (d, J = 8.7 Hz, 2H), 6.82 (d, J = 8.7 Hz, 2H), 
3.78 (s, 3H), 2.35 – 2.32 (m, 2H), 2.26 – 2.11 (m, 4H), 1.98 (t, J = 5.0 Hz, 1H). 13C NMR (125 
MHz, CDCl3) δ 213.5, 158.5, 131.0), 127.2, 114.1, 55.4, 39.0, 32.6, 30.4, 23.4. HRMS (ESI) 
([M+H]
+) Calc’d. for C13H15O2: 203.1067; Found 203.1069. IR (neat, cm
-1
): 3031, 2938, 2869, 
2839, 1713, 1612, 1514, 1255, 1029. [α]20D = -75.31 (c = 0.64, CHCl3). HPLC analysis: ee = 
95%. AD-H (97% hexanes: 3% isopropanol, 0.8 mL/min): tmajor = 23.8 min, tminor = 21.2 min.  
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6-(thiophen-2-yl)bicyclo[3.1.0]hexan-2-one (2s): 97% yield. Rf = 0.45 (hexanes/ethyl acetate 
5:1). 
1
H NMR (500 MHz, CDCl3) 7.10 (dd, J = 5.1, 1.1 Hz, 1H), 6.91 - 6.90 (m, 1H), 6.80 (dd, 
J = 2.6, 0.8 Hz, 1H), 2.60 (t, J = 5.0 Hz, 1H), 2.41 (d, J = 4.0 Hz, 1H), 2.25 – 2.23 (m, 2H), 2.16 
– 2.13 (m, 2H), 2.09 (dd, J = 5.0, 2.5 Hz, 1H). 13C NMR (125 MHz, CDCl3) 212.5, 142.6, 
127.1, 123.9, 123.4, 39.5, 32.3, 31.5, 26.3, 23.3. HRMS (ESI) ([M+H]
+) Calc’d. for C10H11OS: 
179.0525; Found 179.0547. IR (neat, cm
-1
): 3053, 2946, 2921, 2881, 1722, 1606, 1266, 1187. 
758. [α]20D =  -70.24 (c = 1.69, CHCl3).  HPLC analysis: ee = 92%. Whelk (97% hexanes: 3% 
isopropanol, 0.8 mL/min): tmajor = 32.1 min, tminor = 48.8 min.  
 
Hydrogenation of [3.1.0]Carbobicycles for the Synthesis of Enantioenriched 
Cyclopentanone Derivatives.  
 
To a solution of bicycle compounds (0.3 mmol) in MeOH (1.8 mL) was added 10% Pd 
on carbon (21 mg). The reaction mixture was charged with an atmosphere of H2 and allowed to 
stir at room temperature for 14 hours. The catalyst was filtered off, and the solvent was removed 
under reduced pressure. The crude product was purified by flash chromatography on silica gel 
eluting with EtOAc/hexane to give the desired product.   
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Methyl -2-benzyl-5-oxocyclopentane-1-carboxylate (3a): 83% yield. Rf = 0.40 (hexanes/ethyl 
acetate 5:1). Compounds exist as 96:4 dr of mixture. Only the spectrum of the major isomer 
reported: 
1
H NMR (500 MHz, CDCl3) δ 7.35 – 7.13 (m, 5H), 3.62 (s, 3H), 3.01 – 2.73 (m, 4H), 
2.45– 2.39 (m, 1H), 2.34 – 2.26 (m, 1H), 2.19 – 2.10 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 
211.5, 169.6, 138.6, 129.3, 128.6, 126.6, 61.2, 52.5, 43.1, 40.6, 38.5, 27.1. IR (neat, cm
-1
): 3027, 
2919, 1754, 1723, 1603, 1495, 1453, 1435, 1265, 1222, 1161, 1128, 1071, 1045, 981, 913, 752, 
700, 589, 507. HRMS (ESI) ([M+H]
+) Calc’d. for C14H17O3: 233.1172. Found 233.1174.    
 
methyl 2-(4-methoxybenzyl)-5-oxocyclopentane-1-carboxylate (3j): 80% yield, >99:1 dr. Rf = 
0.36 (hexanes/ethyl acetate 5:1). 
1
H NMR (400 MHz, CDCl3) δ 7.07 (d, J = 8.5 Hz, 2H), 6.82 (d, 
J = 8.6 Hz, 2H), 3.77 (s, 3H), 3.62 (s, 3H), 3.07 – 2.60 (m, 3H), 2.52 – 2.20 (m, 2H), 2.18 – 2.05 
(m, 1H), 1.69 – 1.39 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 211.6, 169.6, 158.4, 130.6, 130.3, 
113.9, 61.2, 55.4, 52.5, 43.3, 39.6, 38.5, 26.9. IR (neat, cm
-1
): 2970, 1749, 1725, 1512, 1264, 
1246, 1178, 1033, 732. HRMS (ESI) ([M+H]
+) Calc’d. for C15H19O4: 263.1278. Found 263.1277. 
[α]20D 
=
 62.08 ( c = 1.3, CHCl3).  
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Decarboxylation of α,β-Disubstituted Cyclopentanones:  
 
To a solution of α,β-disubstituted cyclopentanones (0.2 mmol) in MeOH (0.8 mL) was 
added concentrated HCl (0.48 mL). The reaction mixture was refluxed overnight. The solvent 
was removed under reduced pressure. The crude product was purified by flash chromatography 
on silica gel eluting with EtOAc/hexane to afford the desired product.   
 
3-benzylcyclopentan-1-one (3d’): 82% yield. Rf = 0.63 (hexanes/ethyl acetate 5:1). The 
spectrum of 3d’ is the same as 3d. [α]20D = 102.40 ( c = 1.3, CHCl3). HPLC analysis: ee = 97%. 
AD-H (97% hexanes: 3% isopropanol, 0.8 mL/min): t major = 9.7 min, tminor = 10.7 min. (Lit.
16
 
[α]22D = - 96 for S isomer, 96 % ee, c = 1.3, CHCl3).   
 
3-(4-methoxybenzyl)cyclopentan-1-one (3r’): 84% yield. Rf = 0.52 (hexanes/ethyl acetate 5:1). 
The spectrum of 3r’ is the same as 3r. [α]20D = 73.97 ( c = 0.78, CHCl3). HPLC analysis: ee = 
98%. OD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): t major = 15.5 min, tminor = 16.8 min.   
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3-benzylcyclopentan-1-one (3d): Colorless oil. 95% yield. Rf = 0.63 (hexanes/ethyl acetate 5:1). 
1
H NMR (400 MHz, CDCl3) δ 7.35 – 7.27 (m, 2H), 7.24 – 7.14 (m, 3H), 2.79 – 2.70 (m, 2H), 
2.52 – 2.44 (m, 1H), 2.37 – 2.27 (m, 2H), 2.23 – 2.08 (m, 2H), 1.92 (ddd, J = 18.2, 9.9, 1.3 Hz, 
1H), 1.68 – 1.57 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 219.4, 140.2, 128.9, 128.6, 126.4, 45.1, 
41.7, 39.0, 38.5, 29.2. HRMS (ESI) ([M+H]
+) Calc’d. for C12H15O: 175.1117. Found 175.1103. 
IR (neat, cm
-1
): 2926, 1738, 1496, 1454, 1403, 1275, 751. [α]20D = - 79.2 (c = 1.0, CHCl3) (Lit.
17 
[α]22D = 83.9 for R isomer, 90 % ee, c = 1.0, CHCl3) HPLC analysis: ee = 92% AD-H (97% 
hexanes: 3% isopropanol, 0.8 mL/min): tmajor = 10.4 min, tminor = 9.5 min.  
 
3-(3-methylbenzyl)cyclopentan-1-one (3q): 92% yield. Rf = 0.65 (hexanes/ethyl acetate 5:1). 
1
H NMR (500 MHz, CDCl3) 
 δ 7.19 (t, J = 7.5 Hz, 1H), 7.03 (d, J = 7.6 Hz, 1H), 7.00 – 6.96 (m, 
2H), 2.70 (dd, J = 7.3, 1.9 Hz, 2H), 2.55 – 2.41 (m, 1H), 2.36 – 2.28 (m, 5H), 2.17 – 2.11 (m, 
2H), 1.91 (dd, J = 18.2, 9.9, 1.3 Hz, 1H), 1.66 – 1.58 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 
219.5, 140.1, 138.2, 129.7, 128.5, 127.1, 125.9, 45.1, 41.6, 39.0, 38.5, 29.3, 21.6. HRMS (ESI) 
([M˙  ׄ ]+) Calc’d. for C13H16O: 188.1196. Found 188.1140. IR (neat, cm
-1
): 2918, 1738, 1608, 
1488, 1402, 1157, 781, 740, 701. [α]20D = -53.50 ( c = 0.80, CHCl3). HPLC analysis: ee = 92%. 
OD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): tmajor = 11.07 min, tminor = 10.22 min.   
 
3-(4-methoxybenzyl)cyclopentan-1-one (3r): 99% yield. Rf = 0.52 (hexanes/ethyl acetate 5:1).  
1
H NMR (400 MHz, CDCl3) δ 7.08 (d, J = 8.3 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 3.79 (s, 3H), 
- 106 - 
 
2.69 – 2.67 (m, 2H), 2.50 – 2.38 (m, 1H), 2.38 – 2.22 (m, 2H), 2.20 – 2.01 (m, 2H), 1.90 (dd, J = 
17.9, 9.7 Hz, 1H), 1.69 – 1.51 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 219.5, 158.2, 132.2, 
129.8, 114.0, 55.4, 45.0, 40.7, 39.2, 38.5, 29.2. HRMS (ESI) ([M+Na]
+) Calc’d. for 
C13H16NaO2:227.1048. Found 227.1051. IR (neat, cm
-1
): 2913, 1736,1611, 1583, 1511, 1463, 
1245, 1032, 807, 752. [α]20D = - 61.39 (c = 1.15, CHCl3). HPLC analysis: ee = 94%. OD-H (95% 
hexanes: 5% isopropanol, 0.8 mL/min): tmajor = 16.6 min, tminor = 15.5 min.  
Synthesis of Chiral Methyl (1S,3S,3aR,6aR)-1-(4-chlorophenyl)-4-oxo-3-phenyltetrahydro-
1H-cyclopenta[c]furan-3a(3H)-carboxylate (4):   
 
Sc(OTf)3 (0.05 mmol) was placed in an oven-dried, resealable Schlenk tube. The tube 
was capped with a Teflon screwcap, evacuated, and backfilled with nitrogen. The screwcap was 
replaced with a rubber septum. Benzaldehyde (29 mg, 0.3 mmol), 2f (26 mg, 0.1 mmol) in 1.0 
mL DCM was added once via syringe. Schlenk tube was capped by teflon screw cap instead of 
rubber septum and stirred at room temperature for overnight. After the reaction finished, the  
resulting mixture was concentrated to remove DCM, followed by purification of the residue by 
column chromatography, 32 mg (85 %) of 4 was isolated as solo diastereomer. Rf = 0.75 
(hexanes/ethyl acetate 2:1). 
1
H NMR (500 MHz, CDCl3) δ 7.48 (d, J = 7.5 Hz, 2H), 7.44 – 7.33 
(m, 6H), 7.32 – 7.27 (m, 1H), 5.76 (s, 1H), 5.27 (d, J = 5.4 Hz, 1H), 3.83 (s, 3H), 3.65 – 3.57 (m, 
1H), 2.25 – 2.17 (m, 1H), 2.13 – 2.03 (m, 1H), 1.73 (m, 1H), 1.65 – 1.57 (m, 1H). 13C NMR (125 
MHz, CDCl3) δ 210.4, 171.0, 136.5, 136.2, 133.5, 128.8, 128.4, 127.2, 126.3, 84.8, 81.7, 71.7, 
53.3, 52.6, 39.6, 20.8. HRMS (ESI) ([M+Na]
+) Calc’d. for C21H20ClO4: 393.0864; Found 
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393.0880. IR (neat, cm
-1
): 2954, 1750, 1728, 1493, 1455, 1242, 1014, 734. [α]20D = - 9.61 (c = 
0.94, CHCl3). HPLC analysis: ee = 98%. OD-H (95% hexanes: 5% isopropanol, 0.8 mL/min): 
tmajor = 25.9 min, tminor = 19.5 min.   
General procedure for the preparation of alkenoic acid following the reported procedure:
21
  
 
(3-carboxypropyl)triphenylphosphonium bromide (924 mg, 2.16 mmol, 1.08 equiv) was 
suspended in THF (12 mL) at -20 °C. NaHMDS (2.16 mL, 4.32 mmol, 2.16 equiv) was added 
dropwise into the suspension and further stirred for 20 min. The reaction mixture was then 
cooled to -78 °C and the corresponding aldehyde (2.0 mmol, 1.0 equiv) was added. After 18 h, 
the solvent was removed in vacuum. H2O (60 mL) was added to the residue and extracted with 
diethyl ether (3 x 20 mL). The diethyl ether layers were discarded while the H2O layer was 
acidified to pH = 2 using HCl (1 M). The acidified aqueous layer was further extracted with ethyl 
acetate (3 x 20 mL). The organic layers were combined, dried over sodium sulfate, filtered and 
concentrated to dryness. The alkenoic acid was purified over silica. The alkenoic acid was 
further recrystallized using hexane and ethyl acetate.  
(E)-5-(4-methoxyphenyl)pent-4-enoic acid: 
1
H NMR (500 MHz, CDCl3) δ 7.27 (d, J = 8.7 Hz, 
2H), 6.84 (d, J = 8.8 Hz, 2H), 6.39 (d, J = 15.8 Hz, 1H), 6.14 – 6.02 (m, 1H), 3.80 (s, 3H), 2.53 – 
2.51 (m, 4H).  
(E)-5-(m-tolyl)pent-4-enoic acid: 
1
H NMR (500 MHz, CDCl3) δ 7.20 – 7.13 (m, 3H), 7.03 (d, J = 
7.3 Hz, 1H), 6.42 (d, J = 15.8 Hz, 1H), 6.26 – 6.15 (m, 1H), 2.55 (m, 4H), 2.33 (s, 3H) 
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(E)-5-(4-bromophenyl)pent-4-enoic acid: 
1
H NMR (500 MHz, CDCl3) δ 7.42 (d, J = 8.4 Hz, 2H), 
7.21 (d, J = 8.4 Hz, 2H), 6.39 (d, J = 15.8 Hz, 1H), 6.26 – 6.19 (m, 1H), 2.55 (s, 4H).  
(E)-5-(thiophen-2-yl)pent-4-enoic acid: 
1
H NMR (500 MHz, CDCl3) δ 7.12 (d, J = 5.0 Hz, 1H), 
6.95 – 6.90 (m, 2H), 6.58 (d, J = 15.8 Hz, 1H), 6.07 – 6.02 (m, 1H), 2.54 (s, 4H).  
(E)-5-(4-chlorophenyl)pent-4-enoic acid: 
1
H NMR (400 MHz, CDCl3) δ 7.26 (s, 4H), 6.40 (d, J = 
15.8 Hz, 1H), 6.19 (m, 1H), 2.54 (m, 4H).   
(4E,6E)-7-phenylhepta-4,6-dienoic acid: 
1
H NMR (500 MHz, CDCl3) δ 7.37 (d, J = 7.8 Hz, 2H), 
7.30 (t, J = 7.6 Hz, 2H), 7.21 (t, J = 7.3 Hz, 1H), 6.74 (dd, J = 15.7, 10.4 Hz, 1H), 6.48 (d, J = 
15.7 Hz, 1H), 6.27 (dd, J = 15.1, 10.4 Hz, 1H), 5.85 – 5.77 (m, 1H), 2.52 – 2.47  (m, 4H).  
General procedure for the preparation of (E)-Ethyl 5-arylpent-4-enoate following the 
reported procedure:  
Step 1: addition of vinylmagnesium bromide to aryl aldehydes: 
22
   
 
Vinylmagnesium bromide (1 equiv, 1 M in THF) was added a slowly to a stirred solution of 
freshly distilled aldehyde (1 equiv) in dry THF (0.2 M) maintaining an internal temperature 
below 5 ℃. After 15 min the reaction was allowed to warm to RT and stirred for an additional 1–
3 h. The reaction was quenched by addition of saturated NH4Cl solution and extracted with Et2O. 
The combined organic extracts were washed with brine, dried (MgSO4), filtered, and the solvent 
removed in vacuo to give the crude product. 
Step 2: Johnson-Claisen Rearrangement of 1-Arylprop-2-en-1-ol: 
22
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Propionic acid (0.07 eq.) was added to a stirred solution of arylpropenol (1 eq.) in triethyl 
orthoacetate (1.5 mL/mmol arylpropenol) and the reaction was heated to 145 ℃ and stirred for 4-
18 h. After cooling to room temperature, the solution was diluted with EtOAc (1 mL/mmol 
arylpropenol) and washed successively with aqueous 1 M HCl solution (1 mL/mmol 
arylpropenol), water (1 mL/mmol arylpropenol), and brine (1 mL/mmol arylpropenol). The 
organic layer was dried (MgSO4), filtered, and the solvent removed in vacuo to give the crude 
product.  
ethyl (E)-5-phenylpent-4-enoate: 
1
H NMR (500 MHz, CDCl3) δ 7.31– 7.27 (m, 4H), 7.23 – 7.17 
(m, 1H), 6.43 (d, J = 15.8 Hz, 1H), 6.21 (dt, J = 15.8, 6.6 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 2.58 
– 2.45 (m, 4H), 1.26 (t, J = 7.1 Hz, 3H).  
ethyl (E)-5-(4-bromophenyl)pent-4-enoate: 
1
H NMR (500 MHz, CDCl3) δ 7.40 (d, J = 8.5 Hz, 
2H), 7.19 (d, J = 8.4 Hz, 2H), 6.36 (d, J = 15.9 Hz, 1H), 6.20 (dt, J = 15.8, 6.5 Hz, 1H), 4.15 (q, J 
= 7.1 Hz, 2H), 2.60 – 2.44 (m, 4H), 1.25 (t, J = 7.1 Hz, 3H).  
ethyl (E)-5-(3,5-dimethylphenyl)pent-4-enoate: 
1
H NMR (500 MHz, CDCl3) δ 7.05 – 6.83 (m, 
3H), 6.37 (d, J = 15.8 Hz, 1H), 6.18 (dt, J = 15.8, 6.6 Hz, 1H), 4.15 (q, J = 7.1 Hz, 1H), 2.35 – 
2.25 (m, 10H), 1.26 (t, J = 7.2 Hz, 3H).  
ethyl (E)-5-(2,6-difluorophenyl)pent-4-enoate: 
1
H NMR (400 MHz, CDCl3) δ 7.17 – 7.05 (m, 
1H), 6.84 – 6.42 (m, 2H), 4.16 (q, J = 7.1 Hz, 2H), 2.61 – 2.47 (m, 4H), 1.26 (t, J = 7.2 Hz, 3H).   
General procedure for the synthesis of keto nitriles:
23
 
 
An oven dried 100 mL Schlenk tube, that was previously evacuated and backfilled with 
nitrogen gas, The Teflon screw cap was replaced with a rubber septum. The Schlenk tube was 
charged with NaHMDS (1.0 M in THF, 1 equiv), acetonitrile ( 3 equiv) and toluene( 10 mL). 
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(E)-Ethyl 5-arylpent-4-enoate ( 2.0 mmol) was added in one portion and another 15 mL toluene 
was added. The Schlenk tube was then purged with nitrogen for 1 minute and the rubber septum 
was replaced with a Teflon screw cap. The Schlenk tube was then placed in an oil bath for the 18 
h at 120 ℃. The reaction was quenched with a aqueous 1 M HCl solution, and tune the pH to 4. 
Then organic phase was extracted with ethyl acetate, and dried over sodium sulfate. The solvent 
was removed by rotary evaporation under reduced pressure. The crude residue was purified by 
silica gel chromatography to afford the keto nitriles products.  
(E)-3-oxo-7-phenylhept-6-enenitrile: 
1
H NMR (250 MHz, CDCl3) δ 7.45 – 7.13 (m, 5H), 6.44 (d, 
J = 16.0 Hz, 1H), 6.17 (dt, J = 15.0, 7.5 Hz, 1H), 3.47 (s, 2H), 2.82 (t, J = 7.1 Hz, 2H), 2.55 (q, J 
= 7.1 Hz, 2H).  
(E)-7-(3,5-dimethylphenyl)-3-oxohept-6-enenitrile: 
1
H NMR (500 MHz, CDCl3) δ 7.01 – 6.80 
(m, 3H), 6.38 (dd, J = 15.0, 6.5 Hz, 1H), 6.16 (dt, J = 16.0, 7.0 Hz, 1H), 3.46 (s, 2H), 2.80 (t, J = 
7.5 Hz, 2H), 2.54 – 2.51 (m, 2H), 2.29 (s, 6H).   
 (E)-7-(4-bromophenyl)-3-oxohept-6-enenitrile: 
1
H NMR (400 MHz, CDCl3) δ 7.42 (d, J = 8.4 
Hz, 2H), 7.19 (d, J = 8.6 Hz, 2H), 6.38 (d, J = 16.0 Hz, 1H), 6.16 (dt, J = 16.0, 8.0 Hz, 1H), 3.46 
(s, 2H), 2.82 (t, J = 7.2 Hz, 2H), 2.56 – 2.51 (m, 2H).  
(E)-3-oxo-9-phenylnon-6-enenitrile: 
1
H NMR (500 MHz, CDCl3) δ 7.30 – 7.27 (m, 2H), 7.20 – 
7.15 (m, 3H), 5.57 – 5.45 (m, 1H), 5.44 – 5.31 (m, 1H), 3.36 (s, 2H), 2.67(dt, J = 18.1, 7.2 Hz, 
4H), 2.35 – 2.25 (m, 4H).  
(E)-7-cyclohexyl-3-oxohept-6-enenitrile: 
1
H NMR (500 MHz, CDCl3) δ 5.49 – 5.43 (m, 1H), 
5.36 – 5.30 (m, 1H), 3.44 (s, 2H), 2.68 (t, J = 7.2 Hz, 2H), 2.32 (q, J = 7.0 Hz, 2H), 1.97 – 1.84 
(m, 1H), 1.73 – 1.63 (m, 5H), 1.35 – 1.22 (m, 2H), 1.19 – 1.11 (m, 1H), 1.08 – 0.96 (m, 2H).  
General procedure for the preparation of 1, 3-diketones following the reported procedure:24  
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To a mixture of the esters (15 mmol) and NaH (30 mmol, 60%) in dry toluene (4 mL) 
was added acetone dropwise at 40 ℃ within a period of 6 h with stirring. The mixture was stirred 
for one more hour until all the H2 was evolved. After cooled to room temperature, the mixture 
was diluted with toluene (5 mL) and then quenched with EtOH (5 mL) and ice-water (20 mL). 
The mixture was acidified with 3 M HCl to pH 2~3 and then was extracted with EtOAc (20 mL 
x 3). The organic layer was combined and washed with water (20 mL) and brine (20 mL). The 
pure diketone were obtained by silica gel column chromatography with PE and EtOAc as eluent.  
(E)-8-(4-bromophenyl)oct-7-ene-2,4-dione: 
1
H NMR (500 MHz, compound exists as a 4:1 
mixture of enol : ketone tautomers, only major ketone peaks are reported, CDCl3) δ 7.41 (d, J = 
8.5 Hz, 2H), 7.19 (d, J = 8.5 Hz, 2H), 6.36 (d, J = 15.8 Hz, 1H), 6.19 (dt, J = 15.8, 6.6 Hz, 1H), 
2.56 – 2.48 (m, 2H), 2.45 (m, 2H), 2.06 (s, 3H).   
(E)-8-(2,6-difluorophenyl)oct-7-ene-2,4-dione: 
1
H NMR (500 MHz, compound exists as a 4:1 
mixture of enol : ketone tautomers, only major ketone peaks are reported, CDCl3) δ 7.13 – 7.07 
(m, 1H), 6.85 (t, J = 8.6 Hz, 2H), 6.61 – 6.41 (m, 2H), 2.63 – 2.53 (m, 2H), 2.51 – 2.45 (m, 2H), 
2.06 (s, 3H).  
(E)-8-phenyloct-7-ene-2,4-dione was prepared according to the literature:
2
 
1
H NMR (500 MHz, 
compound exists as a 2.3:1 mixture of enol : ketone tautomers, only major ketone peaks are 
reported, CDCl3) δ 7.41 – 7.27 (m, 4H), 7.21 – 7.17 (m, 1H), 6.43 (d, J = 15.8 Hz, 1H), 6.27 – 
6.14 (m, 1H), 2.55 – 2.42 (m, 4H), 2.06 (s, 3H).  
Preparation of methyl 3-oxo-6-arylhexanoate following the reported procedure: 
14a
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A flame-dried 100 mL round-bottom flask equipped with stir bar and reflux condenser 
was charged with potassium monomethyl malonate (1.59 g, 10.1 mmol) and MgCl2 (0.64 g, 6.77 
mmol). This flask was evacuated and backfilled with nitrogen 3 times. THF (10 mL) was added 
and the suspension was heated to 65 °C for 3 h, followed by 30 °C for 2 h. A separate 50 mL 
flame-dried round-bottom flask was charged with the corresponding 4-arylbutyric acid (6.77 
mmol) and carbonyl diimidazole (1.15 g, 7.11 mmol). The flask was fitted with a reflux 
condenser and THF (10 mL) was added, and the solution was heated at 40 °C for 1 hour. The 
resulting acyl imidazole solution was added dropwise via cannula to the magnesium malonate 
suspension at 30 °C (NOTE: a white precipitate forms rapidly, and vigorous stirring is necessary 
to avoid clumping). After 12 h the white suspension was cooled to 0 °C and quenched by the 
addition of 1M HCl (5 mL). The reaction was extracted into EtOAc (3 x 50 mL), washed 
successively with water, brine, and dried over sodium sulfate. Concentration under reduced 
pressure yielded a crude oil, which was purified by flash chromatography yielding β-ketoester.  
methyl (E)-3-oxo-7-phenylhept-6-enoate: 
1
H NMR (500 MHz, CDCl3, compound exists as a 9:1 
mixture of ketone : enol tautomers, only major ketone peaks are reported) δ 7.31 – 7.27 (m, 4H), 
7.24 – 7.19 (m, 1H), 6.42 (d, J = 15.8 Hz, 1H), 6.26 – 6.13 (m, 1H), 3.74 (s, 3H), 3.48 (s, 2H), 
2.73 (t, J = 7.3 Hz, 2H), 2.51 (dd, J = 14.3, 7.1 Hz, 2H).  
methyl (E)-7-(2-bromophenyl)-3-oxohept-6-enoate: 
1
H NMR (500 MHz, CDCl3, compound 
exists as a 9:1 mixture of ketone : enol tautomers, only major ketone peaks are reported) δ 7.52 
(dd, J = 8.0, 1.2 Hz, 1H), 7.45 (dd, J = 7.8, 1.6 Hz, 1H), 7.24 (dd, J = 7.9, 0.6 Hz, 1H), 7.11 – 
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7.04 (m, 1H), 6.73 (d, J = 15.6 Hz, 1H), 6.23 – 6.09 (m,  1H), 3.74 (s, 3H), 3.49 (s, 2H), 2.62 – 
2.57 (m, 4H).  
methyl (E)-7-(4-chlorophenyl)-3-oxohept-6-enoate: 
1
H NMR (500 MHz, CDCl3, compound 
exists as a 9:1 mixture of ketone : enol tautomers, only major ketone peaks are reported) δ 7.30 – 
7.26 (m, 4H), 6.38 (d, J = 15.8 Hz, 1H), 6.17 (dt, J = 15.9, 6.9 Hz, 1H), 3.75 (s, 3H), 3.49 (s, 2H), 
2.74 (t, J = 7.2 Hz, 2H), 2.56 – 2.47 (m, 2H).   
methyl (E)-7-(4-methoxyphenyl)-3-oxohept-6-enoate: 
1
H NMR (500 MHz, CDCl3, compound 
exists as a 6:1 mixture of ketone : enol tautomers, only major ketone peaks are reported) δ 7.26 
(d, J = 8.8 Hz, 2H), 6.85 – 6.82 (d, J = 8.8 Hz, 2H), 6.36 (d, J = 15.8 Hz, 1H), 6.09(dt, J = 15.8, 
6.9 Hz, 1H), 3.80 (s, 3H), 3.74 (s, 2H), 3.02 (t, J = 7.4 Hz, 2H), 2.53 (qd, J = 7.3, 1.4 Hz, 2H).   
methyl (6E,8E)-3-oxo-9-phenylnona-6,8-dienoate: 
1
H NMR (500 MHz, CDCl3, compound exists 
as a 19:1 mixture of ketone : enol tautomers, only major ketone peaks are reported) δ 7.37 – 7.28 
(m, 4H), 7.20 (t, J = 7.5 Hz, 1H), 6.72 (dd, J = 15.7, 10.4 Hz, 1H), 6.46 (d, J = 15.7 Hz, 1H), 6.30 
– 6.19 (m, 1H), 5.85 – 5.72 (m, 1H), 3.75 (s, 3H), 3.47 (s, 2H), 2.69 (t, J = 7.3 Hz, 2H), 2.45 (q, J 
= 7.2 Hz, 2H).  
methyl (E)-3-oxo-7-(4-(trifluoromethyl)phenyl)hept-6-enoate: 
1
H NMR (400 MHz, CDCl3, 
compound exists as a 20:1 mixture of ketone : enol tautomers, only major ketone peaks are 
reported) δ 7.54 (d, J = 8.2 Hz, 2H), 7.41 (d, J = 8.2 Hz, 2H), 6.45 (d, J = 15.9 Hz, 1H), 6.29 (dt, 
J = 15.8, 6.8 Hz, 1H), 3.74 (s, 3H), 3.48 (s, 2H), 2.76 (t, J = 7.2 Hz, 2H), 2.54 (q, J = 6.8 Hz, 2H).   
X-ray Crystallography  
The X-ray diffraction data for 2e, 2p and 4 were measured on a Bruker D8 Venture PHOTON 
100 CMOS system equipped with a Cu Kα INCOATEC Imus micro-focus source (λ = 1.54178 
Å). Indexing was performed using APEX2 [1] (Difference Vectors method). Data integration and 
reduction were performed using SaintPlus 6.01 [2]. Absorption correction was performed by 
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multi-scan method implemented in SADABS [3]. Space groups were determined using XPREP 
implemented in APEX2 [1]. The structure was solved using SHELXS-97 (direct methods) and 
refined using SHELXL-97 (full-matrix least-squares on F
2
) contained in APEX2 [1] and WinGX 
v1.70.01 [4,5,6,7] programs packages.  
2e, 2p, 4: All non-hydrogen atoms were refined anisotropically. Hydrogen atoms were placed in 
geometrically calculated positions and included in the refinement process using riding model 
with isotropic thermal parameters: Uiso(H) = 1.2Ueq(-CH,-CH2). In the structure of 4 there are 
two independent molecules in asymmetric unit. Crystal data and refinement conditions are 
shown in the following Tables.  
[1] Bruker (2008). APEX2 (Version 2008.1-0). Bruker AXS Inc., Madison, Wisconsin, USA. 
[2] Bruker (2001b). SAINT-V6.28A. Data Reduction Software. 
[3] Sheldrick, G. M. (1996). SADABS. Program for Empirical Absorption 
Correction. University of Gottingen, Germany. 
[4] Farrugia L.J. Appl. Cryst. (1999). 32, 837±838 
[5] Sheldrick, G.M. (1997) SHELXL-97. Program for the Refinement of Crystal 
[6] Sheldrick, G.M. (1990) Acta Cryst. A46, 467-473 
[7] Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  
                                               
Figure 3.3. Single-Crystal X-ray Structure of 2p.  
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Table 3.4. Crystal data and structure refinement for compound 2p. 
Identification code              
Empirical formula                
Formula weight                   
Temperature                      
Wavelength                       
Crystal system, space group      
Unit cell dimensions             
                                 
                                 
Volume                           
Z, Calculated density            
Absorption coefficient           
F(000)                           
Crystal size                     
Theta range for data collection  
Limiting indices                 
Reflections collected / unique   
Completeness to theta = 68.86    
Absorption correction            
Max. and min. transmission       
Refinement method                
Data / restraints / parameters   
Goodness-of-fit on F^2           
Final R indices [I>2sigma(I)]    
R indices (all data)             
 
2p 
C12 H11 Br O 
251.12 
100(2) K 
1.54178 A 
Monoclinic,  P21 
a = 7.1700(2) A   alpha = 90 deg. 
b = 8.9434(3) A    beta = 94.6950(10) deg. 
c = 7.8442(2) A   gamma = 90 deg. 
501.32(3) A^3 
2,  1.664 Mg/m^3 
5.262 mm^-1 
252 
0.05 x 0.05 x 0.02 mm 
5.66 to 68.86 deg. 
-8<=h<=8, -10<=k<=10, -9<=l<=9 
6554 / 1831 [R(int) = 0.0251] 
99.7 % 
Semi-empirical from equivalents 
0.9021 and 0.7788 
Full-matrix least-squares on F^2 
1831 / 1 / 127 
1.062 
R1 = 0.0182, wR2 = 0.0416 
R1 = 0.0195, wR2 = 0.0423 
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Table 3.4. Continued 
Absolute structure parameter     
Largest diff. peak and hole      
  
0.017(18) 
0.249 and -0.198 e.A^-3 
 
                  
Figure 3.4. Single-Crystal X-ray Structure of 2e.  
Table 3.5. Crystal data and structure refinement for compound 2e. 
Identification code             
Empirical formula               
Formula weight                  
Temperature                     
Wavelength                      
Crystal system, space group     
 
Unit cell dimensions            
                                
                                
Volume                          
Z, Calculated density           
Absorption coefficient          
F(000)                          
2e 
C14H13BrO3 
309.15 
100(2) K 
1.54178 A 
Monoclinic,  P21 
 
a = 6.9662(2) A   alpha = 90 deg. 
b = 7.4144(2) A    beta = 104.3820(10) deg. 
c = 12.8649(4) A   gamma = 90 deg. 
643.65(3) A^3 
2,  1.595 Mg/m^3 
4.344 mm^-1 
312 
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Table 3.5. Continued  
Crystal size                    
Theta range for data collection 
Limiting indices                
Reflections collected / unique  
Completeness to theta = 68.87   
Absorption correction           
Max. and min. transmission      
Refinement method               
Data / restraints / parameters  
Goodness-of-fit on F^2          
Final R indices [I>2sigma(I)]   
R indices (all data)            
Absolute structure parameter    
Largest diff. peak and hole     
 
0.05 x 0.03 x 0.01 mm 
3.55 to 68.87 deg. 
-8<=h<=8, -8<=k<=8, -15<=l<=15 
8425 / 2313 [R(int) = 0.0233] 
99.2 % 
Semi-empirical from equivalents 
0.9579 and 0.8121 
Full-matrix least-squares on F^2 
2313 / 1 / 164 
1.083 
R1 = 0.0186, wR2 = 0.0445 
R1 = 0.0196, wR2 = 0.0451 
0.003(14) 
0.344 and -0.227 e.A^-3 
 
 
Figure 3.5. Single-Crystal X-ray Structure of Compound 4.  
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Table 3.6. Crystal data and structure refinement for compound 4. 
Identification code             
Empirical formula               
Formula weight                  
Temperature                     
Wavelength                      
Crystal system, space group     
Unit cell dimensions            
                                
                                
Volume                          
 
Z, Calculated density           
Absorption coefficient          
F(000)                          
Crystal size                    
Theta range for data collection 
Limiting indices                
Reflections collected / unique  
Completeness to theta = 69.00   
Absorption correction           
Max. and min. transmission      
Refinement method               
Data / restraints / parameters  
Goodness-of-fit on F^2          
Final R indices [I>2sigma(I)]   
R indices (all data)            
4 
C21H19ClO4 
370.81 
100(2) K 
1.54178 A 
Monoclinic,  P21 
a = 7.9655(3) A   alpha = 90 deg. 
b = 25.5812(8) A    beta = 111.6750(10) deg. 
c = 9.4669(3) A   gamma = 90 deg. 
1792.65(10) A^3 
 
4,  1.374 Mg/m^3 
2.088 mm^-1 
776 
0.11 x 0.06 x 0.01 mm 
3.46 to 69.00 deg. 
-9<=h<=9, -30<=k<=30, -11<=l<=11 
23380 / 6425 [R(int) = 0.0324] 
98.9 % 
Semi-empirical from equivalents 
0.9794 and 0.8029 
Full-matrix least-squares on F^2 
6425 / 1 / 471 
1.028 
R1 = 0.0259, wR2 = 0.0596 
R1 = 0.0286, wR2 = 0.0610 
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Table 3.6. Continued  
Absolute structure parameter    
Largest diff. peak and hole     
 
0.009(8) 
0.173 and -0.138 e.A^-3 
 
3.4 Conclusion  
In conclusion, an efficient and enantioselective process has been delineated for the synthesis of 
[3.1.0]carbobicycles bearing three contiguous chiral centers with multi-functionalities via Co(II)-
based metalloradical catalysis. This chemistry is easily performed and marks the first successful 
catalytic system for enantioselective intramolecular cyclopropanation of α-esterdiazoketones, α-
ketodiazoketones and α-cyanodiazoketones. The effectiveness of such technologies for the 
construction of chiral functionalized cyclopentanones is displayed via cyclopropane ring-opening 
or ring-extension reactions while retaining high optical purity.     
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Chapter 4 
Asymmetric Cyclopropanation of Alkene with Fluoroaryl Diazomethane via Co (II)-Based 
Metalloradical Catalysis  
4.1 Introduction  
  Cobalt(II)-based metalloradical catalysis (MRC) has emerged in recent years as a 
powerful platform for a new type of cyclopropanation reactions through stereoselective radical 
pathways.
1
 The Co(II) complexes of porphyrins activate diazo reagents to form a new class of α-
Co(III)-alkyl radicals, which are able to undergo unique  reactions with reactivity and selectivity 
controlled by the metal center and porphyrin ligands.
2
 With D2-symmetric chiral amidoporphyrin 
ligands, the reactivity and stereocontrol of the radical cyclopropanation are likely to be further 
enhanced by potential hydrogen bonding interactions between the amido group of the porphyrin 
ligand and the diazo moiety in the Co(III)-alkyl radical species. Although Co(II)-based radical 
cyclopropanation has been shown considerably effective in activating an array of widely used 
diazo compounds, including different acceptor,
1f-h
 and acceptor/acceptor-substituted diazo 
reagents,
1a-e
 the radical cyclopropanation of donor diazo reagents, however, remained unexplored. 
In particularly, fluoroaryl diazomethanes are worthy of investigation because of the common 
occurrence of fluoroaryl groups in medically relevant molecules. As shown is Scheme 1, radical 
transfer from a Co(II) metalloradical to the α-carbon of the diazo is hypothesized to produce 
Co(III)-alkyl radical A, which is stabilized by the potential double hydrogen bonding interactions 
that incorportate the two fluorine atoms as acceptors. The resulting stereoselective cyclopropanes 
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could allow direct construction of invaluable, optically active fluoroaryl substituted 
cyclopropanes, leading to a variety of useful properties in pharmaceuticals and agrochemicals.
3
  
 
 
Figure 4.1. Radical Cyclopropanation with α-Halodiazoacetates via Cobalt (II)-Based 
Metalloradical Catalysis (MRC). 
Fluoroaryl diazomethanes
4
 are classified as donor-type diazo reagents, which have 
historically been regarded as unstable reagents, therefore limiting the synthetic applications of 
these compounds. Indeed, at this time, exploration of these reagents has remained scarce. 
However, we investigated several fluoroaryl diazomethanes and provide evidence of their 
stability
5
 and application in asymmetric radical cyclopropanation. Here, we want to present the 
first highly diastereo- and enantioselective cyclopropanation with fluoroaryl diazomethanes, 
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which represents the first successful and general method to prepare enantioenriched fluoroaryl 
cyclopropanes.   
4.2. Results and Discussions  
4.2.1. Reaction Condition Optimization  
Table 4.1. Enantioselective Radical Cyclopropanation of Styrene with Fluoroaryl Diazomethanes 
by [Co(P1)].
a 
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a 
Carried out initially at -50 ℃ for 48 h in a one-time protocol under N2 with [olefin] = 0.20 M. 
b
 
Isolated yields after column chromatography. 
c 
Determined by 
1
H NMR spectroscopy of the 
crude mixture. 
d 
Determined by chiral HPLC after derivatization.. 
 
For initial cyclopropanation studies, 3, 4-difluoroaryl diazomethane was chose as the 
diazo reagent (Table 1). The desired asymmetric cyclopropanation was realized in 70% yield and 
with 66% ee. The subsequent studies revealed that the position of the fluorine atoms on the 
phenyl ring are critical in controlling the enantioselectives of the products. When 2-fluoroaryl 
diazomethane was used as the diazo reagent, the ee of the product was improved to 74%. 2, 6-
Difluorodiazo methane was used to afford the desired product in 70% yield and with 98% ee, 
indicating the potential double hydrogen bonding interactions in intermediate A. Further 
substituion of fluorine atoms on the phenyl ring exert little effect on the asymmetric induction, 
by a high level of enantioselectivities was maintained, as demonstrated by the use of 2, 4, 6-
trifluoroaryl diazomethane and pentafluoroaryl diazomethane in this transformation at -50 °C for 
48 h.   
4.2.2 Substrate Scope  
With optimized conditions in hand, we next examined the scope of the alkene component 
in this new cyclopropanation method. As described in Table 2, a wide range of alkenes bearing 
aromatic and aliphatic substituents were amenable to this radical mechanism. For example, 
styrene derivatives bearing electron-rich and electron-deficient substituents were used to 
generate fluoroaryl cyclopropanes (products 3be, 3ce, 3dc, 3ee and 3fc, 70% - 82% yield, 90% - 
97% ee). Not surprisingly, conjugated alkenes also served as good substrates to afford the 
product in 97% yield, albeit with moderate dr and ee. As a critical requirement for the broad-  
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Table 4.2 [Co(P1)]-Catalyzed Enantioselective Radical Cyclopropanation of Alkenes with 
Fluoroaryl Diazomethanes.
a 
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a 
Carried out on a 0.2 mmol scale of alkenes at -50 ℃ for 48 h in a one-time protocol using 3 
mol % [Co(P1)] under N2 with [olefin] = 0.20 M; isolated yields after column chromatography; 
diastereomeric ratio determined by 
1
H NMR spectroscopy of the crude mixture; ee determined 
by chiral HPLC. 
b 
[1S,2S] Absolute configuration determined by X-ray crystal structural analysis.
 
c 
ee not available.  
 
scale implementation of this transformation, hetero-arene alkenes were successfully employed to 
rapidly build nitrogen-containing aryl and fluoroaryl substituted cyclopropanes (products 3hd, 
3id, 3jd, 3hc, 67 – 84% yield, 95 – 98% ee). Last, we further determined that ethyl vinyl ketone 
and N, N-dimethylacrylamide are valuable coupling partners, affording the cyclopropanes in 
moderate yield, but with low ee (products 3kc, 3lc).  
4.3. Experiment Section  
General Considerations.  
 
All reactions were carried out under a nitrogen atmosphere in oven-dried glassware 
following standard Schlenk techniques. Chlorobenzene (Anhydrous, ≥99%) was used directly 
from Sigma-Aldrich Chemical Co. Dichloromethane was freshly distilled/degassed prior to use. 
Thin layer chromatography was performed on Merck TLC plates (silica gel 60 F254) visualizing 
with UV-light 254 nm or 365 nm fluorescence quenching, and ceriumammonium-molybdate 
(CAM) stain (ammonium pentamolybdate, cerium(IV) sulfate, sulfuric acid aqueous solution). 
Flash column chromatography was performed with ICN silica gel (60 Å, 230-400 mesh, 32-63 
μm). Nuclear magnetic resonance spectra were recorded on a Bruker a Bruker 500-MHz, 400-
MHz or 250-MHz instrument. Chemical shifts for protons are reported in parts per million 
downfield from tetramethylsilane and are referenced to residual proton in the NMR solvent 
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(CHCl3 = 7.26 ppm). Chemical shifts for carbon are reported in parts per million downfield from 
tetramethylsilane and are referenced to the carbon resonances of the solvent residual peak 
(CDCl3 = 77.16 ppm). 
19
F spectra were recorded on a Bruker 400 spectrometer (376 MHz), 
using CFCl3 (δ=0) as internal standard. HPLC measurements were carried out on a Shimadzu 
HPLC system with Whelk-O1, Chiralcel OD-H, OJ-H, AS-H and AD-H columns. Infrared 
spectra were measured with a Nicolet Avatar 320 spectrometer with a Smart Miracle accessory. 
HRMS data was obtained on an Agilent 1100 LC/MS ESI/TOF mass spectrometer with 
electrospray ionization or Agilent 7890 GC-7200 QToF MS with electron impact. Optical 
rotations were measured on a Rudolph Research Analytical AUTOPOL® IV digital polarimeter. 
The X-ray diffraction data were collected using Bruker-AXS SMART-APEXII CCD 
diffractometer (CuKα, λ = 1.54178 Å) and Bruker D8 Venture PHOTON 100 CMOS 
diffractometer equipped with a Cu Kα INCOATEC Imus micro-focus source (λ = 1.54178 Å).  
Catalyst Synthesis:  
 
[Co(P1)]  were synthesized according to our previous reported procedure.
6
  
Synthesis of Hydrozone:
4
  
 
p-Tol-uenesulfonhydrazide (9.30 g, 0.050 mol) was added to a solution of 0.050 mole 
fluorobenzaldehyde in 90 mL of absolute ethanol. The suspension was stirred under nitrogen for 
48 h at room temperature. The solution was then cooled in an ice bath. The white crystalline 
solid was filtered and washed with cold absolute ethanol. The filtrate was further concentrated to 
90 mL by pumping off the solvent under vacuum. The concentrated solution was cooled in ice 
bath, and then the crystalline solid was filtered and washed with cold ethanol. The mother liquid 
and the washing solution were combined to give a third crystallization.  
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4-methyl-N'-((perfluorophenyl)methylene)benzenesulfonohydrazide: 
87% yield.  
1
H NMR (400 MHz, DMSO) δ 11.98 (s, 1H), 7.90 (s, 1H), 7.73 (d, J = 8.4 Hz, 2H), 7.42 (d, J = 
8.0 Hz, 2H), 2.38 (s, 3H).  
19
F NMR (376 MHz, CFCl
3
, DMSO), -142.06, (m, 2F), -152.79(m, 1F), -162.16(m, 2F).  
13
C NMR (125 MHz, DMSO) δ 145.4 – 109.01(m), 143.84 (s), 135.73 (s), 134.39 (s), 129.73 (s), 
127.20 (s), 21.00(s).  
HRMS (ESI) ([M+H]
+
) Calc’d. for C14H10F5N2O2S: 365.0378. Found 365.0400.  
IR: 3175.7, 1596.2, 1526.9, 1495.7, 1449.7, 1325.0, 1275.6, 1161.9, 972.9, 910.1, 749.9, 678.2, 
592.2, 553.9.  
 
N'-(2,6-difluorobenzylidene)-4-methylbenzenesulfonohydrazide:  
85% yield.  
1
H NMR (400 MHz, DMSO) δ 11.70 (s, 1H), 7.98 (s, 1H), 7.74 (d, J = 8.0 Hz, 2H), 7.50 - 7.44 
(m, 1H), 7.41 (d, J = 8.0 Hz, 2H), 7.13 (t, J = 8.7 Hz, 2H), 2.37 (s, 3H). 
19
F NMR (376 MHz, CFCl
3
, DMSO), -112.32(m, 2F). 
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13
C NMR (126 MHz, DMSO) δ 161.07(dd, J = 253.8, 6.4 Hz), 143.63 (s), 136.77 (s), 135.95 (s), 
131.89 (t, J = 10.0 Hz), 129.64 (s), 127.21 (s), 112.29 (d, J = 23.75 Hz), 110.91 (t, J = 13.9 Hz), 
21.02 (s).  
HRMS (ESI) ([M+H]
+
) Calc’d. for C14H13F2N2O2S: 311.0660. Found 311.0680.  
IR: 3139.7, 1625.1, 1468.2, 1365.7, 1328.9, 1275.6, 1162.4, 1063.1, 1004.5, 925.3, 808.0, 780.9, 
749.9, 663.7, 571.1, 504.5.  
 
4-methyl-N'-(2,4,6-trifluorobenzylidene)benzenesulfonohydrazide: 
90% yield.  
1
H NMR (400 MHz, DMSO) δ 11.69 (s, 1H), 7.91 (s, 1H), 7.73 (d, J = 8.0 Hz, 2H), 7.47 – 7.37 
(m, 2H), 7.24 (t, J = 10.0 Hz, 2H), 2.36 (s, 3H).  
19
F NMR (376 MHz, CFCl
3
, DMSO), -104.57(m, 1F), -108.94(m, 2F). 
13
C NMR (126 MHz, DMSO) δ 163.44 (t, J = 15.0 Hz), 161.65 – 161.31(m), 159.52 (dd, J = 
15.0, 8.7 Hz), 143.63 (s), 136.05 (d, J = 12.5 Hz), 129.62 (s), 127.24 (s), 108.18 (td, J = 13.8, 4.2 
Hz), 101.45 (t, J = 15.0 Hz), 20.98 (s). 
HRMS (ESI) ([M+H]
+
) Calc’d. for C
14
H
12
F
3
N
2
O
2
S: 329.0566. Found 329.0587.  
IR: 3218.0, 3080.9, 1638.8, 1591.5, 1497.5, 1323.1, 1276.0, 1165.0, 1124.7, 1072.9, 941.8, 814.0, 
764.3, 750.0, 570.0, 550.5, 496.8 
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N'-(3,4-difluorobenzylidene)-4-methylbenzenesulfonohydrazide: 
85% yield.  
1
H NMR (400 MHz, DMSO) δ 7.88 (s, 1H), 7.77 (d, J = 8.3 Hz, 2H), 7.65 – 7.55 (m, 1H), 7.47 – 
7.40 (m, 4H), 2.36 (s, 3H), 2.36(s, 3H).  
19
F NMR (376 MHz, DMSO) δ -135.54 – -135.74 (m, 1F), -137.36 (m, 1F).   
13
C NMR (126 MHz, DMSO) δ 151.35 (d, J = 12.8 Hz), 150.64 (d, J = 13.1 Hz), 149.37 (d, J = 
12.8 Hz), 148.67 (d, J = 13.1 Hz), 144.63 (s), 143.55 (s), 136.01 (s), 131.45 (s), 129.70 (s), 
127.24 (s), 123.93 (d, J = 3.4 Hz), 118.05 (d, J = 17.7 Hz), 115.17 (d, J = 18.2 Hz), 21.00 (s).  
IR  3214.2, 1596.6, 1518.2, 1437.8, 1320.2, 1283.1, 1161.0, 1119.3, 1056.8, 914.8, 788.6, 752.3, 
664.2, 585.2, 546.4.   
HRMS (PCI) ([M+H]
+
) Calc’d. for C14H13F2N2O2S: 311.066. Found 311.0651.  
 
N'-(2-fluorobenzylidene)-4-methylbenzenesulfonohydrazide:  
87% yield.  
1
H NMR (400 MHz, DMSO) δ 11.63 (s, 1H), 8.08 (s, 1H), 7.78 – 7.76 (m, 1H), 7.76 – 7.74 (m, 
1H), 7.69 (td, J = 7.7, 1.7 Hz, 1H), 7.48 – 7.43 (m, 1H), 7.43 – 7.38 (m, 2H), 7.27 – 7.20 (m, 2H), 
2.36 (s, 3H). 
19
F NMR (376 MHz, DMSO) δ -120.59 (m, 1F). 
13
C NMR (125 MHz, DMSO) δ 160.50 (d, J = 123.8 Hz), 143.65 (s), 139.66 (s), 136.13 (s), 
132.09 (d, J = 8.3 Hz), 129.80 (s), 127.28 (s), 126.20 (s), 124.96 (s), 121.26 (d, J = 9.9 Hz), 
116.05 (d, J = 20.7 Hz), 21.07 (s).  
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IR:  3190.9,  1611.27, 1597.30, 1487.66, 1453.84, 1323.60, 1164.07, 1050.66, 952.54, 813.35, 
758.17, 665.53, 589.86, 551.07.  
HRMS (PCI) ([M+H]
+
) Calc’d. for  C14H14FN2O2S: 293.0755. Found 293.0749.  
Synthesis of Sodium Hydrozone:
4
  
To an ice-cooled solution of 5.50 mmol of the corresponding fluorobenzaldehyde 
tosylhydrazone in 60 mL freshly distilled ether was added 0.132 g (5.50 mmol) of NaH (60% in 
mineral oil) upon stirring. The solution was then stirred at room temperature for 24 h under N2. 
The large solid suspension formed was filtered and washed with dry ether. The solid was finally 
dried under high vacuum at room temperature. The sodium hydrozone was used immediatedly 
for next step. (sodium hydrozones are unstable. If kept for long time, the yield of next step 
decreased dramatically.) 
Synthesis of Diazo Reagents:
4
 
In a two- necked round bottom flask was placed a magnetic stirrer. One of the necks of 
the round bottom flask was connected to a modified side arm addition flask containing 1.30 
mmol  sodium salt of the corresponding fluorobenzaldehyde tosylhydrazone while a short 
distillation path was connected to the second. A receiving flask attached to the distillation path 
was cooled in dry ice-isopropyl alcohol bath. After the round bottom flask was heated under 
vacuum (ca. 0.05 mmHg) in a 100°C oil bath in the dark, the salt was slowly added in small 
portions upon stirring and by tapping the addition flask in 2 min intervals. The orange-colored 
gas produced upon decomposition of the sodium salt was collected as an orange solid in the 
receiving flask. The flasks were finally flashed with nitrogen, and the product was warmed to 
room temperature to give an orange-colored oil.  
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1-(diazomethyl)-2,3,4,5,6-pentafluorobenzene : 
72% yield.  
1
H NMR (400 MHz, CDCl
3
) δ 4.91(s, 1H). 
19
F NMR (376 MHz, CFCl
3
, CDCl
3
): -147.02(m, 2F), -162.55(m, 1F), -163.28(m, 2F). 
 
2-(diazomethyl)-1,3-difluorobenzene:  
67% yield. 
1
H NMR (400 MHz, CDCl
3
) δ 6.97 – 6.89 (m, 1H), 6.87 – 6.78 (m, 2H), 4.91 (s, 1H).  
19
F NMR (376 MHz, CFCl
3
, CDCl
3
), -147.02(m, 2F), -162.55(m, 1F), -163.28(m, 2F). 
 
 
 
2-(diazomethyl)-1,3,5-trifluorobenzene:  
 
77% yield.  
1
H NMR (400 MHz, CDCl
3
) δ 6.70 – 6.61 (m, 2H), 4.83 (s, 1H). 
19
F NMR (376 MHz, CFCl
3
, CDCl
3
), -114.43(m, 1F), -115.40(m, 2F). 
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1-(diazomethyl)-2-fluorobenzene:  
64% yield.  
1
H NMR (400 MHz, CDCl
3
) δ 7.13 – 7.05 (m, 1H), 7.01 – 6.98 (m, 2H), 6.91 (t, J = 7.8 Hz, 1H), 
5.07 (s, 1H). 
19
F NMR (376 MHz, CDCl
3
) δ -120.86 (m, 1F). 
 
 
4-(diazomethyl)-1,2-difluorobenzene:  
70% yield.  
1
H NMR (400 MHz, CDCl
3
) δ 7.15 – 7.02 (m, 1H), 6.72 – 6.67 (m, 1H), 6.62 – 6.58 (m, 1H), 
4.91 (s, 1H). 
19
F NMR (376 MHz, CDCl
3
) δ -137.44 – -137.63 (m, 1F), -144.24 – -144.51 (m, 1F). 
General Procedure for Cyclopropanation Reactions:  
 
Catalyst (3 mol %) was placed in an oven-dried, resealable Schlenk tube. The tube was 
capped with a Teflon screwcap, evacuated, and backfilled with nitrogen and cooled to -50 ℃. 
The screwcap was replaced with a rubber septum, and 1.0 equiv. of alkene (0.2 mmol) in 0.65 
mL  Toluene was added via syringe, followed by 2.0 equivalents of diazo compound (0.40 mmol) 
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and the remaining solvent (0.3 mL). The tube was wrapped with alumina foil, purged with 
nitrogen for 1 min and its contents were stirred at -50 ℃ for 48 h. When the reaction is finished, 
the reaction mixture was concentrated under reduced pressure to give the crude reaction mixture 
for the d.r. value determination, and was additionally purified by silica gel column to give 
desired products.  
 
1,2,3,4,5-pentafluoro-6-((1S,2S)-2-phenylcyclopropyl)benzene: 82% yield and 99:1 dr. Rf = 
0.94 (solvent : hexane).   
1
H NMR (400 MHz, CDCl
3
) δ 7.35 – 7.31 (m, 2H), 7.26 – 7.17 (m, 3H), 2.48 (dt, J = 8.0, 5.6 Hz, 
1H), 2.14 – 1.99 (dt, J = 8.0, 5.6 Hz, 1H), 1.62 (dt, J = 12.0, 4.0 Hz, 1H), 1.56 – 1.51(m, 1H).   
19
F NMR (376 MHz, CFCl
3
, CDCl
3
):  -144.28(m, 2F), -158.38 (m, 1F), -163.72(m, 2F) 
13
C NMR (125 MHz, CDCl
3
) δ 147.15 (s), 145.16 – 115.29(m),  141.01 (s), 128.69 (s), 126.56 
(s), 126.37 (s), 24.33 (s), 16.57 (s), 15.40 (s). 
HRMS (EI) ([M]+.) Calc’d. for C15H9F5:  284.0619 ; Found 284.0606.  
IR: 3029.3, 2926.1, 1522.4, 1493.5, 1299.1, 1141.8., 1035.5, 965.6, 753.1, 697.2, 560.0 
[α]
20
D 
= +191.67 (c = 1.2, CHCl3).  
HPLC analysis: ee (Z)-isomer = 97 %. OD-H (100% hexanes: 0% isopropanol, 0.8 mL/min): (Z)-
isomer:  t
major 
= 9.7 min, t
minor
 = 10.8 min.  
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1,2,3,4,5-pentafluoro-6-((1S,2S)-2-(4-methoxyphenyl)cyclopropyl)benzene: 82% yield, 96:4 
dr, Rf = 0.86 (solvent : hexane).   
1
H NMR (400 MHz, CDCl
3
) δ 7.13 (d, J = 8.6 Hz, 2H), 6.85 (d, J = 8.7 Hz, 2H), 3.79 (s, 3H), 
2.41 (dt, J = 8.9, 5.6 Hz, 1H), 2.01 – 1.86 (m, 1H), 1.56 (dt, J = 8.9, 5.7 Hz, 1H), 1.45 (dt, J = 9.1, 
5.8 Hz, 1H).  
19
F NMR (376 MHz, CFCl
3
, CDCl
3
), -144.32(m, 2F), -158.57(m, 1F), -163.79(m, 2F).  
13
C NMR (126 MHz, CDCl
3
) δ 158.42 (s), 147.16 - 115.10(m),  132.98 (s), 127.59 (s), 114.10 (s), 
55.45 (s), 23.70 (s), 16.15 (s), 15.00 (s).  
HRMS (EI) ([M]+.) Calc’d. for C16H11F5O:  314.0725 ; Found 314.0715.  
IR: 3015.5, 2957.0, 2837.6, 1611.5, 1526.3, 1513.2, 1492.0, 1292.5, 1181.1, 1032.2, 967.2, 852.7, 
609.2, 535.8.  
[α]
20
D 
= - +183.67 (c = 1.8, CHCl3).  
HPLC analysis: ee (Z)-isomer = 91%. OD-H (100% hexanes: 0% isopropanol, 0.8 mL/min): (Z)-
isomer:  t
major 
= 22.86 min, t
minor
 = 26.09 min. 
 
1-((1S,2S)-2-(3,4-dimethoxyphenyl)cyclopropyl)-2,3,4,5,6-pentafluorobenzene: 87:13 dr.  
major diastereoisomer: 81% yield. Rf = 0.77 (solvent : hexane).   
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1
H NMR (400 MHz, CDCl3) δ 6.83 (d, J = 8.1 Hz, 1H), 6.80 – 6.70 (m, 2H), 3.90 (s, 3H), 3.87 (s, 
3H), 2.43 (dt, J = 8.9, 5.6 Hz, 1H), 2.08 – 1.92 (m, 1H), 1.57 (dt, J = 8.9, 5.7 Hz, 1H), 1.48 (dt, J 
= 9.0, 5.8 Hz, 1H).  
19
F NMR (376 MHz, CFCl3, CDCl3): -144.28(m, 2F), -158.43(m, 1F), -163.72(m, 2F).  
13
C NMR (125 MHz, CDCl3) δ 147.11 – 115.39(m), 149.12(s), 147.90(s), 133.52 (s), 118.26 (s), 
111.44(s), 110.33 (s), 56.05(d, J = 13.75 Hz), 24.09(s), 16.13(s), 14.93(s).  
HRMS (EI) ([M]+.) Calc’d. for C17H13F5O2:  344.0830 ; Found 344.0824.  
IR: 3003.5, 2965.0, 2940.6, 1605.7, 1587.2, 1515.8, 1492.4, 1485.6, 1447.7, 1331.0, 1268.1, 
1235.6, 1141.6, 1029.5, 992.0, 806.6, 628.7, 546.0. 
[α]20D = +156.79 (c = 0.78, CHCl3).  
HPLC analysis: ee (Z)-isomer = 96%. OJ-H (99% hexanes: 1% isopropanol, 0.8 mL/min): (Z)-
isomer:  tmajor = 27.28 min, tminor = 24.41 min. 
 
 
1,3-difluoro-2-((1S,2S)-2-phenylcyclopropyl)benzene: 70% yield, 95:5 dr. Rf = 0.94 (solvent : 
hexane).   
1
H NMR (400 MHz, CDCl3) δ 7.35 – 7.27 (m, 2H), 7.25 – 7.19 (m, 3H), 7.15 – 7.08 (m,1H), 
6.86 – 6.81(m, 2H), 2.50 (dt, J = 8.0, 5.5 Hz, 1H), 2.14 – 2.09 (m, 1H), 1.66 (dt, J = 8.0, 4.0Hz, 
1H), 1.47 – 1.42 (m, 1H).  
19
F NMR (376 MHz, CFCl3, CDCl3): -115.48(m, 2F).  
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13
C NMR (125 MHz, CDCl3) δ 162.24 (dd, J = 246.25, 8.2 Hz), 142.29 (s), 128.54 (s), 127.19 (t, 
J = 10.0 Hz), 126.32 (s), 126.10 (s), 117.84 (t, J = 16.6 Hz), 111.43 (dd, J = 20.3, 6.4 Hz), 24.23 
(s), 17.35 (s), 15.75 (s).  
HRMS (EI) ([M]+.) Calc’d. for C15H12F2:  230.0902 ; Found 230.0904.  
IR: 3029.5, 11624.6, 1604.8, 1584.1, 1464.4, 1267.5, 1233.8, 1116.4, 1032.7, 1009.2, 966.3, 
909.5, 779.4, 750.1, 695.5, 526.8, 508.1.  
[α]20D =  +250.91 (c = 0.55, CHCl3).  
HPLC analysis: ee (Z)-isomer = 96%. AD-H (100% hexanes: 0% isopropanol, 0.8 mL/min): (Z)-
isomer:  tmajor = 10.14 min, tminor = 7.94 min. 
 
2-((1S,2S)-2-(3,5-dimethoxyphenyl)cyclopropyl)-1,3-difluorobenzene: 89:11 dr.  
Major diastereoisomer: 72% y. Rf = 0.80 (solvent : hexane).   
δ 1H NMR (500 MHz, CDCl3) δ 7.14 – 7.08(m, 1H), 6.83 (t, J = 8.3 Hz, 2H), 6.38 (d, J = 2.2 Hz, 
2H), 6.32 (t, J = 2.2 Hz, 1H), 3.80 (s, 6H), 2.44 (dt, J = 8.8, 5.5 Hz, 1H), 2.17 – 2.06 (m, 1H), 
1.68 – 1.60 (m, 1H), 1.42 (dt, J = 10.1, 5.5 Hz, 1H). 
19
F NMR (376 MHz, CFCl3, CDCl3) : δ -115.24 – -115.57 (m).  
13
C NMR (100 MHz, CDCl3) δ 163.32 (d, J = 8.2 Hz), 160.85 (s), 144.67 (s), 127.07 (t, J = 10.5 
Hz), 117.56 (t, J = 16.6 Hz), 111.26 (dd, J = 19.2, 7.2 Hz), 104.33 (s), 98.00 (s), 55.26 (s), 24.39 
(s), 17.15 (s), 15.57 (s). 
HRMS (EI) ([M]+.) Calc’d. for C17H16F2O2:  290.1113 ; Found 290.1111.  
IR: 3002.1, 2936.1, 1593.6, 1462.8, 1203.8, 1151.2, 1024.2, 1003.2, 826.7, 726.3, 721.7, 510.5.  
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[α]20D = +169.74 (c = 1.95, CHCl3).  
HPLC analysis: ee (Z)-isomer = 98%. AD-H (99% hexanes: 1% isopropanol, 0.8 mL/min): (Z)-
isomer:  tmajor = 11.89 min, tminor = 10.80 min.  
 
1,3-difluoro-2-((1S,2S)-2-(4-(trifluoromethyl)phenyl)cyclopropyl)benzene:  
95:5 dr. Major diastereoisomer: 70% y. Rf = 0.92 (solvent : hexane).  
1
H NMR (400 MHz, CDCl
3
) δ 7.56 (d, J = 8.1 Hz, 2H), 7.30 (d, J = 8.1 Hz, 2H), 7.14 (s, 1H), 
6.85 (t, J = 8.1 Hz, 2H), 2.52 (dt, J = 8.8, 5.5 Hz, 1H), 2.14 (dt, J = 9.3, 5.9 Hz, 1H), 1.73 (dt, J = 
8.6, 5.9 Hz, 1H), 1.53 – 1.41 (m, 1H).  
19
F NMR (376 MHz, CDCl
3
) δ -62.81 (s, 3 F), -115.35 – -115.47 (m, 2 F). 
13
C NMR (100 MHz, CDCl
3
) δ 162.13 (dd, J = 246.0, 8.2 Hz), 146.41 (s), 128.21 (q, J = 32.0 
Hz ), 127.46 (t, J = 10.0 Hz), 126.33 (s), 125.32 (d, J = 3.0 Hz), 127.70 –120.29 (m), 117.03 (t, J 
= 16.6 Hz), 111.78 – 110.93 (m), 23.94 (s), 17.77 (s), 15.98 (s).  
HRMS (EI) ([M]+.) Calc’d. for C16H11F5: 298.0775 ; Found 298.0770.  
IR: 2926.4, 1620.1, 1583.5, 1466.3, 1323.4, 1268.2, 1163.5, 1013.3, 830.6, 777.5, 542.0.  
[α]
20
D 
= + 141.92 (c = 0.73, CHCl
3
).  
HPLC analysis: ee (Z)-isomer = 98%. AD-H (100% hexanes: 0% isopropanol, 0.8 mL/min): (Z)-
isomer:  t
major 
= 13.90 min, t
minor
 = 8.13 min. 
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1,3,5-trifluoro-2-((1S,2S)-2-phenylcyclopropyl)benzene: compounds exist as 93:7 
diastereoisomers in 81% total yield. Rf = 0.94 (solvent : hexane). 
1
H NMR (400 MHz, CDCl3) δ 7.41 – 7.28 (m, 2H), 7.21 (t, J = 5.3 Hz, 3H), 6.63 (dd, J = 10.6, 
6.4 Hz, 2H), 2.41 (dt, J = 8.8, 5.5 Hz, 1H), 2.03 (dt, J = 8.8, 5.5 Hz, 1H), 1.59 – 1.54 (m, 1H), 
1.43 (dt, J = 8.8, 5.5 Hz, 1H).   
19
F NMR (376 MHz, CDCl3) δ -111.66 – -112.06 (m). 
13
C NMR (125 MHz, CDCl3) δ 162.14 (ddd, J = 250.0, 14.2, 11.7 Hz), 160.73 (dt, J = 246.3, 
16.0 Hz),  141.85 (s), 128.41 (s), 126.11 (d, J = 17.8 Hz), 114.23 – 113.54 (m), 100.54 – 99.65 
(m), 23.90 (s), 16.42 (s), 15.30 (s).  
HRMS (EI) ([M]+.) Calc’d. for C15H11F3: 248.0007 ; Found 248.0002.  
IR: 3029.7, 2925.3, 1634.9, 1597.8, 1496.3, 1437.5, 1116.1, 1034.7, 999.0, 838.6, 756.7, 695.0, 
612.4, 531.8.  
[α]20D = + 215.96 (c = 0.89, CHCl3).  
HPLC analysis: ee (Z)-isomer = 94%. AD-H (100% hexanes: 0% isopropanol, 0.8 mL/min): (Z)-
isomer:  tmajor = 10.40 min, tminor = 7.40 min.   
 
 
2-((1S,2S)-2-(2,4,6-trifluorophenyl)cyclopropyl)pyridine: 
87:13 dr. Major diastereoisomer: 77% y. Rf = 0.62 (hexane: ethyl acetate = 5:1 ).  
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1
H NMR (400 MHz, CDCl3) δ 8.51 (d, J = 4.2 Hz, 1H), 7.59 (td, J = 7.7, 1.7 Hz, 1H), 7.28 (s, 
1H), 7.10 (dd, J = 6.7, 5.1 Hz, 1H), 6.63 (t, J = 8.5 Hz, 2H), 2.63 – 2.49 (m, 1H), 2.50 – 2.35 (m, 
1H), 1.87 – 1.71 (m, 2H), 1.64 – 1.59 (m, 1H).  
19
F NMR (376 MHz, CDCl3) δ -111.89 – -112.16 (m, 2F). 
13
C NMR (125 MHz, CDCl3) δ 162.11 (ddd, J = 247.5, 14.6, 11.1 Hz), 160.67 (dt, J = 246.3,  
16.3 Hz), 160.61 (s), 149.43 (s), 135.91 (s), 122.18 (s), 120.86 (s), 113.67 (td, J = 17.3, 4.8 Hz), 
100.52 – 99.63 (m), 25.19 (s), 16.95 (s), 16.28 (s). 
HRMS (EI) ([M]+.) Calc’d. for C15H12F2: 249.0765 ; Found 249.076.  
IR: 3013.1, 1635.6, 1592.7, 1474.6, 1498.8, 1437.7, 1168.7, 1116.3, 838.6, 788.7, 772.7, 612.5, 
513.6, 487.2.   
[α]20D = +282.30 (c = 1.22, CHCl3).  
HPLC analysis: ee (Z)-isomer = 98%. OD-H (97% hexanes: 3% isopropanol, 0.8 mL/min): (Z)-
isomer:  tmajor = 6.23 min, tminor = 5.88 min. 
4.4 Conclusions 
In conclusion, a practical and expedient cyclopropanation reaction has been developed 
via Co(II)-based MRC. This protocol can be conducted with diverse fluoroaryl diazomethanes 
and a wide range of olefins with various electronic properties and functionalities. This strategy 
allows for the synthesis of a collection of valuable fluoroaryl cyclopropanes.  
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Chapter 5. Spectral Data 
 
5.1. Spectral Data for Chapter 2 
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